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CHAPTER 1. INTRODUCTION 
1.1 Protein kinases 
Intracellular phosphorylation catalyzed by protein kinases leads to the integration 
of information from the extracellular environment to the cell nucleus. Phosphorylation 
affects every basic cellular process including metabolism, growth and differentiation. 
Protein kinases catalyze the transfer of the !-phosphate from adenosine triphosphate 
(ATP) to the amino acid residues serine (Ser), threonine (Thr) and tyrosine (Tyr) in 
eukaryotes. Kinases account for ~2% of the human genome and include at least 500 
genes, which makes them one of the largest families of genes in eukaryotes. (1) Protein 
kinases can be classified into two subfamilies based on their ability to phosphorylate Tyr 
or Ser and Thr residues. These classifications can be further divided into receptor or 
nonreceptor based on localization of the kinases. It has been estimated that 30% of all 
proteins are phosphorylated on at least one residue and 100,000 phosphorylation sites 
have been identified in the proteome to date. The number of sites phosphorylated by each 
kinase varies greatly and this variation can be accounted for by the mechanisms 
responsible for kinase substrate recognition. 
1.2 Kinase substrate recognition 
Deciphering the kinases that are responsible for phosphorylation of the various sites in 
the proteome is a difficult task. Protein kinases contain structurally similar catalytic
2 
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 domains comprised of an N-terminal lobe composed of !-sheets and a C-terminal lobe 
containing "-helices. Between the two lobes is a catalytic cleft which is responsible for 
binding ATP and the substrate sequence as well as catalyzing phosphotransfer from ATP 
to the hydroxyl group of the phosphorylatable residue. (2-4) While all kinases share these 
similar structural folds, they differ in their recognition of the phosphorylation site 
residues and surrounding sequence. The depth of the catalytic cleft promotes 
discrimination between Ser/Thr and Tyr residues for their respective kinases. Tyr kinases 
have a deeper cleft compared to Ser/Thr kinases to accommodate the longer and larger 
side chain of tyrosine. The ability of the catalytic cleft to identify the phosphorylatable 
residue makes a significant contribution to substrate recognition through its affect on the 
binding energy of the substrate to the kinase through this residue. This has been observed 
from the large difference in binding energy between substrate peptides and 
pseudosubstrates, in which the phosphorylatable residue is replaced with an 
unphosphorylatable structural mimic (i.e. substitution of tyrosine to phenylalanine, or 
serine to alanine). The PKA substrate Kemptide (LRRASLG) has a Km = 16 µM, which 
is a surrogate for binding affinity, Kd; whereas the pseudosubstrate LRRAALG has a Ki = 
490 µM, which is the dissociation constant of the inhibitor (pseudosubstrate)-PKA 
complex, a 30-fold decrease in affinity for the peptide. (5, 6) Likewise the Src substrate 
YIYGSFK has a Km = 55 µM, while the tyrosine to phenylalanine substituted 
pseudosubstrate YIFGSFK displays significantly weaker interaction (by an order of 
magnitude) with a Ki = 575 µM. (7, 8) These results demonstrate that the 
phosphorylatable residue (or phosphorylation site) contributes a substantial amount of 
3 
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binding energy to the kinase-substrate interaction, facilitating substrate recognition and 
differentiation between Ser/Thr and Tyr kinases. 
Kinase catalytic domains also differ based on the hydrophobicity and charge of 
surface residues surrounding the catalytic cleft. These residues interact with the amino 
acids in the immediate vicinity of the phosphorylation site through electrostatic 
interactions, hydrogen bonding, and van der Waal’s interactions contributing 
significantly to the kinase-substrate recognition. The effects of these interactions on 
kinase substrate recognition have been demonstrated by examining the effect of varying 
substrate sequence lengths on kinase recognition. A peptide library containing a range of 
sequences from dipeptides to hexapeptides was used to examine the effects of varying the 
number of flanking residues as well as the charge and hydrophobicity using glutamic acid 
and alanine. The Km values of the majority of these peptides were rather large (1-16 mM) 
demonstrating a weak interaction between the substrate and the kinase. However, the 
sequences containing five acidic flanking residues on either side of the phosphorylation 
site (EEEEEY or YEEEEE) exhibited significantly reduced Km = 130 µM. (9) These 
observations suggest that a sufficient amount of interaction through an appropriate 
number of contacts is required between the kinase and substrate to promote 
phosphorylation of the sequence.  
Additionally, the results described above suggest that the chemical properties of 
the substrate cooperate with the residues in the kinase surrounding the catalytic cleft to 
affect substrate recognition. The effects of the residues residing in the catalytic cleft on 
substrate recognition have been demonstrated using a structural homology model of the 
catalytic domains of Abl and Src, based on the crystal structure of insulin receptor 
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tyrosine kinase (IRK) bound to a peptide substrate. (10, 11) Substitutions of residues in 
the kinase and the substrate were made based on IRK substrate interaction, and peptide 
substrates and mutant kinases tested resulted in distinct changes in substrate kinetics. For 
Abl, the optimal substrate sequences contain the motif Ile-Tyr-Ala-X-Pro; substitutions 
of the substrate sequence at the critical positions -1, +1 and +3 resulted in significant 
changes in the Km and Vmax of the substrates. However, substitutions made to the 
catalytic domain residues did not change substrate residue preference and resulted in only 
modest changes in the Km values for the substrate. Significant changes were observed in 
the catalytic efficiency (Vmax/Km) of the mutant kinases due to elevated Vmax values. 
These changes could arise due to several factors, including the possibility of substituted 
residues not being directly involved in the interaction with the substrate. Recognition 
could involve multiple residues and it may be that a single substitution is not sufficient to 
alter the interaction. Another possibility is that the conformation of the catalytic domain 
is altered due to the substitution. Without a crystal structure of the kinase-substrate 
complex, it is difficult to fully assess and define the kinase domain residues involved in 
recognition of a substrate. Nevertheless, these models demonstrate the importance of 
kinase-substrate recognition determinants in both the catalytic domain and the substrate 
itself for maintaining kinase substrate specificity.  
Another example of the contribution of the substrate sequence to kinase specifity 
was shown by substrate substitution effects on the autophosphorylation site in the A-loop 
of anaplastic lymphoma kinase (ALK). (12) Isoleucine at the -1 position was found to be 
an important determinant for ALK substrate recognition, as a substitution at this position 
resulted in a 10-fold decrease in phosphorylation compared to the wild-type sequence. 
5 
!
More importantly, the basic residues at the +6 and +7 positions resulting in 33-fold and 
5-fold decrease in substrate phosphorylation, respectively. Substitutions at the -3, -2 and 
+1 did not have the same marked effect, resulting in just 2-fold decreases in 
phosphorylation. These distal interactions were demonstrated to facilitate substrate 
release rather than promoting other behaviors that could reduce phosphorylation, such as 
substrate inhibition. The substrate specificity of ALK found in this study exhibited that 
substrate specificity through kinase-substrate interactions can also occur with portions of 
the kinase outside of the catalytic cleft and substrate residues distal to the 
phosphorylation site.  
Distal kinase-substrate interactions are able to increase the affinity of the substrate 
for the kinase, thus increasing the specificity of the substrate for the kinase. One of the 
most well studied examples is the control of mitogen activated pathway kinase (MAPK) 
substrate specificity through binding to the D and DEF domains (Figure 1-1). The D-
domain with the consensus sequence (Arg/Lys)2-3-(X)1-6-!-X-! is 50-100 residues away 
from the phosphorylation site, and increases the affinity of the substrate by binding to a 
complementary docking site on the opposite side of the kinase relative to the catalytic 
site. This docking site is composed of a highly acidic patch and a hydrophobic pocket that 
are complementary to the consensus sequence. (13) Many MAPK substrates also contain 
the DEF domain, which is characterized by the consensus sequence Phe-X-Phe-Pro. This 
sequence facilitates binding to a region adjacent to the catalytic cleft. (14) The 
application of these motifs individually and together has been shown to significantly 
enhance the specificity of peptide substrates not just for MAP kinases but also between 
6 
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family members Erk, p38 and JNK by facilitating lower KM values, higher Vmax values 














Figure 1-1 Representative schematic of MAPK substrate recognition through distal 
catalytic domain interactions.  The kinase recognition sequence within the substrate 
interacts with the MAPK through the catalytic cleft.  
 
The contribution of distal interactions between substrates and kinases has also 
been shown to extend beyond the kinase domain to noncatalytic domains of the kinase. 
For Src-family kinases (SFKs) the SH2 and SH3 domains facilitate important protein-
protein interactions and have been demonstrated to assist in kinase recognition of 
substrates. This concept was demonstrated in vitro by examining the effect of adding SH3 
or SH2 domain ligands to an Hck peptide substrate. (17, 18) The addition of the protein-
protein interaction domain ligands resulted in significantly lower Km values (10-fold) and 
increased the efficiency of phosphorylation of the substrate. This organization of kinase 
specificity through noncatalytic domains has been observed in vivo as a mechanism to 
allowed highly related kinases have distinct functional roles. The mitogen activated 
pathway kinase kinases (MAPKKs) share closely related kinase domains, yet have very 
distinct functions in yeast. (19) By introducing the required interaction motif of the 
MAPKK Ste7 into other MAPKK family members, these other MAPKKs could be made 
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to perform the same functions (Figure 1-2). These results demonstrate the importance of 



















Figure 1-2 Protein-protein interactions determine yeast MAPKK function. A) MAPK 
signaling cascade in yeast is facilitated through protein-protein interaction resulting in 
Fus3 phosphorylation by Ste7 B) Localization of other MAPKKs to the scaffold protein 
is not sufficient to recapitulate Ste7 function C) The Ste7-Fus3 interaction motif is 
necessary and sufficient for Mkk2 and Pbs2 to recapitulate the same function of Ste7.   
 
The recombination of noncatalytic domains to alter kinase specificity and function 
is not limited to the same family or even closely related families of kinases. The 
exchange of SFK Hck’s SH2 domain with acidic motif recognition PDZ domain, not 
found in tyrosine kinases, results in redirecting the kinase specificity, observed by 
alterations in proteome wide phosphotyrosine. (20) This manipulation of the Hck 
modular structure resulted in rewiring of the Cas migratory pathway. Without the SH2 
domain Hck could no longer interact with or phosphorylate Cas. Only when a PDZ 
domain ligand was engineered into Cas were the Hck interaction and phosphorylation of 
Cas reconstituted. This serves as a key demonstration that the noncatalytic domain 
interaction can redefine substrate specificity and rewire signaling pathways. 
The rewiring of signaling networks through noncatalytic domain interaction has 
extended beyond substitution of protein-protein interaction domains to the use of scaffold 
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proteins. In one example, an artificial synthetic adaptor protein was used to facilitate a 
novel protein-protein interaction between the SH3 domain of SFK Hck and the !–helix 
of the hDM2 protein, resulting in phosphorylation of hDM2. (21) This further 
demonstrates the importance of protein-protein interaction in kinase substrate 
recognition. Together with the results described above for SH2 and SH3 domains, these 
results show that protein-protein interactions can play a dominant role in defining kinase 
substrate specificity, and new kinase functions can arise from recombining catalytic 
domains with interaction domains or facilitating novel interactions. 
To summarize, kinase substrate specificity is determined by a number of factors, 
including the structure of the catalytic domain, the residues of the substrate sequence, 
distal interaction of the substrate sequence within the kinase domain, and noncatalytic 
domain interactions with other proteins. The ability to define the specificity of the 
catalytic domains as well as noncatalytic domains would provide insight as to how each 
kinase recognizes substrate proteins and the substrate sequence within the protein. These 
insights could then be applied to decipherthe vast number of phosphorylation sites 
identified to date and in the future. 
1.3 Methods for determining kinase substrate sequence specificity 
The determination of the favorable residues in the substrate for each kinase at 
each position has proven to be a daunting task, as the sizes of combinatorial peptide 
libraries considering the key residues in the immediate vicinity of the phosphorylation 
site (-4 to +4 positions) comprise more than 2.5 billion sequences. Several approaches 
have been developed to use peptide libraries to empirically determine the substrate 
sequence features responsible for kinase specificity. These libraries can broadly be 
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categorized as encoded libraries, such as phage displays, or synthetic libraries, including 
oriented peptide libraries and one-bead-one-peptide libraries. Both of these categories of 
methods are based on generating large sequence libraries for kinase substrates, subjecting 
them to kinase reactions, selecting and identifying the phosphorylated library members, 
and then determining the features responsible for kinase recognition based on the patterns 
within sequences observed to be phosphorylated. 
1.3.1   Genetically encoded peptide libraries  
 Nature is able to generate vastly diverse collections of functional biomolecules, 
including peptides, proteins and antibodies, by subjecting libraries of nucleic acids 
(genomes) to cycles of translation, selection, amplification and diversification. 
Genetically encoded peptide libraries mimic this biological process in vitro by exploiting 
the link between the properties of the library such as binding affinity or substrate 
specificity (the phenotype) and the genetic information encoded (the genotype). 
Translation of the encoded genetic constructs under appropriate conditions produces a 
library of peptides fused to a protein, RNA, or DNA. The library can be subjected to in 
vitro selection for desired properties, such as binding affinity or substrate specificity. The 
library members that contain the desired properties are enriched, the genetic information 
is amplified using PCR, and hits are identified using (for example) high-throughput 
sequencing (Figure 1-3). The use of genetic material to encode the library offers several 
key advantages for screening. The information content of DNA is sufficiently high that a 
21-mer nucleotide could encode 1.28 x 109 sequences. Also the ability to amplify sub-
femtomole quantities of DNA by PCR provides extremely sensitive and specific 
quantitative detection. As opposed to other screening methods such as small molecule 
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inhibitor screening libraries where each library member is examined individually, an 
entire encoded library can be screened simultaneously in a single experiment. This 
concept has been applied to examine protein-ligand interactions, antibody epitope 
binding, and protease substrate specificity. (22-24) In the next section, the application of 
genetically encoded libraries of peptide sequences and selection for the determination of 









Figure 1-3 In vitro screening and selection of genetically encoded peptide libraries 
 
1.3.1.1 Phage display libraries 
Phage display libraries are constructed by using bacteriophages to translate the 
encoded peptide library as peptide sequences fused to minor or major coat proteins to be 
displayed on the outer coat of a filamentous phage with the encapsulated DNA within. 
The peptides can be fused to the most abundant coat protein pVIII, which allows for 
multiple copies to be displayed; however, instability of the phage coat is a concern with 
this approach. The use of the single copy pIII coat protein located at the tip of the phage 
11 
!
has been shown to more amenable, since it does not cause as much instability in the 
phage coat. Once the library is expressed it can be incubated with a purified kinase. 
Selection of substrate peptides can be achieved using affinity enrichment by 
immunoprecipitation or metal affinity. Identification of substrate peptides can also be 
performed using radioactive labeling with 
32
P-ATP during the kinase assay. Following 
selection, phages can be genetically sequenced to identify their displayed peptide 
substrate sequence. (25)  
The use of phage display suffers from some limitations as a result of the library 
expression and display. Phage display libraries require an in vivo step to facilitate 
expression; the DNA library must be transformed into the bacteria resulting in limitation 




 sequences. Additional concerns arise from the need for the 
in vivo step with the use of phage display, including poor expression in the host, failure to 
process peptide-protein fusion to the phage surface, toxicity of the gene product, and 
maintenance of phage coat integrity. Together these issues make it difficult to ensure the 
entire sequence library is expressed. Nevertheless, this approach has been productive; for 
example, phage display was applied for the identification of substrate motifs for tyrosine 
kinases Syk, Src, Lyn and Blk. The following concensus motifs were identified for the 
kinases: Src, EXLYWXFX; Blk, XXIYDXLP; Lyn, DXIYEXLP; Syk, XXDYEXXX. 
(26) 
1.3.1.2 mRNA fusion peptide libraries 
mRNA display is an alternative cell free technique that eliminates the limitations 
associated with the in vivo step of phage display libraries. In mRNA display, the encoded 
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peptide library is fused directly to the mRNA by the formation of a covalent linkage 
between the mRNA template and the expressed peptide through 3’-puromycin. 
Puromycin mimics an amino-acyl tRNA, resulting in covalent binding to the nascent 
peptide following the peptidyl transferase activity of the ribosome. The coupling 
efficiency through is puromycin is low (10-40%), reducing the number of expressed 
sequence that can be identified. Despite this low efficiency the sequence complexity 
achieved is greater than phage display by 10,000 fold. (27) 
A mRNA-peptide fusion library designed to display a tyrosine residue surrounded 
by five random amino acids was applied to interrogate v-Abl tyrosine kinase specificity. 
Following exposure to v-Abl, phosphorylated peptides were isolated through rounds of 
immunoprecipitation with the phosphotyrosine-specific antibody 4G10. Amplification of 
the mRNA by PCR allowed for DNA microarray identification of sequences. (28) v-Abl 
was found to select substrates with the motif I/L/V-Y-X3-4–P/F which was in agreement 
with the results obtained by several other methods.  Despite the success of this approach, 
the application of mRNA display is limited due to the instability of mRNA. This 
constrains the types of assays and selection conditions available to probe the library. The 
stability of the mRNA template can be improved by reverse transcription to form a 
RNA/DNA hybrid; however, this only provides a modest improvement. 
1.3.1.3 cDNA display libraries 
Using DNA fused to the peptide rather than mRNA provides greater stability for 
the library, allowing for the use of a variety of selection conditions in which RNA would 
otherwise degrade. The increased stability also allows for selection assays that require 
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longer experimental times, such as off-rate selections for affinity reagents such as 
antibodies and aptamers, as well as enzyme inhibitors. Also, the use of DNA allows for 
directed evolution of the selected sequences from the library due to the compatibility with 
PCR-based mutagenesis, which can’t be performed with mRNA display libraries. The 
construction of a cDNA display library is accomplished by first expressing the library as 
mRNA-peptide fusions as described above using a covalent puromycin linkage. Next, a 
DNA primer is crosslinked to the RNA by psoralen and the RNA is reverse transcribed to 
produce a single stranded DNA (ssDNA)/single strand RNA (ssRNA) hybrid. The RNA 
is removed from the ssDNA/ssRNA by RNase treatment and the single stranded cDNA-
peptide fusion is transcribed to form a double stranded DNA (dsDNA)-peptide fusion. 
The dsDNA has been shown to be stable in cell lysates for over two hours making them 
ideal for cell-based selections, which provide more biologically-relevant systems than 
purified kinases. (29) 
The substrate specificity of Abl was assessed using cDNA fusion by encoding a 
combinatorial mutation library of the previously identified optimal Abl substrate, Abltide, 
EGEAIYAAPFA. (30) This approach allowed for the entire sequence space to be 
examined through all iterations of this sequence to access single substitutions 
quantitatively. It was ultimately determined that Abltide was the optimal substrate for 
Abl, but a more detailed analysis of Abl specificity was also performed. This analysis 
revealed that Abl substrate sequence preference also included the motif E-A/L/P/G-I-Y-
A/W/S/E/Q-X-P, where X is any amino acid.    
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1.3.1.4 DNA/PNA programmed synthetic libraries 
The translation of the biosynthetic approaches of encoded peptide libraries to 
organic synthesis of peptide using DNA has many advantages over traditional peptide 
chemistry. The use of DNA encoded peptide libraries is an attractive synthetic approach 
for the development of a combinatorial library because the DNA not only facilitates 
construction of the library but also tags the sequence. Several distinct synthetic 
approaches have been developed to produce peptide libraries including DNA-templated, 
DNA-routed and YocotReactor syntheses. (31-33) In each of these methods, each unique 
DNA/PNA triplet contained in the genetic tag encodes a specific amino acid monomer. 
The synthesized libraries can be subjected to in vitro selection to identify individual 
compounds possessing the desired property through amplification and sequencing of the 
DNA template.  
This approach was used to examine the substrate specificity of Abl, VEGFR2, and 
ErbB2/Her2 with a PNA encoded library containing 10,000 fluorescently labeled 









Ile- Lys. (34) The library was exposed to the kinases and then hybridized to a DNA 
microarray. The array was probed for phosphorylation using the antiphosphotyrosine 
antibody 4G10 followed by a Cy3 conjugated secondary antibody (Figure 1-4). The 
substrate specificity profiles determined for Abl, VEGFR2 and ErbB2/Her2 were F-E-
S/E-E-Y-E/S, K-E/K/S-Y-E/K/S-D-Pro and K/E/S-S/K/D-Ala-Y-D-Pro/S/D-Val-D-Pro/S 
respectively. 
This approach provides several advantages for determination of kinase substrate 
specificity. This assay allows for radioactive isotope-free detection and rapid 
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identification of individual sequences with high sensitivity and accurate profiling, and 
also gives relative quantification of phosphorylation. Relative quantification is 
accomplished through normalization of the fluorescent phosphorylation signal to the 
fluorescent peptide signal, allowing for variation in hybridization and synthesis yields to 
be taken into account. The use of the DNA array permits rapid identification of the 
peptide sequences due to the hybridization to specific locations on the microarray. PNA 
encoded libraries also provide the additional advantage of allowing for the incorporation 













Figure 1-4 Workflow of PNA-encoded peptide library for the determination of Abl kinase 
substrate specificity. The PNA library is translated through peptide synthesis. The library 
is then exposed to Abl kinase in an in vitro kinase assay. The library is hybridized to a 
DNA microarray and probed for phosphorylation. 
 
1.3.2 Synthetic peptide libraries 
 Synthetic peptide libraries provide the most robust way to have absolute control 
over the sequence space available in the kinase screen. However, challenges arise due to 
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the time and cost required to synthesize large peptide libraries that are capable of 
exhaustively examining the entire sequence space. Also, without the genetically encoded 
tag present for identification, determining the individual sequences is a technical 
challenge. Several approaches have successfully used synthetic peptide libraries and 
sufficiently addressed the technical challenges of sequence identification to determine 
kinase substrate specificity. 
1.3.2.1 Oriented Peptide libraries 
Oriented peptide libraries are typically designed to cover the entire combinatorial 
sequence space (more than 2.5 billion sequences) The library of peptides is synthesized 
exhausting all possible combinations of amino acids, in which each residue is screened at 
each position. The entire library is exposed to the kinase of interest and the 
phosphorylated peptides are enriched using antibody-based or metal affinity 
chromatography. Due to the large number of sequences selected as substrates (~1%, 25 
million sequences) it is usually impossible to identify each sequence individually; 
however, since each sequence is the same length, Edman sequencing can determine the 
abundance of each amino acid at each position in selected pools of sequences. This 
approach allows for universal determination of kinase substrate specificity and has been 
applied to 13 Tyr kinases and 18 Ser/Thr kinases. (35, 36) However, due to the selection 
of only phosphorylated sequences and the population-based determination of specificity, 
any potential information concerning interpositional dependence (in which certain amino 
acids at a given position influence the interactions of those at other positions) and/or non-
permissive residues (residues that actively decrease phosphorylation as opposed to either 
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promoting or being neutral for phosphorylation) is lost. Additionally, these libraries are 
unable to determine substrate interactions outside of the -5 and +4 (which may influence 
specificity) without resulting in an exponential increase in the library size. Finally, the 
time and cost to synthesize this type of library and determine amino acid abundance can 
make this approach somewhat cumbersome for determination of kinase substrate 
specificity.  
1.3.2.2 Positional scanning peptide libraries 
 To improve on the limitations of oriented peptide libraries, the synthetic library 
approach was modified by partitioning the entire sequence space into 198 sublibraries. 
Each library contains a fixed amino acid at one position and random residues at all other 
positions. Each sublibrary is exposed individually to the kinase in solution with 32P-
labeled ATP, and then captured on streptavidin-coated nitrocellulose paper by a C-
terminal biotin tag. The level of phosphorylation is typically assessed based on 
incorporation of radioactive phosphate. Rather than simply determining the abundance of 
each amino acid at each position represented overall, this method enables the effect of an 
individual amino acid at each position to be empirically determined. This approach also 
increases the throughput by eliminating Edman’s sequencing. This method has been 
successfully applied to determine the substrate specificity of 61 yeast kinases as well as at 
least 179 human kinases. (37-39). Like OPL, since only one amino acid is fixed and 
known at a given position, PSPL do not provide information about the individual 
sequences that were phosphorylated; therefore, any potential contextual information, 
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including the possibility of nonpremissive residues, cooperativity, and/or interdependent 
positions, is lost. 
1.3.2.3 One-bead-one-peptide (OBOP) libraries 
 Solid supported synthetic combinatorial peptide libraries have also been applied 
for the determination of kinase substrate specificity. These peptide libraries are 
synthesized using solid-phase split-and-pool peptide synthesis such that in principle, only 
a single peptide sequence is conjugated to each individual bead of the solid support. The 
on-bead library of peptides is then exposed to the kinase of interest and substrate 
sequences can be detected by a variety of methods including radioactive labeling with 
32P-labeled ATP followed by autoradiography. The identities of the phosphopeptides then 
must be determined by Edman sequencing. (7) The universal application of this method 
has been limited due to the requirement for Edman sequencing for determination of 
substrates.  
 An alternative approach to allow for higher throughput identification of individual 
peptide sequences is to apply mass spectrometry (MS) analysis following selection of the 
phosphorylated peptides. To facilitate MS sequence identification the OBOP library is 
synthesized to contain a sequence ladder by terminating the peptide during each amino 
acid coupling using competitive acetylation. (Figure 1-5A) (40) The ladder provides a 
mass fingerprint in the MS spectra facilitating analyses of matrix-assisted laser 
desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) data and 
increasing the throughput of the sequence identification compared to Edman sequencing. 
(Figure 1-5B) Following selection of phosphorylated sequences using alkaline 
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phosphatase-conjugated antiphosphotyrosine antibody, the mass ladder can be liberated 
from the solid support via a UV-cleavable linker and analyzed by MALDI-TOF MS. This 

















Figure 1-5 Synthesis of one-bead-one peptide ladder library. The library is synthesized 
with a photolabile linker (PLL) and spacer group (BEBE). The peptide sequence is 
synthesized with the Fmoc-amino acid and 10% (mol/mol) acetic acid resulting in 
acetylation and termination of the peptide sequence. This process is repeated until the 
peptide sequence is completed. B) Experimental workflow using one-bead-one-peptide 
ladder library for determination of kinase substrate specificity. The library is exposed to 
the kinase of interest and phosphorylated sequences are identified based on alkaline 
phosphate fluorescent. The positive beads are isolated and the peptide ladder is liberated 
from the bead by UV irradiation. The substrate sequence is then determined by MALDI-
TOF analysis of the peptide ladder.  
 
This method can be adapted for the identification of Ser/Thr kinase substrate 
specificity using chemical modifications of the phosphorylated Ser/Thr resiudes. Specific 
detection of Ser/Thr kinase substrates leverages the availability of !-protons and the 
presence of a good leaving group, phosphate. Under alkaline conditions phosphoserine 
and threonine undergo !-elimination resulting in the formation of dehydroalanine and !-
methyldehydroalanine. (41) These residues provide an ", !-unsaturated system that can 
be chemically modified by the addition of a nucleophile-linked probe, such as an organic 
dye or affinity tag such as biotin, via a Michael addition. However, a notable limitation of 
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this approach is the !-elimination reaction can give rise to false positive selection of 
sequences, which could alter the interpretations of the specificity profile. 
Recently, an alternative approach for the determination of kinase specificity that 
overcomes the limitations of the OBOP methods discussed has been developed using 
thiophosphorylation to label substrate sequences. The kinase reactions are performed in 
the presence of adenosine 5’-O-(3-thio)triphosphate, which resulted in the labeling the 
substrate sequences with a thiophosphate. (42) Phosphorylated peptides are selected 
using a pyridyldithio-containing fluorescent probe that results in a disulfide exchange 
covalently attaching the organic dye to the peptide. The identify of the positive sequences 
was determined by partial Edman degradation mass spectrometry (PED/MS), where the 
sequences are converted to a sequence ladder of progressively shorter fragment peptides 
by performing multiple cycles of partial Edman degradation similar to the acetylation 
terminated peptide ladder synthesis. The series of peptides can then be analyzed by 
MALDI-TOF MS to give the amino acid series for the sequence. This approach has 
successfully been applied to identify the substrate specificities of the Ser/Thr kinases 
Pim1 and MKK6 and the Tyr kinase Csk demonstrating the potential for universal 
application of the method to all types of kinases. 
While the OBOP library methods described here are successful, they each still 
suffer from some limitations. The synthesis of the library requires a complicated method 
to produce the sequence fragment ladder, which must be optimized. If the whole 
sequence is synthesized the method still relies on the costly and time-consuming Edman’s 
degradation. While promising, the use of thiophosphorylation significantly reduces 
catalytic efficiency of some kinases unless conditions such as metal cofactor are 
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optimized resulting in lower sensitivity, as well as altering the kinetics of the substrates. 
(43) 
1.3.3 Computational methods for the prediction of kinase specificity 
In the past, short sequence motifs have been used to attempt to describe the 
pattern of kinase substrate recognition. These motifs are generally insensitive and 
unspecific. For example, the motif [S/T]-[Q] has been used in the past to describe DNA 
protein kinase (DNA-PK) kinase substrate recognition. This motif is expected to occur 
often in the proteome and be recognized by many other Ser/Thr kinases including ataxia 
telangiectasia muatated (ATM) kinase. This means that without further elaboration, 
“traditional” substrate motifs to describe kinase substrate specificity offer little 
information. The identification of more complex and subtle patterns is required to 
accurately predict kinase substrate specificity with the necessary specificity and 
sensitivity. 
The use of computational approaches provide an alternative method to probe 
deeper into the information obtained from experimental biology to predict and identify 
kinase substrates. Prediction of kinase substrate specificity is a binary classification 
problem as each sequence included in a training set could be classified as phosphorylated 
(substrate) or non-phosphorylated (non-substrate). The establishment of a method for the 
prediction of kinase substrate specificity requires 1) having a well-collected and curated 
data set of positive and negative sequences 2) identification of features to characterize the 
sequences as one of the two classes and 3) the development of a classifier trained from 
the known sequences that is capable of making the prediction for new sequences. Over 
the past decade more than 40 methods have been developed to predict phosphorylation 
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sites. These methods differ in their approaches based on a number of attributes associated 
with them including the algorithm or machine learning technique used, the number of 
residues considered in a sequence, the incorporation of kinase sequence and/or structural 
information, focusing the prediction for individual kinases or families, and the training 
and testing data.   
1.3.3.1 Position-specific scoring matrices (PSSM) 
 Position-specific scoring matrices represent the simplest of the machine learning 
methods for kinase substrate prediction. PSSMs are matrices that represent each amino 
acid at every position within the sequence. Each element in the matrix can represent a 
variety of features describing each amino acid depending the construction of the matrix. 
The elements can represent the frequency of a given amino acid at a particular position. 
The values can also represent the weighted contribution of each amino acid to the overall 
ability to be a substrate. (44) In any case, PSSMs are ideal for expressing the value of a 
residue at a particular position for promoting or impeding phosphorylation by a particular 
kinase. However, more complex patterns in the substrate motif such as cooperativity or 
interdependence of positions are overlooked. Additional features could provide insight 














Figure 1-6 Representations of higher order machine-learning models A) Artificial neural 
networks and B) support vector machines.  
1.3.3.2 High order machine learning models 
Artificial neural networks (ANNs) are computational approaches that attempt to 
mimic the processing that occurs in the human brain. These methods aim at having highly 
parallel, distributive computation learning to achieve a generalized understanding of the 
classification. The algorithm accomplishes this task by receiving inputs from a number of 
features, weighing each input and adding them together. If the total sum of the inputs is 
above an arbitrary threshold, the output will classify that sequence as a substrate. Weights 
of the inputs and the definition of the threshold can be determined in an iterative manner 
by training the algorithm with examples of both classifications (positive and negative). 
(Figure 1-6A) The application of this method for prediction of kinase substrates can take 
into account many features of kinase substrate interactions including the peptide 
sequence and any structural elements associated with the potential substrate and/or the 
kinase for the prediction. One of the inherent problems with ANNs is that it is difficult to 
determine why the algorithm makes a particular decision while weighting the features for 
classification; this leaves the algorithm as a “black box”, which makes it difficult to 
examine and understand the learning and classification process. 
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 Another higher order model is Support Vector Machines (SVMs), which are 
kernel methods build on two concepts first to map the feature vectors in a nonlinear way 
to a high dimensional space, then utilize linear classifiers in the new space. This means 
that the algorithm manages the inputs and translates them into processed data that can be 
represented in a high dimensional space (for example, three features produces data 
represented in a 3-dimensional plot) and then separates the data sets into classes based on 
a linear function (plane). (Figure 1-6B) This method has been applied to kinase substrate 
specificity in the cell by using known information about the kinase recognition 
sequences, protein-protein interactions, and subcellular localization as input features to 
build the classification model.  
 One of the shortcomings of machine learning techniques for prediction of kinase 
substrates is that the model is only as good as the data used to develop the model. While 
some kinases are extremely well studied (Abl, Src and Erk had 710, 1,047 and 2,512 
articles published studying each of them, respectively, in 2012 alone), other kinases are 
poorly studied (Ack, GRK4 and PRP4 had 4, 11 and 1 articles published studying each of 
them, respectively, in 2012 and only 64, 116 and 27 articles, respectively, total in 
Pubmed). These results are also reflected in the number of phosphorylation sites 
identified for each kinase. Examining the Phosphosite Plus database 
(www.phosphosite.org), which consists of over 13,000 phosphorylation sites (many from 
proteomics datasets), 220 of the 518 kinases in the kinome do not have a single identified 
and verified substrate. (Figure 1-7) This limited or even complete lack of data makes it 
difficult, and in some cases impossible, to generate an accurate model of kinase substrate 
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Figure 1-7 Number of identified phosphorylation sites for each kinase annotated in the 
Phosphosite Plus data set.  
 
1.4 The role of protein kinases in disease 
As demonstrated above, kinase function is governed by substrate specificity 
through sequence recognition and protein-protein interactions. Other regulatory 
mechanisms, including regulation of the on/off state of the kinase by phosphatases 
(which remove phosphates), subcellular localization, and alterations in expression level 
or proteasomal targeting for degradation through ubiquitination, also contribute to the 
control of kinase activity. The synchronization of these processes is critical for 
maintaining normal cellular function, and deregulation of one these processes can 
drastically affect the dynamics of a kinase’s activity often leading to overactivation of the 
kinase. Given the importance phosphorylation plays in most cellular processes, it is not 
surprising that dysfunction in kinase activity results in numerous disease states including 
neurological diseases such as Alzheimers disease, metabolic disorders including type 2 
diabetes and cancer.  
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A recent review examining 915 kinase mutations that underlie 67 single-gene 
diseases identified that more than 80% of mutations identified in kinases directly affected 
the catalytic domain. (45) These mutations result in gain- and/or loss-of-function in the 
kinase. Gain-of function mutations increase the activity of the kinase through an 
additional function; whereas loss of function mutations that lead to increases in kinase 
activity occur through mutational loss of inhibitory regulatory elements. Specific kinases 
have been seen to be mutated in a variety of diseases states, such as Btk in X-linked 
agammaglobulinaemia, and Akt2 in type 2 diabetes and lipodystrophy, resulting in 
overactivation of kinase activity. (46, 47) Somatic mutations can also arise due to large 
chromosomal rearrangements such as translocations. The most well studied example of 
this occurs in chronic myeloid leukemia (CML), which is characteristically caused by the 
reciprocal translocation of chromosomes 9q and 22p forming the Philadelphia 
chromosome. This genetic aberration results in the fusion of the Breakpoint cluster region 
(BCR) gene and Abl tyrosine kinase gene (Abl) into the BCR/ABL gene. This gene 
product produces the oncogenic fusion protein Bcr-Abl, which possesses constitutive Abl 
tyrosine kinase activity. Constitutive activation is conferred through the loss of function 
of a normal Abl intramolecular inhibition mechanism due to the presence of Bcr on the 
N-terminus of Abl. Additionally, there is also a gain of function facilitated by the coil-
coiled domain of Bcr, which results in trans-autophosphorylation and activation of the 
Abl kinase domain. (48) 
Given the role protein kinases play in these diseases, and the direct link between 
the genotype of certain disease states and aberrant kinase activity, the development of 
therapeutic treatments targeting kinases has been a major focus of the pharmaceutical 
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industry over the past two decades. Despite this effort by the pharmaceutical industry, 
only 24 small molecule inhibitors have been FDA approved since the approval of the first 
kinase inhibitor imatinib in 2001. These inhibitors target only 18 different kinases (~5 % 
of the kinome) and are only approved for the treatment of various cancers for which 
constitutive kinase activity is involved. (49) One of the rate limiting factors in the 
discovery of new small molecule inhibitors is the lack of specific probes that provide 
sensitive detection of kinase activity. Therefore there is a need for tools that provide 
sensitive, selective and high throughput monitoring of kinase activity. 
1.5 Peptide biosensors for monitoring kinase activity 
The use of peptide substrates for detection of kinase activity is attractive for a 
number of reasons including the specificity and sensitivity of kinase substrate recognition 
and interactions (as reviewed above), the compatibility of peptides with multiple 
chemistries and multiple detection platforms ranging from traditional biochemistry 
techniques such as radioactivity and ELISA to emerging techniques such as surface 
enhanced Raman spectroscopy (SERS) and fluorescence lifetime imaging. (50, 51) The 
following is a review of the current methods used for monitoring kinase activity using 
peptide substrates. 
1.5.1 Traditional molecular biology techniques   
 The use of traditional molecular biology techniques such as Western blotting and 
radioactive labeling have been applied for the detection of kinase activity using peptide 
substrates. Radioactive detection using 32P-ATP has long been the traditional strategy for 
detecting peptide phosphorylation, but is unattractive for large scale implementation due 
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to the waste generated during detection and the specific considerations for disposal as 
well as the safety concerns. 
 Antibody-based detection has also been applied for monitoring the 
phosphorylation status of peptide substrates using traditional Western blotting. The 
development of new multiwell read-out platform technologies using fluorescence 
polarization, time-resolved lanthanide-based resonance energy transfer, and 
chemifluorescent solid-phase kinase assays has drastically increased the throughput for 
monitoring kinase activity in vitro. (52, 53) (Figure 1-8) However, detection in these 
formats requires phosphospecific antibodies or generic phosphoantibodies such as 4G10 
for phosphotyrosine. Such an antibody does not exist for phosphoserine or threonine; 
however, recently introduced small molecule and nanoparticle-based phosphate affinity 
reagents including Phos-tag and pIMAGO show promise in providing more universal 
phosphate probes. (54, 55) Regardless, the use of generic phosphate affinity reagents also 
reduces the number of phosphorylation events that can be monitored without 
confounding the results. This prevents the detection of more than one phosphorylation 
event (i.e. multiplex detection). Additionally, the number of handling, wash, and labeling 
steps required with some antibody–based methods reduces the throughput as well as 




















Figure 1-8 ELISA-based detection of peptide biosensor phosphorylation. Following 
exposure of the peptide biosensor to the cells, the cells are lysed and added to a 
Neutravidin™-coated 96-well plate. The substrate is captured from the lysate by the high 
affinity interaction of biotin and Neutravidin™. Phosphorylated substrates are labeled 
with the anti-phosphotyrosine antibody, 4G10. The primary antibody is labeled with a 
horseradish peroxidase-conjugated secondary antibody. Finally, Amplex Red™ is added 
to the well and oxidized to a fluorescent reporter in the presence of horseradish 
peroxidase. 
 
1.5.2 Mass Spectrometry detection 
 Post-translation modifications of proteins have long been studied using mass 
spectrometry due to the unique mass changes associated with each modification, which 
enables label-free detection. Peptide phosphorylation can be detected by the shift 80 Da 
mass shift, and the peptide sequence and phosphorylation site can also be identified 
simultaneously through its mass fragmentation spectra. The ability to determine 
individual sequences based on the fragmentation patterns provides robust identification of 
peptides and allows for multiplexed detection of thousands of peptides in a single assay. 
Mass spectrometry also provides high sensitivity of detection, which allows for small 
amounts of biological material (cell lysate or number of cells) to be used. Additionally, 
MS detection is compatible with online and offline enrichment strategies such as metal 
chromatography for phosphopeptides, which can further increase the sensitivity of 
detection. Finally, MS detection can also provide quantitative detection through a number 
of techniques including the incorporation of isotopically labeled standards. (56) All of 
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these features make mass spectrometry an attractive detection platform for monitoring 
kinase activity using peptide biosensors. 
A recently developed technique named “Kinase ActivitY Assay for Kinome 
profiling” (KAYAK) has enabled quantitative, simultaneous detection of phosphorylation 
rates for 90 different peptides from proteins representing selected signal transduction 
pathways from cell lysates in a single in vitro reaction. (57) Following quenching of the 
kinase reaction, a set of the identical stable isotope-labeled phosphopeptides are added to 
provide a quantitative internal standard. The phosphopeptides are enriched and detected 
using Orbitrap MS to allow for high sensitivity and mass resolution. This approach 
allows for phosphorylation signatures to be generated that can be associated with a 
particular cellular stimulus or inhibitor. A setback of this approach is that it has limited 
utility to study biology de novo. The peptides used to generate the signature via KAYAK 
are not specific enough to provide information about which kinases are active, and 
without a previously well-studied inhibitor or stimulus signature to compare against, it is 
difficult to discern the significance of the biology. Additionally, using cell lysate to 
perform the kinase reaction can result in drastic changes in the organization of signaling 
networks due to removal of the compartmentalization of the cell. This can result in 
alterations in the kinase activity, since changes in protein-protein interaction can occur. 
Therefore, measuring kinase activity in intact, live cells is desirable for achieving the 
most biologically relevant detection. 
Recent work in our lab has aimed at circumventing these issues by delivering 
kinase-specific peptide biosensors into live cells to directly monitor kinase activity. (58) 
The design of these sensors leverages two degrees of kinase specificity by using both an 
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artificial kinase specific substrate and a specific protein-protein interaction domain 
ligand. The application of artificial substrates with multiple reaction monitoring mass 
spectrometry (MRM-MS) has the advantage that the tryptic fragment is an unnatural 
sequence providing a unique mass fingerprint that is unconfounded by the background of 
tryptic peptides from native proteins in the cell lysate. MRM-MS allows for greater 
sensitivity for detection in the fmol-amol range depending on the specific analytes and 
instrumentation. MRM detection can achieve this sensitivity because it uses targeted 
mass analysis, in which the mass analyzer focuses on detection of specific parent and 
fragment masses (termed “transitions”) while filtering out all other ions. Monitoring two 
transitions for an Abl-specific substrate provided confident identification of the peptide 
and quantificative detection with limits of detection (LOD) and limits of quantification 
(LOQ) of 0.5 fmol from a whole cell lysate.  
1.5.3 Fluorescence detection techniques 
 Fluorescent techniques have become widespread in biological research. 
Fluorescent proteins, small molecule organic dyes, semiconductor nanoparticles and 
organometallic chelators have been developed and applied to monitor a wide array of 
cellular events including protein localization, protein-protein interactions and cation 
signaling. The application of these strategies has provided continuous real-time detection 
with high sensitivity and selectivity as well as high spatial and temporal resolution in the 
cell. The use of peptides for detection of kinase activity has been applied with a number 
of fluorescent techniques including lifetime measurements and anisotropy. The following 
is a review of peptide biosensor technologies using steady-state fluorescence and time-
resolved measurements for detection of kinase activity.      
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1.5.3.1 Genetically encoded FRET-based biosensors 
The discovery and development of fluorescent proteins including GFP and its 
engineered variants has led to the development of numerous cellular probes for 
monitoring virtually every cellular process. Perhaps the most widely used and extensively 
developed sensors for detection of cellular kinase activity are genetically encoded Förster 
resonance energy transfer (FRET) biosensors. These biosensors are designed to contain a 
FRET pair of two terminal fluorescent proteins with a kinase-dependent molecular switch 
that induces a conformation change upon phosphorylation. (59) The molecular switch is 
designed to contain a polypeptide substrate recognized by the kinase of interest and an 
appropriate phospho-recognition domain (i.e. SH2, 14-3-3, WD40 domains). Upon 
phosphorylation, the phospho-recognition domain binds the kinase substrate, altering the 
distance between the fluorescent proteins and resulting in detectable FRET signal (Figure 
1-9). These sensors allow for real-time continuous monitoring of cellular kinase activity 
with high spatial and temporal resolution at the single cell level. Recently FRET sensors 
were applied to monitor the temporal regulation of Erk kinase activity at the single cell 
level following steady-state EGF stimulation. The ability to continuously monitor Erk 
activity revealed that Erk is activated in discrete pulses and the duration of the pulse 
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Figure 1-9 Genetically encoded FRET-based biosensor. The biosensor is composed of a 
FRET pair of, for example, cyan fluorescent protein and yellow fluorescent protein, as 
well as a kinase substrate and a phosphopeptide binding domain. 
 
The development of genetically encoded FRET biosensor suffers from a severe 
bottleneck due to a number of factors. The identification of sensitive and specific kinase 
recognition sequences that are simultaneously compatible with phosphobinding domains 
is a laborious process that has not yet been optimized to provide high throughput 
development. The sensitivity and amplitude of response of these sensors varies based on 
FRET pair, phosphobinding domain and conformation change induced by the 
phosphobinding domain and kinase recognition sequence. This requires time and effort to 
develop iterations of the sensor to achieve optimal detection. Even with optimization, 
these sensors display small dynamic ranges due to modest changes in signal (10-60%) 
making them only moderately quantitative and not ideal for detection of kinase activity 
compared to other fluorescent methods.   
 
1.5.3.2 Nanoparticle-conjugates 
 Quantum dots (QDs) are nanometer-size luminescent semiconductors that possess 
many unique optical properties, making them excellent fluorescent probes. QDs have 
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high fluorescence quantum yield, robust photostability, broad absorption bands and 
narrow emission bands, which reduces spectral bleed through. These properties can be 
tuned by controlling the size, shape and composition of the QD. Also, the surface 
chemistry of QDs can be modified to allow for number of conjugation chemistries that 
are compatible with peptides. These conjugation chemistries include Michael-addition 
reactions, coupling through carbodiimide reactions, and succinimide ester activation. 
Additionally, traditional metal surface chemistries are also available for conjugation by 
self-assembly through chemisorption and electrostatic interactions. (61) These properties 
of QDs have been exploited for the detection of kinase activity through the use of QD-
peptide substrate conjugates.  
 QD-peptide substrate conjugates have been applied for sensitive detection of the 
activity of the Ser/Thr kinase casein kinase 2 (CK2) using !-adenosine triphosphate-Atto-
590, which fluorescently labels the peptide substrate upon phosphorylation. (62) FRET 
and electron transfer quenching processes between the QD and the Atto-590 labeled 
peptide were used to monitor CK2 activity. In this system the QD is the electron donor 
and Atto-590 fluorophore is the electron acceptor; therefore, phosphorylation of the 
peptide results in decreasing QD fluorescence and increasing Atto-590 fluorescence. 
(Figure 1-10A) Quantification of phosphorylation was determined by the percent 
decrease in the fluorescence of the QD. A similar strategy was used to monitor Abl and 
Src kinase activity using a CdSe/ZnS QD-peptide conjugate and an AlexaFluor 647 
conjugated anti-phosphotyrosine antibody for fluorescent labeling. (63) While these 
applications demonstrate the potential of QDs for kinase activity detection, the use of 
ATP-analogs and fluorophore labeled antibody increases the handling steps and prevents 
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these platforms from being applied for real-time detection or to in vivo models, which 
would require a label-free approach. 
 A label-free approach for the detection of kinase activity using QD-peptide 
conjugates exploits effect of surface charge on QD dispersion in solution.  QDs are 
monodisperse in solution due to electrostatic repulsion; however, neutralizing the surface 
charge abolishes the electrostatic effects resulting in aggregation of the semiconductors. 
(Figure 1-10B) A cationic substrate for PKA when unphosphorylated was capable of 
neutralizing the surface charge of the QD leading to aggregation and diminished red-
shifted fluorescence. (64) Phosphorylation of the substrate results in the addition of a 
negative charge to the peptide neutralizing the cationic charge and eliminating 
aggregation leading to an increase in blue-shift fluorescence emission. 
 
Figure 1-10 Quantum dot detection of kinase activity using A) phosphorylation-
dependent fluorescent labeling and FRET and B) surface charge aggregation. 
1.5.3.3 Environmentally-sensitive Fluorescence 
 Environmentally-sensitive fluorophores (ESFs) display differences in their 
spectroscopic properties depending on the physiochemical conditions of their 
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environment. These fluorophores include 7-nitrobenz-2-oxa-1,3-diazole (NBD), pyrene, 
and dapoxyl. ESFs are characterized by large excited-state dipole moments and low 
quantum yields in polar solvents such as water but become highly fluorescent with blue-
shifted emission in non-polar environments such as nonpolar solvents or hydrophobic 
binding pockets of proteins. The properties of these fluorophores have been exploited for 
the detection of kinase activity through the incorporation of ESFs into kinase peptide 
substrates positioned one to five residues from the phosphorylation site. Protein kinase-
catalyzed incorporation of phosphate into the sequence in the proximity of the ESF 
should, in principle, result in a change in the local polarity of the fluorophore resulting in 
enhanced fluorescence emission. (Figure 1-11A) This approach has been applied to the 
detection of PKC activity. (65) 
An alternative approach using ESFs combines kinase substrate recognition with 
phosphopeptide recognition domains such as phosphotyrosine-binding SH2 domains, 
phosphoserine/threonine-binding 14-3-3 and WD40 domains. Once the sequence is 
phosphorylated the phosphopeptide product is recognized by the binding domain 
introducing the ESF to the hydrophobic environment of the phosphorecognition domain-
binding pocket resulting in a change in polarity and fluorescence. (Figure 1-11B) This 
strategy has been applied for the detection of Src kinase activity using the Src SH2 
domain with dapoxyl; however, this robust result was not obtained with other ESFs. (66) 
The lack of universally robust detection with ESFs makes it difficult to design peptide-

















Figure 1-11 Environmentally-sensitive fluorescent peptide biosensors. A) 
Phosphorylation alters the local environment of the fluorophore leading to an increase in 
fluorescence. B) Phosphorylation of the peptide substrate results in SH2 domain binding 
and a change in the fluorophore environment leading to an increase in fluorescence. 
1.5.3.4 Chelation-enhanced Fluorescence 
Another approach for fluorescent detection of kinase activity using peptide 
substrates uses hard metal ions such as zinc, calcium, magnesium or lanthanide ions 
including terbium and europium to mediate fluorescence or luminescence detection. 
These sensors display low affinity for the metal ions in the unphosphorylated state and as 
a result have little to no fluorescence. Introduction of the hard phosphate di-anion 
increases the binding affinity of the sensors for the metal ions, causing enhanced 
fluorescent or luminescent signal corresponding to kinase activity. 
1.5.3.5 Biologically available metal chealation 
One strategy is the use of chelation-sensitive fluorophores containing heteroatoms 
that can coordinate biologically available divalent metal ions such as Zn2+, Mg2+ and Ca2+. 
These fluorophores have different electronic structures when coordinated with a metal 
ion than in the absence of the metal ion, which results in difference in the spectroscopic 
properties. These changes can be attributed to a lone electron pair of the fluorophore, 
which quenches fluorescence by an electron transfer mechanism in the absence of the 
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metal ion; however, the involvement of the electron pair in metal coordination results in 
increased fluorescence. These sensors are designed to leverage the ability of phosphate to 
coordinate hard metal ions such as those mentioned above, so once incorporated in 
proximity to the fluorophores, the phosphate group can aid in coordination to produce the 
enhanced fluorescence signal. 
1.5.3.6 Calcium-based chelation-enhanced fluorescence peptide biosensors 
Detection of phosphorylation through calcium chelation has been facilitated by 
the development of fluorophores that combine the eight coordination positions of 
tetracarboxylate in 1,2-bis(2-amino-phenoxyethane-N,N,N’,N’)-tetracetic acid (BAPTA) 
with a xanthene chromophore. These fluorophores displayed strong Ca2+ coordination 
through the four carboxylic acids with binding constants in the range of 0.37-2.3 µM. 
Calcium coordination changes the electronic configuration of the fluorophore resulting in 
3-40 fold enhanced fluorescein fluorescence. (67) Placing the fluorophore next to the 
phosphorylation site of a peptide allowed for one of the iminodiacetate arms of the 
fluorophore to be replaced. (Figure 1-12A) This biosensor has been successfully applied 
for the detection of cellular PKC activity by exploiting the Ca2+ dependent activation of 
PKC. (68)  However, the vast majority of protein kinases are not Ca2+ dependent making 
this approached limited to detection of PKC and other Ca2+ dependent kinases.  
1.5.3.7 Magnesium-based chelation enhanced fluorescence peptide biosensors 
To circumvent the dependence on calcium activation, an alternative approach is to 
achieve enhanced fluorescence through chelation of metals with consistently high 
intracellular concentrations such as Mg2+, K+ and Na+. Mg2+ has steady-state intracellular 
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concentration in the millimolar range making it an ideal metal for chelation-based 
detection. The development of sulfonamide-oxime (Sox) fluorophores has utilized Mg for 
enhanced fluorescence following phosphorylation for detection of kinase activity. The 
Sox residue is separated from the phosphorylation site by a !-turn, which results in a 
change in the directionality of the peptide and facilitates coordination between the 
phosphorylation site and nonnatural fluorescent amino acids.  (Figure 1-12B) Installation 
of the !-turn is accomplished through a two amino acid sequence consisting of a proline 
and glycine. Phosphorylation typically results in a 4-12 fold increase in fluorescence. (69) 
However, the structural requirement for the !-turn hinders the ability of sensor design to 
consider all aspects of kinase substrate recognition within the sequence. The development 
of the next generation C-Sox, which consists of an alkylated cysteine containing the Sox 
chromophore, allows for greater flexibility in sensor design by alleviating the 
requirement for a !-turn. (70) The next generation design of Sox-containing biosensors 
has focused on kinase recognition, resulting in sensors with comparable catalytic 























































































Figure 1-12 Biologically available metal based CHEF biosensors A) CHEF-based Ca
2+
 
dependent kinase biosensor; B) Sox; C) C-Sox 
 
1.5.3.8 Lanathanide-based chelation-enhanced luminescence 
 The lanthanide metals (Ln3+), elements 57-71, also known as the “Rare Earth” 
metals, display many unique photophysical properties due to the presence of electrons in 
the 4f orbitals, which offers several advantages compared to biologically available hard 
metals. The luminescence emission of lanthanides produces large Stokes shifts (~100-200 
nm) between the absorption and the emission compared to organic fluorophores (~ 20-30 
nm). The emission spectra produce very narrow bands (~20 nm wide) and are insensitive 
to the chemical environment. The f-f electric dipole transitions that would lead to short 
lifetimes are Laporte-forbidden by parity rules, therefore the Ln3+ ions have extremely 
long luminescence lifetimes (millisecond for Tb3+ and Eu3+ and microseconds for Sm3+ 
and Dy3+). The long lifetimes make lanthanides well suited for time-resolved 
measurements. Organic dyes and biological chromophores have fluorescence lifetimes in 
the nanosecond ranges, therefore time-resolved measurements will allow for these short 
41 
!
lived fluorophores to decay prior to collection of the longer-lived lanthanide-specific 
signal. This is ideal for a detection method because it allows for highly specific and 
sensitive signal from the sensor’s phosphorylation. (72) 
Another direct result of Laporte-forbidden nature of the f-f transitions is that Ln3+ 
have extremely low molar extinction coefficients. This results in the need for a 
chromophore to absorb the incident radiation and transfer it to the Ln3+ to facilitate 
excitation. This has been accomplished by a variety of UV-absorbing chromophores 
including coumarin derivatives, tryptophan, and tyrosine. Excitation of the chromophore 
results in an excited singlet state. This singlet can either fluoresce or undergo 
intersystem-crossing to an excited triplet state.  The triplet state can emit a photon and 
phosphoresce, or it can undergo energy transfer to and excitation of Tb3+. The excited 
state of Tb3+ can be either quenched by nonradiative energy transfer or can emit 
producing luminescence. Quenching can occur through nonradiative energy transfer to O-
H oscillators due to the similarity in the energy levels between the excited state of Tb3+ 
and the fourth overtone of water; therefore, water molecules coordinated to Tb3+ can 
quench luminescence emission. This makes it important to consider the incorporation of 
an appropriate chromophore as well as the coordination environment provided by the 
sensor during the design of probes for the detection of kinase activity using lanthanides. 
(72)  
1.5.3.9 EF-hand based sensors 
The Ln3+ are very similar to Ca2+, with Tb3+ and Eu3+ having only slight 
differences in atomic radius and both elements are hard acids. The calcium-binding EF 
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hand domains contain five hard base side chains and one main chain carbonyl to facilitate 
coordination of Ca2+. Upon binding, these domains undergo drastic conformational 
changes into well organized helix-loop-helix structures. In the past Tb3+ has been used as 
a probe to determine Ca2+ binding affinity of these domains as well as to survey for 
potential Ca2+ binding sites in proteins. Zondlo and coworkers have leveraged the 
properties of the EF hand domains to develop kinase responsive sensors using Tb3+ 
luminescence for detection. (73) To accomplish this design, serine (Ser) was used as a 
phosphorylation inducible mimic of glutamic acid (Glu) due to the similarities in 
electrostatic and Lewis base properties. The Glu at position 12 of the EF hand domain is 
critical for Ca2+ binding through its bidentate coordination, and thus is conserved amongst 
EF hand domains. The replacement of this Glu with Ser generates a phosphorylation 
responsive motif. Unphosphorylated Ser is a poor mimic of Glu and results in poor Tb3+ 
binding and minimal luminescence, while phosphorylated Ser provides the required 
bidentate coordination through the phosphate group, and has the appropriate side chain 
length to tightly bind Tb3+ and enhance luminescence. (Figure 1-13A) Additionally, the 
residues on either side of this Glu are poorly conserved across EF hand domains, 
allowing some elements of kinase substrate recognition to be incorporated at these 
positions. This design has been applied to develop a sensor for Ser/Thr kinase PKA. 
 This approach has been modified to apply this sensor design to tyrosine kinases. 
The size of phosphotyrosine prevents it from mimicking Glu, but length of side chain 
allows for an alternative structure-based design by shifting the phosphorylation inducible 
mimic motif by one position to replace Glu. (74) This strategy was applied to the 
detection of Abl activity and inhibition. Similar to the first generation of Sox-based 
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chemosensors, the requirements for the conformational change and Tb3+ binding 
somewhat limits the ability of the sensor design to consider all the necessary kinase 
substrate recognition features, ultimately limiting the catalytic efficiency and sensitivity 
of the sensors. 
1.5.3.10 Macrocyclic terbium chelate sensors  
Another approach using lanthanides for detection of kinase activity has employed 
binuclear Tb3+ complexes.  Similar to the dinuclear zinc-pyridylmethlamine complex, 
“phos-tag”, which binds the divalent phosphate anion selectively, Komiyama and 
coworkers have developed a dual 1,4,7,10-tetrazacyclododecane-1,4,7,10-tetraacetic acid 
(DOTA) chelator incorporated with Tb3+ for selective detection phosphotyrosine.  This 
design allows one water molecule to be coordinated at each Tb3+ ion and does not contain 
a chromophore for sensitization. Once bound to pTyr the water molecules are displaced 
and the aromatic ring of tyrosine can facilitate sensitization resulting in a 10-fold increase 
in luminescence. (Figure 1-13B) (75) This approach was shown to be selective in the 
presence of other phosphate contain molecules including ATP, ADP, GMP, GDP due to 
the required appropriate chromophore for sensitization being absent or too far away for 
energy transfer. The application of this technique for detection of Ser/Thr kinases is 
limited due to the lack of an appropriate chromophore attached to the phosphate 
containing Ser/Thr residue. 
1.5.3.11 Chelator Based 
 Inspired by the design of the Ca2+ chelating BAPTA-xanthene peptide conjugate 
described above, a similar design was applied for lanthanide-based detection of tyrosine 
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kinases Src and Abl. The chemosensor was designed to contain an iminodiacetate 
chelator, which would coordinate a lanthanide ion in the presence of phosphotyrosine 
contained within the generic Tyr kinase substrate. (76) Sensitization of both Tb3+ and 
Eu3+ was achieved through incorporation of the chromophore carbostyril 124 as an 
“antenna”. (Figure 1-13C) Phosphorylation of the sensor resulted in binding of Tb3+ or 
Eu3+ and a 10-fold increase in luminescence. This sensor design could also be applied to 
Ser/Thr kinases due to the incorporation of the antenna into the sensor. However, the low 
substrate efficiency resulting in the requirement for the kinase reaction to proceed for 20 
hours and the lack of quantitative detection suggest that the sensors require further 





















































Figure 1-13 Lanthanide-based CHEF biosensors. A) Phosphorylation inducible EF-hand 
domain B) Binuclear Tb
3+




1.6 Dissertation Objective 
 As demonstrated above, previous work has successfully established a number of 
techniques for the identification of optimal kinase specific substrates. These substrates 
have been applied to develop various peptide biosensors for specific detection of kinase 
activity through a wide range of methods. However, over the last decade there has been a 
bottleneck in the identification of kinase specific substrates and thus also in the 
development of peptide-based biosensors for novel kinases. Herein, strategies for the 
development of various novel peptide biosensors as well as novel detection methods will 
be presented. 
 Spleen tyrosine kinase (Syk) is critically important to B-cell function through the 
B-cell receptor pathway, but there are few methods that provide direct detection of Syk 
activity. Chapter 2 will describe the development of a novel modular peptide biosensor 
for live cell detection of Syk activity. The design of this sensor was inspired by a 
biosensor previously developed in the lab for detection of intracellular Abl activity. The 
Syk artificial substrate peptide (SAStide) sequence was identified using a semi-empirical 
bioinformatic analysis of Syk phosphorylation sites. The specificity of the biosensor will 
be demonstrated using a small panel of purified kinases as well as control cell lines. The 
application of this sensor for specific detection of Syk activity and inhibition in response 
to physiologically relevant stimuli and inhibitors will be demonstrated. The development 
of an enzyme-linked immunosorbent assay (ELISA)-based chemifluorescent method for 
detection of SAStide phosphorylation will also be discussed. 
Based on the similarity of SAStide with the !–synuclein sequence surrounding 
Y125, which has been demonstrated to sensitize Tb3+ luminescence in a phosphorylation 
46 
!
dependent manner, the use of Tb for detection of Syk activity using SAStide was 
explored. Chapter 3 will report the use of SAStide to sensitize Tb in a phosphorylation 
dependent manner as well as characterization of the mechanism of sensitization through 
the photophysical properties of Tb3+. The characterization of this method for detection of 
Syk activity and the application for monitor activity and inhibition in vitro will also be 
reported.  
Expanding on this initial work of SAStide for phosphorylation-dependent 
enhanced Tb3+ luminescence detection, the development of a pipeline to identify peptide 
substrates, but also substrates that are not only kinase specific, but that would also 
sensitize Tb3+ in a phosphorylation-dependent manner will be presented in Chapter 4. 
Although previous methods have successfully identified kinase specific substrates, these 
methods require costly and laborious analysis and experimentation, which has lead to the 
aforementioned bottleneck in the development of kinase peptide biosensors for new 
kinases. New computational approaches have attempted to identify kinase substrate 
specificity and predict phosphorylation networks de novo from phosphoproteomic data. 
However, these approaches have yet to be applied to the development of new artificial 
peptide substrates. Chapter 4 will detail the development of a new algorithm aimed at 
identifying kinase substrate specificity and key determinants involved in determining 
specificity. Biochemical validation of the key determinants for kinase specificity as well 
as the predictive power of the algorithm will be examined. Additionally, the algorithm 
will also predict the ability of the sequences to sensitize Tb3+ luminescence in a 
phosphorylation-dependent manner. The generation of novel biosensors for Abl, Jak2, 
and Src-family kinases and their application in kinase assays will also be detailed. 
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The development of multiple kinase specific phosphorylation-dependent Tb3+ 
sensitizing biosensors inspired further engineering of the sensors to obtain simultaneous 
detection of the activity of two kinases in a single assay. To achieve this goal, the 
multiple emission bands of Tb3+ will be exploited to excite conjugated fluorophores using 
the time-resolved lanthanide-based resonance energy transfer (TR-LRET) for multiplex 
detection. Chapter 5 details the development of this approach using SAStide and the Src-
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CHAPTER 2. A PEPTIDE-BASED BOSENSOR ASSAY TO DETECT 
INTRACELLULAR SYK KINASE ACTIVATION AND INHIBITION 
2.1 Abstract 
Spleen Tyrosine Kinase (Syk) has been implicated in a number of pathologies including 
cancer and rheumatoid arthritis and thus has been pursued as a novel therapeutic target. 
Because of the complex relationship between Syk’s auto- and other internal 
phosphorylation sites, scaffolding proteins, enzymatic activation state and sites of 
phosphorylation on its known substrates, the role of Syk’s activity in these diseases has 
not been completely clear. To approach such analyses, we developed a Syk-specific 
artificial peptide biosensor (SAStide) to use in a cell-based assay for direct detection of 
intracellular Syk activity and inhibition in response to physiologically relevant stimuli in 
both laboratory cell lines and primary splenic B cells. This peptide contains a sequence 
derived from known Syk substrate preference motifs linked to a cell permeable peptide, 
resulting in a biosensor that is phosphorylated in live cells in a Syk-dependent manner, 
thus serving as a reporter of Syk catalytic activity in intact cells. Because the assay is 
compatible with live, primary cells and can report pharmacodynamics for drug action on 
an intended target, this methodology could be used to facilitate a better understanding of 
Syk’s function and the effect of its inhibition in disease. 
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2.2 Introduction 
Syk is a 72 kDa non-receptor tyrosine kinase originally isolated from bovine 
thymus and porcine spleen1 best known for its role in B lymphocyte development and 
activation.  Loss of Syk expression results in perinatal lethality in mice and an arrest in 
the development of B cells at the pro-B to pre-B cell and immature to mature B cell 
transitions.2 Upon antigen binding to the B cell antigen receptor (BCR), the Src family 
kinase, Lyn initiates the phosphorylation of immunoreceptor tyrosine-based activation 
motifs (ITAMs) on components of the BCR. Phosphorylation of the ITAMs in turn 
recruits and activates Syk, inducing its phosphorylation on multiple tyrosines including 
Y525 and Y526 in its activation loop.  Following this activation of Syk, numerous 
signaling pathways are initiated leading to the activation of downstream transcription 
factors including NFAT, NF!B and Elk1 and ultimately contributing to the induction of 
cell proliferation and differentiation.   
Dysregulation of the expression or the activity of Syk contributes to various 
disease states, making it a potential therapeutic target.3 Syk has been implicated as a 
factor in rheumatological disorders (such as rheumatoid arthritis) and malignant diseases 
of myeloid, lymphocytic and even epithelial origin. For instance, Syk was found to be 
constitutively active in primary blasts from a set of patients with acute myeloid leukemia 
(AML).4 Inhibition of Syk decreased the viability of these AML blasts in vitro and 
reduced the number of these cells infiltrating spleen and bone marrow in a mouse 
xenograft model. In some chronic lymphocytic leukemia cells (B-CLL), Syk is 
hyperactive despite exhibiting normal expression levels,5 and inhibition of Syk or 
silencing of Syk expression via siRNA decreases cell viability.6 In another example, 
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several peripheral T-cell lymphomas (PTCLs) exhibit aberrant expression of Syk.7 In 
these cells, siRNA silencing of Syk translation or inhibition of its activity with a kinase 
inhibitor (R406, Rigel Pharmaceuticals) induces apoptosis and blocks proliferation in 
cells with elevated Syk Y525/Y526 phosphorylation.8 These results suggest that Syk 
could be a novel therapeutic target for the treatment of PTCLs. Conversely, in breast 
cancer, which has an epithelial origin, Syk appears to have tumor suppressor functions: 
while Syk is expressed in normal breast epithelia, there is little to no Syk present in more 
metastatic breast cancer cells.9 Expression of Syk negatively affects motility and invasion 
in these carcinomas.9-10 Accordingly, to guide both the treatment of these cancers and the 
development of novel therapeutics, it would be beneficial to selectively measure Syk 
activity in patient samples.  
There are three predominant methods currently in use to measure Syk activity: in 
vitro kinase assays, luciferase reporter assays of downstream transcription factors and 
phosphotyrosine antibody-based detection of Syk autophosphorylation or substrate sites. 
Each of these methods has drawbacks that make them less than optimal for both 
determination of Syk biology and translation to the clinical setting. In vitro kinase assays 
measure Syk activity post lysis—however, Syk’s function is integrally dependent on its 
binding partners. For example, in lysed cells proteins such as c-Cbl that normally 
modulate the function of the kinase (and which are known to be critical for obtaining 
biologically-relevant activation for Syk) can become separated from Syk; also, proteins 
normally found in different subcellular compartments are able to artifactually interact 
with Syk and alter its activity.11 Moreover, as a result of changes in Syk’s 
phosphorylation state via phosphatase activity and autophosphorylation in vitro, Syk’s 
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activity can change during in vitro kinase assays in ways that may not be relevant to its 
intracellular activity in a disease context. Transcription factor-driven luciferase reporter 
assays (another common read-out used for determining Syk activity) are performed in 
whole cells and maintain the endogenous context of Syk—however, these represent an 
indirect measure of Syk activity, with numerous proteins in the pathways between Syk 
and the transcription factors allowing potential disruption of additional components of 
these cascades. Phosphotyrosine antibody-based methods such as Western blots and 
Phosphoflow cytometry12 use phosphorylation sites in endogenous proteins, such as 
known Syk-targeted sites and/or Syk autophosphorylation sites, as surrogate reporters of 
Syk activity. However, because of the complex relationship between Lyn and Syk 
activation during B-cell receptor signaling, phosphorylation at endogenous sites (on Syk 
and other proteins) has not been confirmed to be Syk-specific in all cases. Furthermore, 
Syk is phosphorylated on multiple sites (by itself and other kinases including Lyn) 
including some that negatively regulate the kinase,11a making it difficult to parse the 
complex relationship between the phosphorylation state of these native sites and the 
intrinsic activation of the enzyme. Besides these functional caveats, the fundamental 
limitation exists that antibodies for every potentially meaningful site of Syk 
phosphorylation are not available, and their development is subject to the uncertainties 
inherent in epitope and antibody generation. Therefore, an ideal method to measure Syk 
activity would be one that specifically monitors the ability of the kinase to catalyze a 
phosphotransferase reaction in an intact cell.     
 Peptide-based approaches offer an alternative method that allows for direct 
detection of kinase activity. Several peptide substrates for Syk have been previously 
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reported, including some based on endogenous protein sequences and others derived 
artificially from peptide libraries (through e.g. phage display).13 Peptides have been 
applied to the detection of Syk activity in vitro using constrained tyrosine analogs and 
artificial peptides containing fluorescent amino acids.13b, c, 14 Using these substrates, Syk 
activity has been detected in stimulated cell lysates and from recombinant protein, but so 
far they have not been used in live, intact cells that provide the necessary context for Syk 
function. We were interested in developing a peptide biosensor substrate for Syk that 
could be implemented to detect kinase activity in intact cells using a cell-penetrating 
peptide approach. TAT-labeled peptide substrates have been used for specific and 
sensitive detection of endogenous Akt activity in live single cells using capillary 
electrophoresis.15 Our previous work applied a similar approach to detect intracellular 
Abl activity in an over-expression model using a peptide biosensor and matrix-assisted 
laser desorption/absorption ionization-time of flight mass spectrometry (MALDI-TOF) or 
Western blotting.16 Here we present the development of a Syk specific artificial peptide 
substrate capable of detecting physiologically relevant Syk activity in live, intact cells 
following BCR engagement and oxidative stress using an ELISA-based assay. 
2.3 Methods and Materials 
Cell culture and biological reagents. The DG75 and DT40 B cell lines were 
grown to a density of 0.4 x 106 cells/mL in RPMI-1640 medium containing 7.5% FBS, 1 
mM sodium pyruvate, 100 IU/mL penicillin, 100 µg/mL streptomycin and 50 µM 2-
metcaptoethanol. Additionally, DT40 cell medium contained 1% chicken serum. Anti-
chicken IgM and anti-mouse IgM F(ab’)2 fragments were purchased from Bethyl 
Laboratories. Anti-human IgM was purchased from Rockland Immunochemicals. 
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Hydrogen peroxide was purchased from Mallinckrodt. Anti-Syk (N-19) was purchased 
from Santa Cruz Biotechnology. Anti-tubulin and anti-phosphotyrosine (4G10) were 
purchased from Millipore. Anti-phospho Syk (Y525/526) was purchased from Cell 
Signaling Technology.  
Peptide Synthesis and Purification. The Syk peptide biosensor was synthesized 
using ‘Fast’ Fmoc solid-phase peptide chemistry with a Prelude Parallel Peptide 
Synthesizer (Protein Technologies). The synthesized peptides were purified using a C18 
reverse-phase column on an Agilent 1200 preparative HPLC system. The peptide was 
characterized using liquid-chromatography mass spectrometry (LC/MS) on an 
Accela/LTQ system (Thermo-Finnegan) and matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF/TOF) on a Voyager 4800 instrument 
(Applied Biosystems). 
In vitro kinase assay. Recombinant Abl, Src and Lyn enzymes were obtained 
from a commercial source (Millipore). EGFP-conjugated Syk was isolated from DT40 
chicken B cells stably expressing Syk-EGFP. Cells were lysed using a solution 
containing 1% Nonidet P-40, 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 1 
mM sodium orthovanadate, 2 mM NaF and 1X mammalian protease inhibitor cocktail 
(Sigma). Syk-EGFP was immunoprecipitated using anti-GFP magnetic nanoparticle 
beads (MBL, Japan). Lysates were incubated with the beads (40 µl per 1x107 cells) for 1 
h at 4°C. The kinase-bound beads were washed and then used in the in vitro kinase assay. 
Immobilized Syk-EGFP (55 nM per reaction, from 1.2 µg/µl stock, see supporting 
information Fig. S1), recombinant Lyn, Abl or Src kinase (0.1 U each) was incubated 
with kinase reaction buffer (500 !M ATP, 5 mM MnCl2, HEPES, pH 7.2) containing the 
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peptide substrate at 25 µM. Aliquots (22 µL) were taken at designated time points and 
quenched in 0.5 M EDTA, pH 8.5 (22 µL). The quenched sample (1 µL) was diluted into 
ELISA wash buffer and analyzed as described below. For substrate comparison assays, 
kinase reaction conditions were as described above except that substrate concentrations 
were 4 µM, and concentration of enzyme used per reaction was 6 nM. The volume of 
aliquots diluted in an equal volume of quench buffer was 4 µl (for 8 µl total quenched 
volume), and the entire quenched amount was diluted into ELISA wash buffer and 
analyzed as described below. For characterization of SAStide kinetic parameters, 
substrate concentrations and reaction/quench volumes are given in Table S1. 
ELISA-based fluorescence detection. Samples were incubated in a 96-well 
Neutravidin™ coated plate (15 pmol biotin binding capacity per well, Thermo Scientific) 
in Tris-buffered saline (TBS) containing 0.1% BSA and 0.05% Tween 20 for 1 h at room 
temperature on a short-radius plate shaker (600 rpm). Following incubation, wells were 
washed three times with wash buffer (TBS, 0.1% BSA, 0.05% Tween 20), then incubated 
with mouse anti-phosphotyrosine monoclonal antibody 4G10 (1:5000 dilution in wash 
buffer, 100 µL per well) for 1 h at room temperature with shaking. Wells were washed 
three times with wash buffer and incubated with horseradish peroxidase-conjugated goat 
anti-mouse immunoglobulin G (IgG) secondary antibody (Abcam) (1:1000 dilution in the 
wash buffer, 100 µL per well) for 1 h at room temperature with shaking. Wells were then 
washed three times with wash buffer and twice with sodium phosphate buffer (0.05 M, 
pH 7.5). For chemifluorescence detection, Amplex Red™ reaction buffer (100 µL total 
volume/well) consisting of Amplex Red™ reagent (50 µL) (Invitrogen), 20 mM H2O2 
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(500 µL) and sodium phosphate buffer (4500 µL) and allowed to react for 30 min. 
Fluorescence of Amplex Red™ was measure using a Synergy4 multiwell plate reader 
(Biotek) with an excitation wavelength of 532 nm and emission wavelength of 590 nm. 
Cell-based peptide biosensor assay. Cells were cultured as described above, 
harvested and resuspended at a density of 8 x 106 cells/mL (8 mL), then treated with the 
SAStide biosensor peptide (25 !M) for 15 min prior to stimulation with either anti-IgM 
antibody (5 µg/mL), H2O2 (3.33 mM) or both. Concentrations of peptide lower than 25 
µM resulted in low signal to noise in detection of phosphopeptide using the ELISA-based 
read-out, and no toxicity was observed in the presence of the peptide at 25 µM (similar to 
what was observed in our previously published work on Abl kinase16). Aliquots of the 
cell suspension (1 mL) were harvested, lysed in PhosphoSafe Extraction Reagent (EMD 
Millipore) containing 167 mM EDTA and freshly prepared protease inhibitor cocktail 
(Roche) and flash frozen. Half the cell lysate from each sample was used for ELISA-
based fluorescence detection and the other for immunoblotting. For dose-response 
experiments, cells were stimulated with varying concentrations of anti-IgM (2.5-10 
µg/mL) or hydrogen peroxide (1-7 mM), harvested at 5 min post-stimulation and 
processed as described above. For immunoblotting, membranes were blocked in 5% goat 
serum for 1 h.  All primary antibodies were incubated at a dilution of 1:1,000 for 1 h at 
room temperature and visualized using an HRP-conjugated secondary antibody (Pierce) 
and ECL reagents (PerkinElmer). Uniformity of the amount of peptide taken up was 
tested in a representative experiment using Syk-EGFP reconstituted Syk(-/-) DT40 cells, 
and while there was a very slight (but not statistically significant) trend towards higher 
peptide amounts over time, no significant difference was seen across conditions . 
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 Cell-based inhibition assay. Cells (4 x 106 cells/ml) were pre-treated with 
varying concentrations of piceatannol or dasatinib for 30 min and with the SAStide 
biosensor peptide (25 µM) for 15 min. Cells were then stimulated with anti-IgM antibody 
(5 µg/mL) and H2O2 (1 mM) and harvested after 5 min as described above.  
Isolation of primary mouse splenic B-cells and primary cell biosensor assay.  
B cells were enriched from mouse spleens via “panning” as previously described.17 Cells 
6 ml, 5 x 106 cells/mL) were treated with vehicle (DMSO), piceatannol (50 !M) or 
dasatinib (100 nM) for 1 h and with the SAStide biosensor peptide (25 !M) for 15 min 
prior to stimulation. The cells were stimulated with anti-IgM F(ab')2 (5 µg/mL). Cells 
were harvested at 0, 5, 10 and 15 min following stimulation, lysed and analyzed as 
described above. 
2.4 Results 
2.4.1 Development of a Syk biosensor 
Using a Syk substrate consensus motif suggested recently by Geahlen 
(EXXDEEDYEXPXEPX) and incorporating information on the preferences at the 
variable sites of that motif gathered from phosphoproteomic studies,11a, 18 we designed a 
putative Syk peptide substrate, DEEDYEEPDEP, which we named “Syk artificial 
substrate” or SAStide. We incorporated SAStide along with several functional modules to 
form a Syk biosensor peptide. These modules include a biotinylated lysine for affinity 
capture of the substrate, a cell penetrating peptide for delivery of the biosensor into cells 
and a photocleavable amino acid for release of the substrate from the rest of the biosensor 
in case mass spectrometry-based analysis is desired for future applications (Figure 2-1). 
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Figure 2-1 Syk peptide biosensor. The biosensor contains a biotinylated substrate reporter 
that is phosphorylated by Syk, a photocleavable linker for release of the reporter from the 
biosensor (for future mass spectrometry applications) and a cell penetrating peptide (TAT 
peptide) for delivery into live cells. Upon delivery of the biosensor to cells and 
stimulation of the B cell receptor, the substrate reporter is phosphorylated and can be 
enriched via the biotin tag and analyzed using an antiphosphotyrosine antibody in an 
ELISA-style multiwell plate format.  
 
Phosphorylation of the biosensor by Syk was assessed using an in vitro kinase 
assay, incubating the SAStide biosensor with immobilized GFP-tagged Syk kinase 
(immunoprecipitated from DT40 chicken B cells) in the presence of ATP and MnCl2 for 
varying times after which aliquots of the reaction mixtures were removed and kinase 
activity quenched by adding an excess of EDTA. Phosphorylated biosensor peptide was 
detected using a fluorescent ELISA-based assay in which the quenched reaction mixture 
was incubated in a 96-well Neutravidin™ coated-plate to allow for affinity capture of the 
biotinylated substrate. Each well had a biotin binding capacity of 15 pmol. The total 
amount of peptide in the quenched reaction mixture applied to each well was 20 pmol, 
which ensured that each well was saturated with peptide for analysis. The captured 
peptide was then incubated with an anti-phosphotyrosine primary antibody (4G10) 
followed by a horseradish peroxidase-conjugated secondary antibody. Chemifluorescent 
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detection was accomplished by incubating each well with Amplex Red™ reagent and 
hydrogen peroxide, which gives a fluorescence signal readout that is proportional to the 
amount of horseradish peroxidase-conjugated antibody in each well, and thus reports the 
degree of phosphotyrosine present (via the anti-phosphotyrosine antibody) (as described 
by Wu et al. 19). Relative fluorescence units (RFU) were measured, which provided a 
proportional representation of the amount of phosphorylated biosensor present. In control 
experiments to generate a standard curve, phosphorylated SAStide was demonstrated to 
bind reproducibly to the wells, and exhibited a linear increase in signal up to an amount 
of phosphopeptide per well of 0.5 pmol (beyond which saturation of the ELISA signal 
occurred). This validated that the amount of antiphosphotyrosine antibody-related signal 
was proportionally related to the degree of peptide phosphorylation. A substantial 
increase in signal over time was observed, demonstrating that SAStide was 
phosphorylated by Syk in vitro (Figure 2-2A). To provide preliminary evidence for the 
specificity of this substrate for Syk, SAStide was also assayed using Src, Abl and Lyn 
kinases, none of which produced any significant signal for phosphopeptide (Fig. 2-2A).  
We also compared the phosphorylation of SAStide over time with that of two 
other known substrates of Syk kinase, the natural peptide parent of the previously 
reported ‘Syktide’ (EDDEYEEV, which in the original work contained an unnatural 
amino acid in place of the tyrosine that the authors demonstrated conferred specificity for 
Syk over other kinases e.g. Lyn)13b and a Syk substrate discovered from a phage display 
library (EDPDYEWPSA).13d Each was synthesized with glycine spacers on the C- and N-
terminal sides of the substrate portion with a biotinylated lysine included at the C-
terminus for capture and ELISA-based detection of phosphorylation signal (sequences are 
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given in the caption for Fig 2-2). The kinase assay was performed using 
immunoprecipitated Syk-EGFP (6 nM) with each substrate at 4 µM. We found that 
SAStide was phosphorylated more rapidly than the previously reported Syktide sequence, 
but not as rapidly as the phage display-derived sequence (Fig. 2-2B). Performing the 
assay on SAStide at a range of concentrations (Fig. 2-2C) enabled the characterization of 
its substrate kinetics with the immunoprecipitated Syk-EGFP enzyme as sigmoidal, 
indicating some substrate activation through an as-yet unknown mechanism. The kinetic 
parameters were characterized as Khalf = 86±10 µM (which represents the substrate 
concentration at half of Vmax in a sigmoidal curve and is analogous to Km) and Vmax = 
11±1 pmol/min, from which kcat = 216 min
-1 and kcat/Khalf = 2.5 were derived (Fig. 2-2D). 
Previously reported for Syktide13b were Km = 3 µM, kcat = 62.2 min
-1 and catalytic 
efficiency kcat/Km = 20.73 (the kinetic parameters for the Phage substrate have not been 
reported). The SAStide catalytic efficiency is overall comparable to Syktide, with the 
caveat that the assays were performed with different enzyme preparations and under 
different substrate (ATP) concentrations. In the direct comparison shown in Fig. 2-2B 
(under conditions that emphasize the effects of kcat rather than KM on substrate 
phosphorylation), SAStide was phosphorylated more efficiently than the parent Syktide. 
Compared to SAStide, the phage display peptide was more efficiently phosphorylated, 
but exhibits substrate inhibition at higher concentrations (greater than 20 µM).13d SAStide 
exhibited no substrate inhibition at concentrations up to 100 µM.  
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Figure 2-2 Phosphorylation of the artificial peptide substrate for Syk (SAStide) in vitro. 
A) The SAStide biosensor (25 µM) was incubated with Syk-EGFP (closed circles), Lyn, 
Abl or Src in an in vitro kinase assay. Aliquots were removed at designated time points 
and the amount of phosphorylated substrate was measured using ELISA-based detection 
(given as relative fluorescence units, RFU). B) SAStide (GGDEEDYEEPDEPGGKbGG) 
and two known Syk peptide substrates, ‘Syktide’
13a
 (GGEDDEYEEVGGKbGG) and 
‘Phage,’
13d
 a peptide derived from a phage display library 
(GGEDPDYEWPSAGGKbGG), were incubated with immobilized, immunoprecipitated 
Syk-EGFP kinase (Syk-EGFP) as described in the Materials and Methods. Substrate 
concentration for each was 4 µM. C) SAStide was assayed with Syk-EGFP at a range of 
concentrations. D) Initial velocities were calculated from the data in (C) and plotted and 
fitted to a sigmoidal curve to fit Khalf, Vmax, kcat and kcat/Khalf. For all panels, data points 
represent the average of three replicate experiments and error bars indicate the standard 
error of the mean.  
 
2.4.2 Detection of Dose Dependent Activation and Inhibition of Syk in intact cells 
We next examined the ability of the biosensor to detect dose-dependent activation of Syk 
in the context of BCR activation and oxidative stress in intact, living Burkitt’s lymphoma 
DG75 B-cells. DG75 cells incubated with the SAStide biosensor were stimulated by 
cross-linking the BCR using polyclonal antibody specific for IgM11a or by treatment with 
hydrogen peroxide to inhibit protein tyrosine phosphatases and activate Syk.20  The 
stimulated cells were harvested and lysed in Phosphosafe extraction buffer with EDTA 
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and protease inhibitors (to prevent further kinase activity, dephosphorylation by 
phosphatases and proteolytic degradation in the sample), and the lysates were incubated 
in Neutravidin™-coated wells to capture the biosensor peptide. The chemifluorescent 
ELISA-based assay described above was used to detect phosphorylation of SAStide. Syk 
activity was analyzed after 5 min and compared to unstimulated cells as a control. No 
signal above the reagent background was observed in cells not treated with the peptide. 
BCR stimulation resulted in increased phosphorylation of the biosensor in a dose-
dependent manner (Figure 2-3A). Induction of oxidative stress in the B cells via 
hydrogen peroxide treatment also resulted in dose-dependent increases in 
phosphorylation of the biosensor (Figure 2-3B). These results show the ability of the 
peptide biosensor to detect dose-dependent changes in the Syk activity at endogenous 
levels of expression in live cells. 
 
Figure 2-3 Detection of stimulant dose-dependent intracellular Syk activity.  (A) DG75 
cells were treated with the SAStide biosensor (25 µM) 15 min prior to stimulation. The 
cells were stimulated with varying concentrations of anti-IgM (A) or varying 
concentrations of H2O2 (B). Cells were harvested 5 min following stimulation and the 
amount of phosphorylated biosensor was measured. Experiments were performed in 
triplicate and the data are reported as fold change compared to the unstimulated control 
(which exhibited levels of signal similar to background observed in the in vitro assay 
shown in Fig. 2, ~4000-8000 RFU). Data points represent the average of three 
measurements and error bars indicate the standard error of the mean. 
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We also examined the ability of the biosensor to monitor dose-dependent inhibition of 
Syk using the Syk-specific natural product inhibitor piceatannol and the Src-family 
kinase inhibitor, dasatinib (currently being explored as a therapeutic Syk inhibitor21). The 
inhibitors were assayed in a dilution series from 1 mM – 100 pM (Figure 2-4A). We 
found that dasatinib had greater potency than piceatannol for inhibiting Syk 
phosphorylation of the biosensor. However, as expected from the literature22 and 
observed from the loss of tubulin and Syk immunoblot signal (Fig. 2-4B, lanes 17 and 
18), high concentrations of piceatannol in the presence of BCR activation and oxidative 
stress were toxic to DG75 cells whereas dasatinib was not. The apparent IC50 values (the 
concentration at which SAStide phosphorylation was decreased by 50% compared to the 
control uninhibited cells) were calculated using the Hill function to be 10.8±9.3 nM and 
1.2±1.5 !M for dasatinib and piceatannol, respectively. These results were also consistent 
with the reduction in the level of Syk tyrosine phosphorylation as detected by Western 
blot analysis (Figure 2-4B).  
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Figure 2-4 Detection of Syk inhibitor dose-response. Burkitt’s lymphoma DG75 B cells 
were treated with varying concentrations of dasatinib (closed squares) or piceatannol 
(open circles) for 30 min and with the SAStide biosensor (25 µM) for 15 min prior to 
stimulation. The cells were then stimulated with anti-IgM (5 µg/mL) and hydrogen 
peroxide (1 mM) for 5 min and harvested. (A) The extent of biosensor phosphorylation 
was analyzed by ELISA. Data indicate averages +/- SEM of experiments performed in 
triplicate. (B) The level of total Syk, of Syk phosphorylated on Y525 and Y526 (Syk 
pY525/526) and of tyrosine-phosphorylated proteins (pTyr) were analyzed by Western 
blotting of lysates of cells not stimulated (NS), stimulated but not treated with inhibitor 
(NI) or treated with increasing concentrations of the indicated inhibitor. Tubulin was 
measured as an internal loading control.  
 
2.4.3 Time-dependence of Syk activity following activation 
To examine the time dependence of Syk activity following stimulation through the BCR 
and/or oxidative stress, DG75 cells were treated as above and Syk biosensor 
phosphorylation was analyzed every few minutes for the first 15 min following 
stimulation. BCR stimulation gave a rapid increase followed by steadily maintained 
phosphorylation of the biosensor (Figures 2-5A and B). As expected, the addition of 
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hydrogen peroxide following BCR stimulation gave a very robust increase in 
phosphorylation over the time course due to the amplified and extended BCR 
signaling.11a, 12a, 20 Oxidative stress alone also resulted in increased phosphorylation of the 
biosensor, peaking at 5 min and subsequently showing a slight decrease.20 The results of 
this experiment demonstrate that the SAStide biosensor is able to monitor time-dependent 
increases in Syk activity in live cells following stimulation. 
 
Figure 2-5 Detection of time-dependent Syk activity following cell stimulation. DG75 B 
cells were treated with the SAStide biosensor (25 µM) 15 min prior to stimulation. The 
cells were stimulated with anti-IgM (5 µg/mL) (panel A and closed circles in panel D), 
H2O2 (3 mM) (panel B and open squares in panel D) or both (5 µg/mL anti-IgM and 3 
mM H2O2) (panel C and open triangles in panel D). (A-C), the expression of Syk, Syk 
phosphorylated on Y525 and Y526 (Syk pY525/526) and GAPDH (loading control) in 
cell lysates were analyzed by Western blotting.  NS - no stimulation; NB - no biosensor 
(15 min harvest). (D), cells were harvested at varying time points following stimulation 
and analyzed for biosensor phosphorylation. Experiments were performed in triplicate. 
Data are reported as normalized change compared to the unstimulated control; error bars 
are shown either above or below data points for clarity. Data were analyzed using a 
repeat measure one-way ANOVA test and a Dunnet post-test. Statistical significance is 
indicated as follows: *P<0.05, **P<0.01 and ***P<0.001. 
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2.4.4 Determination of the SAStide biosensor specificity in intact cells 
While in vitro kinase assays (such as those described in Fig. 2-2) can provide useful 
preliminary comparisons of the activity of a kinase for a given substrate, they cannot 
necessarily be used to unequivocally demonstrate specificity or selectivity. In particular, 
using classical Michaelis-Menten kinetic parameters such as kcat/Km as “specificity 
constants” to compare the activity of different enzymes on a single substrate is not 
relevant since it relies on assumptions that only apply to comparisons of the same enzyme 
and its interaction with different substrates.23 Therefore, we sought to demonstrate the 
selective phosphorylation of the SAStide biosensor in the context of the complex 
intracellular environment. The specificity of the biosensor as a substrate for Syk and not 
other tyrosine kinases in live cells was explored using DT40 chicken B-cells in which the 
endogenous gene for Syk has been eliminated by homologous gene targeting.24 Syk-
deficient DT40 cells were exposed to the biosensor and stimulated using a polyclonal 
antibody specific for IgM.  As a control, cells were treated with the biosensor but were 
not stimulated. Phosphorylation of the biosensor was then monitored via quenched 
aliquots every few minutes for a total of 15 min following stimulation (Fig. 2-6A). No 
significant change in phosphorylation of the biosensor was detected over the time course 
following stimulation when compared to unstimulated control cells. These results 
indicated that the specificity of the biosensor was maintained in living cells in the context 
of IgM engagement and BCR-activated signaling.  
 Since little tyrosine-phosphorylation was observed in anti-IgM-activated, Syk-
deficient cells (Figure 2-6A), BCR-stimulated phosphorylation was amplified by the 
addition of hydrogen peroxide.  As seen with the anti-IgM stimulation alone, no 
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significant change in the phosphorylation of the biosensor was detected over 
unstimulated cells (Figures 2.6A). Western blot analysis of tyrosine-phosphorylated 
proteins demonstrated amplified phosphotyrosine signaling compared to anti-IgM 
treatment alone, indicating activation of multiple tyrosine kinases and inhibition of 
tyrosine phosphatases (Figure 2-6E). Similarly, no significant change in the 
phosphorylation of the biosensor was detected in cells treated only with hydrogen 
peroxide (Figures 2-6D). This showed that even in the presence of amplified and 
extended BCR-related and other H2O2-related signaling the SAStide biosensor was not 
appreciably phosphorylated by other highly activated tyrosine kinases in Syk-deficient 
cells. This experiment serves as a highly relevant specificity control in the intracellular 
context, given that tyrosine kinase activity was clearly upregulated, yet none of these 
activated kinases phosphorylated the biosensor peptide.  
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Figure 2-6 Intracellular specificity of the artificial peptide substrate for Syk. Syk(-/-) 
DT40 cells or Syk(-/-) DT40 cells reconstituted with stably expressed Syk-EGFP were 
treated with the SAStide biosensor (25 µM) for 15 min prior to stimulation. The cells 
were stimulated by treating with anti-IgM (5 µg/mL) (panels C and F, closed circles in 
graphs A and B), H2O2 (3 mM) (panels D and G, open squares in graphs A and B) or both 
(5 µg/mL anti-IgM and 3 mM H2O2) (panels E and H, open triangles in graphs A and B), 
then harvested at varying time points. (C-H): the phosphorylation of proteins in cell 
lysates was measured by Western blotting using anti-phosphotyrosine (4G10), anti-Syk, 
antiphospho-Syk(Y525/526), antiphospho-BLNK(Y84) and anti-tubulin antibodies 
(loading control). NS - no stimulation; NB - no biosensor (15 min harvest). (A, B): 
chemifluorescence detection of Syk biosensor phosphorylation. The data are reported as 
normalized change compared to the unstimulated control). Data were analyzed using a 
repeat measure one-way ANOVA test and a Dunnet post-test; In graph A, no statistically 
significant difference was seen for any time point or treatment relative to control. 
Experiments were performed in triplicate.   
 
To further support specificity, we performed the same set of experiments in Syk (-/-) 
DT40 cells that had been reconstituted with Syk-EGFP. In the presence of BCR 
stimulation by IgM, signal indicating phosphorylation of the biosensor peptide was 
increased approximately 2-fold over control (unstimulated Syk-EGFP-expressing cells) 
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and decreased slightly over time (Fig. 2-6B). When treated with H2O2 with or without 
concurrent BCR stimulation, biosensor phosphorylation signal increased more 
dramatically (to approximately 12-fold over control) (Fig. 6B). Phosphorylation of the 
biosensor was consistent with that observed for the Syk autophosphorylation site and the 
known Syk substrate BLNK (Fig. 2-6F-H).  
2.4.5 Detection of Syk Activity and Inhibition in Primary Mouse Splenic B-cells 
To examine the ability of the biosensor to monitor Syk activity and response to inhibitor 
treatment in primary cells expressing endogenous levels of Syk, we isolated mouse 
primary splenic B cells and treated these with the biosensor peptide in the presence of the 
Syk inhibitors piceatannol or dasatinib. Primary B cells were treated with 10 nM 
dasatinib, 1 !M piceatannol or vehicle (DMSO) for one h prior to stimulation. The 
SAStide biosensor peptide was added 15 min prior to stimulation, and the cells were then 
treated with anti-IgM F(ab')2 (5 µg/mL) and harvested at 0, 5, 10 and 15 min following 
stimulation. As seen with the DG75 cells, stimulation of Syk activity following BCR 
engagement resulted in a rapid increase in phosphorylation of the SAStide biosensor 
(within approximately two minutes—the time required to handle and process an aliquot 
of cells collected immediately after stimulation) followed by a maintenance of 
phosphorylation over time as compared to control unstimulated cells, which showed only 
background levels of phosphorylation-related signal (Fig. 2-7). In the presence of each 
inhibitor the level of phosphorylation of the biosensor was decreased, giving a signal that 
was close to background levels. These results showed that the biosensor peptide was 
capable of detecting the activation and inhibition of endogenous Syk kinase expressed at 
normal levels in primary cells that exhibit physiologically relevant B cell receptor 
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signaling, and suggest that elevation of Syk activity is very rapid in response to B cell 
receptor engagement in these primary cells.  
 
Figure 2-7 Detection of Syk activity and inhibition in mouse primary splenic B-cells. 
Mouse primary splenic B-cells were treated without (panel A and closed circles in panel 
D) or with the tyrosine kinase inhibitors dasatinib (100 nM) (B), (D !) or piceatannol 
(50 µM) (C), (D ") for 30 min prior to stimulation, then treated with the SAStide 
biosensor (25 µM, 15 min) and stimulated with anti-IgM F(ab’)2 (5 µg/µL). Cells were 
harvested at various time points following stimulation. (A-C) the expression of Syk and 
of Syk phosphorylated on Y525 and Y526 (Syk pY525/526) were determined by Western 
blotting.  NS - no stimulation; NB - no biosensor (15 min harvest). (D) The data are 
reported as normalized change in chemifluorescence signal compared to the unstimulated 
control. N = 6; error bars indicate SEM.  
 
2.5 Discussion 
These studies present the development of a new versatile tool for direct and specific 
monitoring of intracellular Syk kinase activity in physiological contexts. We showed that 
we could develop a Syk-specific biosensor peptide by combining a peptide based on a 
Syk substrate consensus sequence11a, 18a with other modular units including a biotinylated 
lysine for affinity capture of the substrate and a cell penetrating peptide for delivery of 
the biosensor into cells. Similar to the Abl kinase biosensor we previously reported,16 this 
Syk kinase peptide biosensor (SAStide) did not cause toxicity at the concentration used in 
these studies, and was able to detect dose-dependent and time-dependent activation and 
inhibition of endogenous Syk using physiologically relevant stimuli in cultured cell lines 
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as well as primary splenic mouse B cells. These results demonstrate the potential for this 
strategy to be used in a multiwell plate ELISA assay to analyze Syk activity in contexts 
that could include study of signaling processes in a basic research setting or even 
potentially monitoring therapeutic response in translational applications.  
 Crucially, specificity of the SAStide biosensor for detecting Syk activation was 
comprehensively demonstrated in a complex, biologically-relevant system using Syk-
deficient DT40 chicken B cells.  Syk plays a key role in B cell signaling, but is partly 
dependent upon activation of Lyn through antigen binding to the BCR. Stimulation of 
Syk-deficient cells by cross-linking the heavy chain of the BCR in the presence and 
absence of H2O2 allowed for the specificity of the biosensor to be assessed in the context 
of Lyn kinase activation. Phosphorylation of the biosensor was not increased above 
background levels and did not change over time following BCR engagement in the 
absence of Syk, even when overall tyrosine kinase signaling was amplified as a result of 
H2O2 exposure. Syk also plays a major role in oxidative stress signaling, and its activation 
during oxidative stress is the result of both its own activity (via autophosphorylation) as 
well as other protein tyrosine kinases.20a, 25 Other kinases also become activated during 
oxidative stress (as observed via antiphosphotyrosine blotting), yet there was no increase 
in phosphorylation of the biosensor in the absence of Syk under these conditions. 
Reconstitution of the Syk deficient cells with Syk-EGFP resulted in phosphorylation of 
the biosensor peptide under B cell receptor-activating conditions and in the presence of 
oxidative stress. This suggests that even in a complex cellular environment, our biosensor 
is selectively phosphorylated by Syk and not by Lyn or other activated tyrosine kinases in 
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these cells. Together these results demonstrate that our biosensor is specific for the 
detection of Syk activity in B cells and B cell model systems.  
 Another advantage of this strategy is the ability to monitor kinase activation and 
inhibition by compounds such as piceatannol and dasatinib in an intact cell. Isolation of a 
kinase from the cellular environment can alter its function by removing regulatory 
proteins, eliminating alternatively spliced variants, altering post-translational 
modifications and/or disrupting subcellular compartmentalization. Additionally, isolation 
of the kinase precludes evaluation of the contribution of off-target effects of the drug, 
which could potentially affect efficacy (positively or negatively) via inhibition of 
upstream signaling in addition to the direct inhibition of the target. While kinase 
activation in intact cell contexts has been studied by detecting the phosphorylation of 
known endogenous substrate sites, unambiguous detection of these sites requires high-
quality phospho-specific antibodies, and furthermore, not every endogenous site can 
serve as a reliable generic ‘marker’ for the kinase activation state. For Syk, monitoring 
phosphorylation of its tyrosines through surrogate sites (Y348, Y352, Y525/526) has 
been the traditional strategy for determining its activation11a, 21—however, this does not 
necessarily give an accurate report of Syk activity, since some of these sites are 
phosphorylated by upstream kinases and some by Syk autophosphorylation, and 
moreover, phosphorylation of some of these sites modifies the function of the kinase 
while others do not. While Y525/526 is in the activation loop of Syk and is a major 
autophosphorylation site in B cells26 and canonically phosphorylation of these sites would 
suggest enhancement of kinase activity, the role of this phosphorylation in the functional 
activation of Syk remains convoluted. Previous work using a Sox-based fluorogenic, 
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generic tyrosine kinase substrate from Invitrogen has demonstrated that substrate 
phosphorylation kinetics by activation loop-phosphorylated Syk kinase domain (i.e. the 
phospho-Y525/526 form) are similar to those for the unphosphorylated and double 
phenylalanine mutant (F525/F526) forms.14 This suggests that these residues are not 
accurate markers of intrinsic kinase activation, and that a selective tool that can monitor 
Syk’s activation state in complex cellular environments independently of these existing 
markers would be useful for delineating the effects of specific phosphorylation sites and 
kinase inhibitors on different components of the B cell receptor signaling cascade. 
 Using the SAStide biosensor, we also detected inhibition of endogenous 
intracellular Syk activity in a dose-dependent manner by the Src-family kinase inhibitors, 
dasatinib, and piceatannol. We found that the apparent IC50 values were 10 nM and 1 !M 
for dasatinib and piceatannol, respectively. These values are lower than those reported in 
the literature,21, 27 however the literature values were determined using assay formats that 
were very different than the format employed here, and so cannot necessarily be directly 
compared. When examining Syk activation in the mouse primary B cells in the presence 
of these inhibitors, we observed levels of biosensor phosphorylation consistent with those 
observed in EGFP-reconstituted DT40-Syk(-/-) cells—however, according to Western 
blot analysis, Y525/526 remained phosphorylated under these conditions. Since these 
cells were isolated from the spleen, this could be related to the role of kinases acting 
upstream of Syk in signaling pathways.28 Along with the previous report that Y525/526 to 
Phe mutations did not affect the kinase activity, these data also support the idea that 
monitoring an endogenous phosphorylation site as a surrogate for Syk activity does not 
necessarily correctly report the activity of the kinase or response to the inhibitor 
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treatment—whereas phosphorylation of this SAStide biosensor may be used as a marker 
for intrinsic activation of the kinase.  
Aside from its potential utility in basic research on the function of Syk kinase, the 
straightforward workflow and compatibility of this biosensor substrate with the multiwell 
ELISA-style readout might be useful in a translational setting to determine Syk kinase 
pharmacodynamics in patient B cell populations. Despite the observations from the basic 
science research that Syk dysfunction plays a role in disease, the outcomes of clinical 
studies and trials for Syk inhibitors indicate that the benefits of blocking Syk activity in 
patients are less clear. A recent report of results from an ongoing clinical trial in non-
Hodgkins lymphomas (#NCT00446095) of the Syk inhibitor fostamatinib (R788, a 
prodrug form of R406, Rigel Pharmaceuticals) described a range of effects depending on 
lymphoma subtype, which included DLBCL, follicular lymphoma, mantle cell 
lymphoma, MALT lymphoma, marginal zone lymphoma, CLL and SLL.29 The cohort 
was very small, particularly when dissected by lymphoma subtype, and response rates 
were low overall, with slightly better response in chronic lymphocytic leukemia than the 
other types. Notably, in a recent study the R406 form of this drug was found to be one of 
the least selective kinase inhibitors evaluated, in terms of binding affinity for kinases.30 
This highlights the need for pharmacodynamically-relevant assays during the evaluation 
and development of so-called “specific” kinase inhibitors.  
On the immune side, another Syk inhibitor (R112, Rigel Pharmaceuticals), was 
shown to be effective for relieving allergic rhinitis symptoms when delivered 
intranasally, suggesting that there could be a therapeutic benefit to targeting Syk (which 
is upstream of histamine release) for this purpose, and thus may provide an alternative to 
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antihistamine drugs.31 For rheumatoid arthritis, an earlier trial found that Fostamatinib 
provided a significant benefit (over placebo) for rheumatoid arthritis patients receiving 
methotrexate;32 however, a more recent follow-up study by the same group found that this 
inhibitor was not significantly beneficial in another subset of patients who had previously 
failed biologic therapy (e.g. rituximab or abatacept).33 As the authors noted, their “study 
was fraught with seemingly contradictory data.” Many other factors in these patients’ 
diseases (such as status of other inflammatory markers and ability to assess response 
metrics in the presence of confounding factors) may have contributed to the overall 
assessment of responses. Another intriguing possibility is that initial response to biologics 
requires Syk involvement, and therefore this patient subset is inherently unlikely to 
respond to an alternative Syk-targeting strategy. This is also consistent with evidence that 
lower Syk expression in acute myelogenous leukemia is related to a lack of response to 
another therapeutic antibody conjugated to a toxin (gemtuzumab ozogamicin).34 Either 
way, this collection of paradoxical and weak responses indicates that monitoring Syk 
kinase activity and function in the context of individual patients could aid the 
interpretation of outcomes for trials of Syk-targeting agents, and maybe someday help 
guide patient stratification for likelihood of benefit. This will be increasingly important as 
new, more functionally selective Syk inhibitors (e.g. the recently reported compound 
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CHAPTER 3. TIME-RESOLVED LUMINESCENCE DETECTION OF SPLEEN 
TYROSINE KINASE ACTIVITY THROUGH TERBIUM SENSITIZATION 
3.1 Abstract 
Disruption of regulatory protein phosphorylation can lead to disease, and is particularly 
prevalent in cancers. Inhibitors that target deregulated kinases are therefore a major focus 
of chemotherapeutic development. Achieving sensitivity and specificity in high-
throughput compatible kinase assays is key to successful inhibitor development. Here we 
describe the application of time-resolved luminescence detection to the direct sensing of 
Syk kinase activity and inhibition using a novel peptide substrate. Chelation and 
luminescence sensitization of Tb3+ allowed the direct detection of peptide 
phosphorylation without any antibodies or other labeling reagents. Characterizing the 
Tb3+ coordination properties of the phosphorylated vs. unphosphorylated form of the 
peptide revealed that an inner-sphere water was displaced upon phosphorylation, which 
likely was responsible for both enhancing the luminescence intensity and also extending 
the lifetime, which enabled gating of the luminescence signal to improve the dynamic 
range. Furthermore, a shift in the optimal absorbance maximum for excitation was 
observed, from 275 nm (for the unphosphorylated tyrosine peptide) to 266 nm (for the 
phosphorylated tyrosine peptide). Accordingly, time-resolved measurements with 
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excitation at 266 nm via a monochromator enabled a 16-fold improvement in base signal 
to noise for distinguishing phosphopeptide from unphosphorylated peptide. This led to a 
high degree of sensitivity and quantitative reproducibility, demonstrating the amenability 
of this method to both research laboratory and high-throughput applications.  
3.2 Introduction 
Protein kinases play a critical role in multiple cellular processes including growth, 
proliferation and apoptosis. The deregulation of this mechanism can cause an imbalance 
between proliferation and death leading to a number of disease states including cancer. 
Kinase inhibitor drug development is often confounded by the complexity of protein 
kinase signalling pathways, leading to advancement of inhibitors with substantial off-
target effects (which may or may not be beneficial to efficacy) into clinical trials. (1-2) 
Spleen tyrosine kinase (Syk) has recently become an attractive therapeutic target due to 
its role in multiple diseases, including rheumatoid arthritis, non-Hodgkin’s lymphomas 
and chronic lymphocytic leukaemia. (3-5) However, the development of small molecule 
inhibitors specifically and selectively targeting Syk has been challenging, (6-7) with the 
inhibitor fostamatinib (previously described as ‘specific’ for Syk) found to bind to at least 
100 other targets with affinity better than that for Syk. (6) Therefore, sensitive and specific 
tools for monitoring Syk activity are needed to assist in the development of Syk specific 
inhibitors through the rapid screening of therapeutic agents as well as for monitoring 
therapeutic response as a companion diagnostic in the clinic. 
Peptide-based approaches can be used for measuring kinase activity either in vitro 
or in intact cells with a variety of detection strategies. (8-11) Because they enable the 
   98 
!
screening of many samples and conditions at once with high sensitivity using commonly 
available instrumentation, multi-well plate-based detection methods using fluorescence or 
luminescence are most compatible with drug discovery and clinical applications. (12-13) 
Phosphorylation-sensitized lanthanide luminescence has been used as a high-throughput-
compatible probe for kinase activity. Lanthanides have unique optical properties 
including large stokes shifts, long luminescent life times and narrow emission bands. (14) 
Additionally, lanthanides are hard acids giving them preferred coordination with 
negatively charged species such as phosphate, carboxylate and carbonyl groups. (15-16) 
However, lanthanides are poor absorbers and require a sensitizing chromophore to 
achieve luminescence as well as a coordination environment that excludes water to 
prevent solvent luminescence quenching. (17) Accordingly, highly acidic peptides that 
contain appropriate chromophores can provide the necessary coordination environment 
and sensitization for luminescence.   
Several approaches have been developed for the detection of tyrosine 
phosphorylation using terbium (Tb3+) based on these properties. Phosphorylation of a 
peptide can dramatically increase the peptide’s affinity for terbium. (18-24) Sensitization of 
luminescence is achieved either through a chromophore label or through the 
phosphorylated tyrosine itself. (13, 18-20, 22, 25-26) Previously reported approaches provide 
approximately a 2 to 10-fold increase in steady-state luminescence upon phosphorylation, 
depending on the peptide sequence involved—however, since the unphosphorylated 
forms of most acidic peptides also bind Tb3+ and exhibit luminescence to some degree, 
signal to noise and background can be a challenge for distinguishing phosphorylated from 
unphosphorylated peptide. 
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Recently, we developed a Syk specific artificial substrate peptide (SAStide) 
consisting of an acidic motif with a central tyrosine capable of detecting intracellular Syk 
activity in response to physiologically relevant stimuli and pharmacological inhibition (27). 
Based on the similarity of the arrangement of carboxylate groups and the central tyrosine 
in this sequence with the motif found in the atypical phosphorylation dependent terbium 
sensitizing peptide of !-synuclein (Fig. 3.2A), we chose to explore the use of this peptide 
as a probe for the detection of Syk activity through terbium-sensitized luminescence. 
Because (as with all fluorophores) lanthanide luminescent lifetimes are sensitive to the 
chemical environment of the metal ion, (28) we also tested whether chelation of Tb3+ with 
the phosphorylated vs. unphosphorylated peptide could be more easily distinguished 
using time-resolved luminescence detection. In a time-resolved luminescence 
measurement, the short-lived background luminescence is allowed to decay before 
measuring the luminescence of the chelated Tb3+ (Figure 3.1). While the overall 
sensitivity for a time-resolved vs. a steady state measurement is usually lower because of 
the gating of the highest intensity initial signal, this can be mitigated to some degree by 
optimizing the integration times. The long luminescent lifetime of terbium enables use of 
longer integration times, and provides an opportunity to eliminate any interference from 
autofluorescence and other background within the sample increasing the specificity and 
signal to noise for detection. Here we describe the testing and characterization of this 
strategy as a method for detecting Syk kinase activity and inhibition. 




Figure 3-1 Time-resolved luminescence detection of Syk kinase activity using SAStide 
 
3.3 Materials and Methods 
Peptide Synthesis and Purification. Peptides were synthesized at a 50 µmol scale using 
a Protein Technologies Prelude Parallel peptide synthesizer on CLEAR-amide resin 
(Peptides International). Coupling of standard Fmoc (9-fluorenylmethoxy-carbonyl)-
protected amino acids (Peptides International) were achieved with HCTU in the presence 
of NMM in DMF for two 10 min couplings. Fmoc deprotection was achieved in 20% 
piperidine in DMF for two 2.5 min cycles. Side-chain deprotection and peptide cleavage 
from the resin was performed in 5 ml cocktail of trifluoroacetic acid (TFA): water: ethane 
dithiol (EDT): triisopropylsilane (TIS) (94:2.5:2.5:1).  Peptides were precipitated and 
washed three times with cold diethyl ether. The peptides were dissolved in acetonitrile: 
water: TFA (50:50:0.1), flash frozen and lyophilized. The peptides were purified by 
preparative reverse-phase HPLC (Agilent Technologies 1200 Series) a using C18 
reverse-phase column.  
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Luminescence Emission Measurements. Emission spectra (both steady-state and time-
resolved) were collected on a Biotek Synergy4 plate reader equipped with a 
monochromator at 23°C in black 384-well plates (Greiner Fluortrac 200). For time-
resolved measurements, spectra were collected after excitation at either 266 nm or 280 
nm (as denoted in specific experiments) with a Xenon flash lamp followed by a delay of 
50 µsec. A luminescence scan between 450-650 nm was collected in 1 nm increments 
with 1 msec collection time and 10 readings per data point. Sensitivity (an instrument 
parameter similar to gain) was adjusted as necessary and is reported where relevant. 
Job’s Plot.  The molar fraction of the pSAStide biosensor and Tb3+ were continuously 
varied inversely of each other while maintaining a total molar concentration of 16 µM 
(i.e. 1 µM pSAStide and 15 µM Tb3+, 2 µM pSAStide with 14 µM Tb3+, 15 µM pSAStide 
and 1 µM Tb3+) for each data point. Luminescent emission spectra were collected as 
described above and the area under the emission spectra was used as the parameter for 
quantification of complex formation as luminescent increases with complex formation. 
Binding Affinity. Tb3+ binding to SAStide and pSAStide was measured using Tb3+ 
luminescence sensitized by the central tyrosine or phosphotyrosine residue of SAStide 
and pSAStide respectively. Tb3+ was added to 100 nM of either peptide at final 
concentrations ranging from 0 to 20 µM. All experiments were carried out in 10 mM 
HEPES and 100 mM NaCl (pH 7.5) at a volume of 100 µL. After excitation of the 
samples at 266nm (pSAStide) or 280nm (SAStide), Tb3+ luminescence emission spectra 
between 450 to 650 nm were collected for 1 ms following a 50 µs delay and 30 readings 
per data point. Background luminescence emission was subtracted from the peptide in the 
absence of terbium. The area under each spectrum was integrated and used as the metric 
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for quantification. The data were fit to Eq. 1 by using KaleidaGraph nonlinear curve-
fitting software, where I is the Tb3+ luminescence at a given concentration, Imax 
corresponds to the maximum Tb3+ emission, [Tb3+]T is the total Tb
3+ concentration, [P]T is 
the total peptide concentration  and Kd is the equilibrium dissociation constant. 
I = Im * ([Tb
3+]T + Kd + [P]T) - !(([Tb
3+]T + Kd + [P]T)
2 – 4([Tb3+]T * [P]T)) / (2 * [P]T) (1) 
In vitro kinase assay. EGFP-conjugated Syk was isolated from DT40 chicken B cells 
stably expressing Syk-EGFP. Cells were lysed using a solution containing 1% Nonidet P-
40, 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 
2mM NaF and 1X mammalian protease inhibitor cocktail (Sigma). Syk-EGFP was 
immunoprecipitated using GFP-Trap_A beads (Chromotek). Lysates were incubated with 
the beads for 1 h at 4°C. The kinase-bound beads were washed and then used in the in 
vitro kinase assay (0.4 µg/µL). Syk-EGFP was incubated with the kinase reaction buffer 
(3.4 µg Syk-EGFP, 100 µM ATP, 10mM MgCl2, 1µM Na3VO4, leupeptin, aprotinin, 125 
ng/µL BSA and 25 mM HEPES pH 7.5, total volume 170 µL) containing SAStide at 37.5 
µM at 30°C. Aliquots (20 µL) were taken at designated time points (0.5, 5, 10, 15, 30, 45, 
60 and 90 min) and quenched in 6 M urea (20 µL). The quenched samples were then 
treated with the luminescence buffer (500 µM Tb3+ and 500 mM NaCl, 10 µL) for a total 
volume of 50 µL (final concentrations of sample components: 2.4 M urea, 40 µM ATP, 4 
mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50 ng/µL BSA and 10 mM HEPES pH 
7.5). Luminescence emission spectra were collected as described above and the area 
under each spectrum was integrated using GraphPad Prism. An additional aliquot (1 µL) 
of the kinase reaction mixture was taken at each time point for validation of 
phosphorylation using an ELISA-based chemifluorescent assay as previously 
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described. (27) Briefly, each aliquot was quenched with 0.5 M EDTA and incubated in a 
96-well Neutravidin coated plate (15 pmol biotin binding capacity per well, Thermo 
Scientific) in Tris-buffer saline (TBS) containing 0.1% BSA and 0.05% Tween 20 for 1h. 
Following incubation, each well was washed with the TBS buffer and the incubated with 
mouse anti-phosphotyrosine monoclonal antibody 4G10 (Millipore, 1:10,000 dilution in 
TBS buffer) for 1h. Following incubation, each well was washed with TBS buffer and 
incubated with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G 
(IgG) secondary antibody (Abcam) (1:1000 dilution) for 1h. Wells were then washed and 
treated with Amplex Red reaction buffer (Amplex Red reagent, Invitrogen, 20 mM H2O2 
and sodium phosphate buffer) for 30 min. Fluorescence was measured using a Synergy4 
multiwell plate reader (Biotek) with an excitation wavelength of 532 nm and emission 
wavelength of 590 nm. 
Dose-Response Inhibition Assay. Syk-EGFP (0.4 µg/reaction) was incubated with the 
kinase reaction buffer described above before adding SAStide in the presence of DMSO 
(vehicle) or varying concentrations of piceatannol at 30°C for 10 min prior to the start of 
the reaction. The reaction was started with the addition of SAStide (37.5 µM, total 
reaction volume 20 µL). Each reaction was quenched after 30 min in 6 M urea (20 µL). 
The samples were then treated with the luminescence buffer (500 µM Tb3+ and 500 mM 
NaCl, 10 µL) for a total volume of 50 µL. 
High-Throughput Screening Calculations.  The Z’ factor was calculated according to 
Eq. 2. 
Z’ = (µpos - 3!pos/"n) – (µneg + 3!neg/"n) / (µpos - µneg)       (2) 
And the signal window was calculated according to Eq. 3 
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SW = (µpos - 3!pos/"n) – (µneg + 3!neg/"n) / (!pos/"n)         (3) 
Where n is the number of replicates, µpos and µneg are the average luminescence of the 
positive (pSAStide or uninhibited) and negative (SAStide or inhibitor treated EGFP-Syk) 
controls respectively; !pos and !neg are the standard deviation of the positive and negative 
controls. 
3.4 Results 
3.4.1 Time-resolved luminescence measurements increase signal to noise 
Phosphorylated (pSAStide) and unphosphorylated (SAStide) forms of the peptide were 
synthesized and steady-state luminescence of each 1:1 Tb3+ complex with excitation at 
266 nm through a monochromator (for highly resolved excitation energy control) was 
measured (Fig. 3-2B). The optimal excitation energy was determined to be 266 nm for 
pSAStide and 275 nm for SAStide and were used for characterizing each species in 
complex with terbium. At 266 nm excitation energy, pSAStide exhibited strong Tb3+ 
sensitization and SAStide displayed weaker luminescence. Based on this we used 266 nm 
for all further analyses. While SAStide signal was somewhat mitigated by using 266 nm 
excitation energy, there was still weak but significant luminescence from SAStide so the 
signal to noise (comparing pSAStide and SAStide luminescence) was low (2:1). 
However, time-resolved measurements significantly improved the signal to noise to 32:1 
(Fig. 3-2C), demonstrating that taking advantage of the increase in Tb3+ luminescence 
lifetime in the presence of phosphotyrosine vs. unphosphorylated tyrosine improved the 
ability to detect phosphorylation of SAStide. The improvement in the signal to noise ratio 
was accomplished by allowing the short-lived signal of the unphosphorylated peptide to 
decay prior to collection. 
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Figure 3-2 Detection of phosphorylation of SAStide through terbium luminescence. A) 
Sequence alignment of a peptide from !-synuclein, an atypical terbium sensitizing 
peptide, and SAStide. B) Steady-state luminescence and C) time-resolved luminescence 
emission plots for SAStide and pSAStide. pSAStide (—) SAStide (---) and Tb (···). 
Spectra were collected from 15 µM peptide in the presence of 100 µM Tb
3+
 in 10mM 
HEPES, 100mM NaCl, pH 7.0, "ex=266nm, 1000ms collection time, 50 µsec delay time 
and sensitivity 180. Data represent the average of experiments performed in triplicate. 
 
3.4.2 Physical characterization of SAStide-lanthanide binding and luminescence 
Binding studies were performed to determine the stoichiometry and affinity of pSAStide-
terbium complexation. The binding stoichiometry of the highest affinity complex was 
established using the Jobs method of continuous variations. (29) The area under the 
emission spectrum was used as the metric to quantify the pSAStide-Tb3+ binding ratios. 
pSAStide and terbium individually displayed no detectable luminescence; therefore, any 
changes in luminescence could then be attributed the formation of the pSAStide-Tb3+ 
complex. The Jobs plot displayed an increase in total area as the mole fraction of terbium 
increased to 0.5 followed by a linear decrease with further increases in the mole fraction 
(Fig. 3-3A). These data indicated that the preferred binding stoichiometry of pSAStide-
Tb3+ binding is 1:1.  
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Figure 3-3 Characterization of the SAStide/Tb
3+
 physical interaction. A) Jobs Plot of 
continuous variation. The mole fraction of Tb
3+
 and pSAStide were inversely varied 
relative to each to maintain a total molar concentration of the two species at 16 !M. 
Luminescence spectra were collected in 10mM HEPES, !ex = 266 nm, 1000ms collection 
time, 50 µsec delay time and sensitivity 180. Data represent averages ± SEM of 
experiment performed in triplicate. B) Binding affinity of SAStide-terbium complexation. 
Spectra were collected using 1 µM pSAStide (!) or SAStide (") in the presence of 
varying concentrations of Tb
3+
 in 10mM HEPES, 100mM NaCl, pH 7.5, !ex = 266 nm for 
pSAStide and !ex = 275 nm for SAStide, 1000ms collection time, 50 µsec delay time and 
sensitivity 180. Data represent averages ± SEM of experiment performed in triplicate. 
 
Binding affinities were also determined using Tb3+ luminescence as a measure of 
complexation. Terbium was titrated in the presence of 100 nM pSAStide or SAStide and 
luminescence emission spectra were collected and integrated. The binding curves 
displayed a hyperbolic increase in luminescence with increasing terbium concentrations 
from 0-20 µM (representing a large excess of terbium), with saturation between at 20 µM 
characteristic of one site binding (Fig. 3-3B). Additional increases in luminescence, 
ranging up to three fold, were observed with increasing terbium concentrations, which 
mass spectrometry analysis suggested were likely due to complexes containing multiple 
terbium ions. However, for the remainder of this work detection of pSAStide was carried 
out with 6.67 equivalents of terbium relative to peptide, thus the 1:1 binding mode 
characterized by the initial hyperbolic increase was the most relevant to detection under 
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conditions used subsequently for assays. The calculated Kd for the 1:1 pSAStide-terbium 
complex represented by the hyperbolic curve was 1.51 ± 0.087 µM, which is comparable 
to the affinities reported for other terbium binding peptides.  (15, 20) The 
unphosphorylated SAStide-terbium complexation displayed significantly weaker binding; 
the 1:1 complex exhibited a Kd of 7.64 ± 0.32 µM (5-fold weaker than for the 
phosphorylated peptide). These results demonstrate that phosphorylation increased the 
affinity of SAStide for Tb3+. Also, since the greatest fold change in signal for pSAStide-
terbium vs. SAStide-terbium was observed for the 1:1 complex, this represented the best 
ratio to maintain in subsequent kinase assays. 
Measurements of the terbium luminescence lifetime were performed to 
characterize the photophysical properties of pSAStide-terbium and SAStide-terbium 
complexation. The hydration number (i.e. the number of water ligands (q) in the terbium 
coordination sphere) can be determined via the luminescence lifetime of the complex in 
H2O vs. D2O, since the terbium excited state is quenched by the –OH vibrational 
overtones of H2O but not D2O. Luminescence spectra for the pSAStide:Tb
3+ and 
SAStide:Tb3+ complexes were collected in various ratios of H2O/D2O. The luminescence 
lifetimes were fitted to a single exponential decay and were determined to be 2.02 ms and 
2.48 ms in H2O and D2O respectively for pSAStide:Tb
3. These lifetimes lead to a q value 
of 0.12 for the phosphopeptide complex, indicating nearly an absence of H2O in the inner 
coordination sphere of terbium at equilibrium. The unphosphorylated SAStide:Tb3+ had a 
comparably shorter lifetime in H2O at 1.88 ms and a longer lifetime D2O of 2.92 ms 
resulting in a q value of 0.66. These data suggest the SAStide:Tb3+ contain closer to one 
H2O in the coordination sphere at equilibrium, resulting in more quenching of the terbium 
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excited state, which manifested as a shorter lifetime. These differences are likely related 
to the greater luminescence intensity observed for the phosphorylated vs. 
unphosphorylated peptide, and also to the longer lifetime of the phosphopeptide that 
enabled gating of the signal for better dynamic range for discriminating the 
phosphorylated from unphosphorylated species using time-resolved signal collection. 
(Table 3-1) 
Table 3-1 Photophysical properties of the pSAStide-terbium and SAStide-terbium 
complexes.  
Peptide !Ex "H2O "D2O q # 
pSAStide 266 2.02 2.44 0.12 0.34 
SAStide 275 1.88 2.92 0.66 N.D. 
!Ex = maximum excitation wavelength; "H2O
-1
 = luminescence decay in the presence of 
H2O; "D2O
-1
 = luminescence decay in the presence of D2O; q = number of H2O ligands in 
inner coordination sphere at equilibrium; # = quantum yield.
 
 
The quantum yield for the pSAStide-terbium complex was determined using 
diffusion-enhanced energy transfer from the complex to fluorescein isothiocyanate 
(FITC).  (30) Luminescence emission spectra were collected in the presence of varying 
concentrations of FITC with increasing delay times. The time-resolved emission spectra 
and corresponding lifetime plots display an increase in emission intensity and a 
simultaneous decrease in the lifetime with increasing concentrations of FITC, and the 
quantum yield calculated from these data was 0.34. 
3.4.3 Quantitative detection of Syk kinase activity using Tb
3+
 sensitization 
To demonstrate the use of SAStide:Tb3+ as a biosensor for quantitative detection of Syk 
activity, a calibration curve was established using mixed ratios of SAStide and pSAStide 
   109 
!
in the presence of the kinase assay components and quenching buffer conditions (MgCl2, 
BSA, ATP, NaVO4, protease inhibitors, piceatannol, DMSO, urea) at concentrations 
sufficient to mimic an appropriate background matrix for a kinase assay measurement 
(Fig. 3-4A). Luminescence emission spectra were collected for the various 
SAStide/pSAStide ratios and the area under the curves were integrated. Controls showed 
limited interference from the components of the kinase assay and quenching conditions.  
The calibration curve demonstrated that the emission spectral area increased linearly and 
was well correlated with increasing percent phosphorylation (Fig. 3-4B). However, there 
was an increase in the basal signal in the absence of pSAStide (relative to mixtures of just 
peptide and simple buffers) that was likely due to complexation of terbium with ATP. 
The three phosphate groups of ATP can provide an appropriate coordination environment 
and adenosine provides the appropriate chromophore for excitation (!ex=259 nm), giving 
rise to some background even with time-resolved measurements. Compared to detection 
of pSAStide vs. SAStide in HEPES buffer alone, this increase in background signal 
reduced the signal to noise ratio (S/N) by half (Figure 3-2C compared to Figure 3-4B). 
However, despite this decrease excellent S/N (15.3:1) was still achieved.  
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Figure 3-4 Calibration and detection of phosphorylation of SAStide. A) pSAStide-Tb
3+
 
luminescence emission spectra in the presence of the quenched Syk in vitro kinase assay 
buffer (2.4 M urea, 40 µM ATP, 4 mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50 
ng/!L BSA and 10 mM HEPES pH 7.5). Spectra were collected from 15 µM peptide in 
the presence of 100 µM Tb
3+
 (representing a ratio of 6.7 Tb
3+
:peptide, which corresponds 
to the saturated range for 1:1 binding) in 10mM HEPES, 100mM NaCl, pH 7.0, 
!ex=266nm, 1000ms collection time, 50 µsec delay time and sensitivity 180. B) Emission 
spectral area calibration curve based on percent phosphorylation in vitro. C) in vitro Syk 
kinase assay luminescence emission spectra. D) Interpolated percent phosphorylation 
from Syk in vitro kinase assay. Data indicate averages ± SEM of experiments performed 
in triplicate. 
 
The limit of detection (LOD) for phosphorylation was 3.8 ± 0.51%, defined as the 
percentage of pSAStide that gave a signal area corresponding to 3X the standard 
deviation greater than the baseline for unphosphorylated SAStide in the quenched kinase 
reaction buffer (the negative control). The limit of quantification (LOQ) for 
phosphorylation was 7.4 ± 0.52 %, defined as the percentage of pSAStide that gave a 
signal area 10X the standard deviation greater than the signal in the negative control. (31) 
We also calculated the Z’ factor and the signal window (SW) to determine if this sensor 
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would be appropriate for use in a high throughput screening (HTS) assay. The Z’ factor 
should be between 0.5 and 1 for an assay to be considered appropriated for HTS, as 
assays with a Z’ factor in this range exhibit a large dynamic ranges and wide separation 
of positive and negative results.  (32-33) Assays with a SW greater than 2 are also 
considered appropriate for HTS assays.  (32-33) Both parameters were calculated from 
the mean emission and standard deviation of the spectral area from triplicate 
measurements of the negative control SAStide in the in vitro assay buffer and the positive 
control pSAStide in the same conditions. The Z’ factor and SW were determined to be 
0.82 and 14.63, respectively, indicating that time-resolved terbium luminescence 
detection of SAStide phosphorylation is an appropriate method for HTS assays.  
Detection of Syk activity in vitro was accomplished using Syk-EGFP 
immunoprecipitated from engineered DT40 chicken B-cells with the kinase reaction 
buffer and quenching conditions described above. After pre-incubation of the enzyme 
with the kinase reaction mixture, SAStide substrate was added and aliquots of the 
reaction were quenched at various time points in urea (to denature the enzyme). Tb3+ was 
added and time-resolved luminescence was measured (Fig. 3-4C). The areas under the 
emission spectra were calculated, the percent phosphorylation was interpolated from the 
calibration curve and plotted against time (Fig. 3-4D). These data show that enzymatic 
phosphorylation of SAStide can be detected using time-resolved Tb3+ luminescence.  As a 
control to verify phosphorylation, an additional aliquot was used for detection of 
phosphorylation using an ELISA-based chemifluorescent assay.  
We also examined the potential of this strategy to be used for inhibitor screening. 
The effect of the Syk inhibitor piceatannol (34) was assayed in a dilution series from 10 nM 
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to 10 mM. Luminescence emission spectra were collected and integrated (Fig. 3-5A). The 
areas were normalized to the DMSO control and reported as percent activity. The 
observed IC50 for piceatannol was 178±1.4 µM (Fig. 3-5B), consistent with that found in 
the literature.  (35) The Z’ factor and SW were determined in the context of the dose-
response inhibition assay, calculated from the standard deviation and mean from the 
normalized percent activity from triplicate measurements of the negative control (10 mM 
piceatannol) and the positive controls (10 nM – 500 µM piceatannol). Over all the 
positive controls the Z’ factor was greater than 0.5 and the SW was greater than 2 
demonstrating that the application of pSAStide:Tb3+ maintains its appropriateness as a 
HTS tool in practice.  
 
 
Figure 3-5 Detection of dose-dependent Syk inhibition. A) in vitro Syk kinase assay 
luminescence emission spectra. Spectra were collected from 15 µM peptide in the 
presence of 100 µM Tb
3+
 in the presence of the quenched kinase reaction buffer (2.4 M 
urea, 40 µM ATP, 4 mM MgCl2, 0.4 µM Na3VO4, leupeptin, aprotinin, 50 ng/!L BSA 
and 10 mM HEPES pH 7.5), !ex=266nm, 1000ms collection time, 50 µsec delay time and 
sensitivity 180. B) Dose-response inhibition of Syk by the inhibitor piceatannol. The 
extent of biosensor phosphorylation was interpolated from the calibration curve and 
normalized to the uninhibited DMSO control. Data indicate averages ± SEM of 
experiments performed in triplicate 
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3.5 Discussion 
In summary, we have demonstrated that time-resolved Tb3+ luminescence 
measurements substantially increase signal to noise and thus dynamic range for 
quantitative analysis of peptide phosphorylation. Time-resolved luminescence detection 
has been employed in FRET-based assays for kinase activity (e.g. the LanthaScreen® 
assay from Life Technologies), (36) however these assays rely on Tb3+ chelation by a 
macrocyclic carrier conjugated to an anti-phosphosite antibody coupled with a 
fluorescently labeled substrate, and Tb3+ itself is not involved in binding to the 
phosphorylated product of the kinase reaction—therefore the LanthaScreen® technique 
depends on antibody availability and is an indirect, “off-line” measure of substrate 
phosphorylation. Exploiting the binding and sensitization of Tb3+ directly with a 
phosphorylated substrate is essentially “label-free,” since neither antibodies nor 
fluorophore labels are required. In our studies, time-resolved measurements significantly 
improved the signal to noise of detection compared to steady-state measurements by 
minimizing background signal. The ability to discriminate between the coordination 
environments for Tb3+ binding to the unphosphorylated vs. phosphorylated peptides based 
on luminescence lifetime facilitated the improvement we observed in distinguishing 
between species. Accordingly, phosphorylation of the Syk substrate peptide SAStide 
could be applied for rapid, quantitative and sensitive detection of Syk kinase activity and 
inhibition by small molecule inhibitors with little to no interference from the components 
of the kinase reaction.  
Besides the specific application to Syk kinase described here, this strategy has 
broad significance for detecting phosphorylation using lanthanide sensitization. Time-
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resolved detection should expand the possibilities for other peptide- and protein-based 
lanthanide sensitization approaches to achieve better dynamic range and sensitivity. This 
will enable us and others to leverage existing Tb3+-sensitizing substrates for other kinases, 
as well as open a new avenue for development of novel substrates to achieve high-
throughput compatibility for other kinase targets important in therapeutic development, 
that otherwise may not have provided sufficient signal to noise with steady-state 
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CHAPTER 4. PIPELINE TO DEVELOP PHOSPHORYLATION-DEPENDENT 
TERBIUM SENSITIZING TYROSINE KINASE BIOSENSORS 
4.1 Abstract 
Non-receptor protein tyrosine kinases represent a major class of enzymes essential 
for cellular homeostasis, and thus are a major focus of current drug discovery efforts. 
Many of these enzymes display differences in substrate specificity but are structurally 
similar even between families. This makes the design of substrates that can distinguish 
between tyrosine kinase families a challenge. Peptide substrates that can enhance 
lanthanide ion luminescence upon tyrosine phosphorylation enable rapid, sensitive 
screening of kinase activity. However, the bottleneck caused by the laborious task of 
identifying and optimizing sequences has slowed the development of efficient and 
selective substrates for lanthanide-based kinase assays. Streamlined strategies to identify 
sequences that strike an ideal balance between phosphorylation efficiency, selectivity and 
lanthanide binding are needed. Here we present a method to circumvent this bottleneck 
and rapidly identify kinase specific substrates that are capable of detecting tyrosine 
kinase activity through phosphorylation-dependent terbium (Tb3+) sensitization. We 
exploited positional scanning peptide libraries and brought in existing proteomic data 
from natural substrates to identify substrate preference features that can be applied to 
achieve substrate specificity while enabling Tb3+ binding via key substitutions at residues 
that are unimportant for specificity. We applied this strategy to develop biosensors for 






several non-receptor tyrosine kinases, including Abl, Jak2 and Src family tyrosine 
kinases. We demonstrated that these substrates are selective within kinase families and 
are amenable to high throughput drug screening applications. Overall, this strategy 
represents a pipeline for developing efficient and specific assays that use lanthanide-
based detection for virtually any tyrosine kinase/kinase family.  
4.2 Introduction 
Protein kinases catalyze the reversible phosphorylation of proteins and play a 
ubiquitous role in the regulation of signal transduction pathways directing cellular 
processes including proliferation, survival and adhesion. Phosphorylation of a protein can 
result in changes in activity, conformation, and stability as well as facilitate protein-
protein interactions through phospho-recognition domains. The human genome encodes 
for more than 500 protein kinases, 32 of which are non-receptor tyrosine kinases 
(NRTKs). (1) This class of kinases represents the primary mechanism for integrating 
signaling events initiated at the membrane to affect gene regulation in the nucleus. 
Deregulation of these kinases can occur through overexpression or constitutive 
activation, which are facilitated by two mechanisms: 1. Loss of function of tumor 
suppressors (e.g. tyrosine phosphatases PTEN and SHP-1) or loss of autoinhibitory 
mechanisms (e.g. intramolecular binding of protein interaction domains), and 2. Gain of 
function mutations (as seen in Philadelphia chromosome-positive chronic myelogenous 
leukemia, CML, and the Jak2 V617F mutation in myeloproliferative disorders). (2-4) The 
association of many NRTKs with a multitude of disease states has led to a large drug 
discovery effort, resulting in the development of 24 FDA-approved small molecule non-
receptor tyrosine kinase inhibitors since 2001. (5) However, despite the preclinical and 






clinical success of these particular drugs, small molecule inhibitors have only been 
approved for 30 kinases from 12 families (5.8% of the kinome and 9.8% of the families). 
Although most of these are marketed as “specific,” many actually lack selectivity for a 
single target (which is arguably a factor in their success). Therefore, the development of 
tools that allow for sensitive and specific detection of the activity of many kinases, 
including the dissection of multiple targets, is critically important for understanding the 
full scope of on- and off-target effects in kinase inhibitor biology. This integrated 
information will contribute fundamentally to the development of new therapeutics and 
also enable relevant treatment monitoring strategies in the clinic. 
 Typical strategies for monitoring kinase activity use radioactive ATP, antibodies, 
or proteomics to detect phosphorylation of native substrates. (6-8) While these methods 
have successfully generated a wealth of information about kinase activity they each suffer 
from several disadvantages. The dependency of many kinases on upstream activities 
makes interpreting phosphorylation of endogenous substrates difficult. The ability of 
kinases to compensate for each others’ loss can also confound the assignment of 
endogenous phosphorylation sites as targets for a specific enzyme. Artificial peptide 
substrates (as opposed to endogenous substrates) offer an attractive strategy for 
examining kinase activity either in vitro or intact cells due to their diverse chemistries, 
compatibility with a wide variety of detection platforms, and their ability to directly 
report the function of a particular enzyme. These have been used with analytical 
approaches including capillary electrophoresis, voltammetry, mass spectrometry, 
antibody-based detection (e.g. ELISA), light scattering based methods using SERS and 
RLS, and fluorescence-based methods e.g. chelation enhanced fluorescence (CHEF), 






FRET and fluorescence quenching. (9-19) In particular, CHEF methods that sensitize 
lanthanide ions such as terbium (Tb3+) in a phosphorylation-dependent manner can enable 
high sensitivity and analytical reproducibility. Previously, we described the application of 
a kinase specific peptide substrate (SAStide) for the sensitive detection of spleen tyrosine 
kinase (Syk) activity in vitro through phosphorylation-dependent enhanced sensitization 
of Tb3+ luminescence. The peptide biosensor was comprised of kinase recognition motif 
as well as an acidic motif that is appropriately arranged for Tb3+ chelation. (20) The 
luminescence signal is generated when phosphorylation of the tyrosine residue results in 
exclusion of water and completion of the Tb3+ coordination sphere. Phosphorylation also 
alters the excitation wavelength of the aromatic side chain and increases the binding 
affinity for the peptide, resulting in a large increase in luminescence (16-fold in the case 
of SAStide). However, other than this example of a serendipitous case, most CHEF 
substrates are designed primarily to achieve optimal metal binding, which often comes at 
the expense of kinase selectivity and enzyme kinetics. Currently there is no general, 
streamlined method to identify and develop novel substrates that are simultaneously 
specific for an individual kinase and strong metal chelators.  
To develop such an approach, both elements (specificity and binding) must be 
taken into account. Kinase specificity is determined by two factors: protein-protein 
interaction domains and the kinase domain interaction with the substrate sequence. (21, 
22) Typically, once a kinase has been recruited to a substrate through a protein-protein 
interaction (e.g. a local scaffolding protein or a domain in the kinase itself), the kinase 
domain’s recognition of the substrate sequence determines the efficiency of 
phosphotransfer. Therefore, while scaffolding and protein-protein interactions are very 






important, the kinase substrate recognition factor is also critical for the specificity of 
signal transduction. Phage display, degenerate peptide libraries, and related techniques 
have successfully identified substrate specificity profiles for many kinases. (22-25) 
However, these techniques have not universally yielded motifs that can be directly 
translated into efficient, selective kinase substrates. Within the sequence space defined by 
a given motif (which can comprise tens of thousands of permutations), computational 
prediction of preference is not 100% accurate, so not all sequences that score strongly via 
prediction algorithms are efficient substrates when tested empirically. Additionally, 
“positive” sequences of amino acids are selected based on the best residues for catalytic 
turnover in a given assay, which usually only tests one kinase. Therefore, many motifs 
look similar across non-receptor tyrosine kinases, and data from these methods seem to 
imply that there are few selectivity determinants. This suggests that there would be 
limited ability to discriminate between kinase specificities with an individual peptide 
sequence.  
Amino acid residues that prevent the interaction of a protein domain with a 
particular sequence (due to e.g. steric clash or charge-based repulsion), termed “non-
permissive” residues, have recently been identified as important determinants in SH2 
domain specificity. (26) Anecdotal evidence exists in the literature supporting the idea 
that such a hypothesis could apply to kinase substrate interactions as well. For example, 
spleen tyrosine kinase (Syk) has been shown to prefer acidic residues both up- and 
downstream of the phosphorylation site. Substitution analysis of the acidic endogenous 
Syk substrate BLNK Y178 via point mutations of the GST-tagged substrate peptides 
demonstrated that single substitutions of basic residues at the -1 or +1 positions were 






sufficient to attenuate phosphorylation of the sequence by Syk. (27) Similar results were 
observed when a peptide microarray containing 1,433 known phosphorylated peptides 
was screened to determine Abl substrate preference. (28) Peptides containing lysine, 
arginine, proline, and aspartic acid at the -2, -1, +1 and +3 positions, respectively, 
reduced Abl’s ability to phosphorylate these sequences. The determinants for non-
permissive residues have even been demonstrated through structural homology models 
for the catalytic domains of Abl and Src tyrosine kinase based on the crystal structure of 
insulin receptor tyrosine kinase. Site directed mutations of the kinase domains guided by 
these homology models displayed dramatic changes in kinetic parameters. (29, 30) These 
observations suggest that incorporating the concept of non-permissive residues into a 
substrate development model could enable the fine-tuning of motifs for better selectivity. 
In this report, we present a pipeline to develop peptide substrates for tyrosine 
kinases (using the NRTKs as a model system) that are compatible with phosphorylation 
dependent sensitization of Tb
3+
. Using a novel high-density microarray screening assay, 
we analyzed positional scanning peptide libraries against representative members of most 
of the non-receptor tyrosine kinase families and tested peptides based on the consensus 
motifs that were generated out of these analyses against a panel of NRTKs. We then 
refined these motifs by bringing in curated collections of known endogenous substrate 
sequences and combined the concepts of motif profiling and non-permissive residue 
identification in an in silico model that enabled the rapid identification of selectivity 
determinants and the relative “importance” of maintaining certain residues at each 
position. We used this information and Tb
3+
 motif alignment as sequence-space-filtering 
criteria to narrow down the potential substrate library generated from the motif for a 






given kinase to a manageable handful of sequences that could be empirically tested and 
thoroughly characterized. We then applied this pipeline to generate biosensors for Abl, 
Jak2, and Src-Family tyrosine kinases and demonstrated HTS assays using the Abl 
substrate against a small molecule library to identify novel Abl inhibitors. 
4.3 Methods 
Peptide synthesis and purification. Peptides were synthesized using a Protein 
Technologies Prelude Parallel peptide synthesizer on Rink-amide resin. Coupling of 
standard Fmoc-protected amino acids were achieved with HCTU in the presence of 
NMM in DMF for two 10 min couplings. Fmoc deprotection was preformed in 20% 
piperidine in DMF for two 2.5 min cycles. Split-pool libraries were synthesized as a 
single reaction until the +1 position where the resin was split into equal portions and each 
amino acid was coupled with 4 equiv of the Fmoc-amino acid/HCTU/NMM for the same 
length of time as above. Following coupling of the -1 position the resin of all reactions 
with substitutions at the -1 position were combined. The reaction was continued until all 
substitutions were synthesized. 
Feature extraction. Positional Scanning Peptide Library – The positional scanning 
peptide library was generated and assayed using recombinant enzyme and !-P
32
-ATP by 
Dr. Yang Deng in Prof. Benjamin Turk’s laboratory at Yale University. Data 
(unpublished) were provided to the Parker laboratory in the form of tables representing 
the radioactive phosphate signal intensity for the spots on the PSPL arrays. To combine 
the PSPL data with the endogenous substrate information in the filtering algorithm, 
peptide phosphorylation signals for each array were quantified based on the median 






intensity for each spot. The median intensity values were then background corrected and 
signal intensity were then normalized by the following equation: 
!  




where Zij stands for the normalized score of amino acid j at position i having a signal 
score Sij, and m stands for the total number of amino acids. Sci is the signal score of 
amino acid j at position i where i is defined in the summation of all the m amino acids.  
Positional Probability (from endogenous substrates) – To characterize a sequence of nine 
amino acids, four on either side of the phosphorylation site (-4 to +4) were considered in 
the score. These positions were chosen based on the disorder in known substrates, which 
increases substantially beyond that distance from the phosphorylation site. We computed 
the biological probability matrix, BPM, as follows. It is experimentally known that kinase 
k phosphorylates n substrates (n1, n2, …, nn) consisting of nine amino acids, four on each 
side of the phosphorylation site. The frequency of each amino acid at each position in the 
collection of substrates was computed, fj,i, where j is amino acid (A, C, …, W, Y) at 
position i (-4, -3, …, 1). Due to the limitation of identified substrates for some kinases, 
when j = 0 for those amino acids the value of j = 1/n, where n is the number of substrate 
sequences for kinase k. The matrix values were computed by comparing the observed 
frequency, fi,j, within the substrates to the expected frequency (background frequency), 
bi,j, derived from the frequency of each amino acid in each protein containing a substrate 
sequence as well as non-phosphorylated interacting proteins (defined using protein-
protein interaction databases (Human Protein Reference Database, String 9.0 and 






BioGRID 3.2) and curated by literature analysis). We constructed the probability matrix 
20 x 9 for each amino acid and position defined as si,j = fi,j / bi,j. 
Positional Scoring Matrix – The two individual matrices, BPM and PSPLM, were then 
multiplied together to form the positional scoring matrix, PSM. The value for each amino 
acid was then used to identify favorable and unfavorable residues at each position. Values 
greater than 0.9 were considered favorable or permissive for the kinase, while values less 
than 0.9 were consider unfavorable or impermissive. 
For an nonapeptide of a given amino acid sequence the product of all si,j values yields the 
raw probability score, SR. 
! 




The raw score was normalized by probability of any nonapeptide being a substrate for 
kinase k, Ps. Ps was determined by the number of kinase substrates collected, n, plus the 
number of significantly peptides from the PSPL compared to the total number tyrosine 
center nonapeptides seen in substrate and interacting proteins and the 200 peptides from 






















Positional selectivity was determined by the ratio of the number of significantly abundant 
amino acids found at the subsite, n
sig
i,j, to that the expected abundance from a random 








i,j, multiplied by the ratio of the number of significantly abundant amino 























An amino acid was defined as being significantly abundant if its frequency was found to 
be greater than two standard deviations above the mean frequency observed in the total 
sequence library. 
Performance Evaluation. To evaluate the predictive performance of the algorithm, 
receiver operator characteristic (ROC) curves were calculated and plotted based on the 
specificities (Sp) and sensitivities (Sn) by taking different thresholds. 
Specificity (Sp) = TN / (TN + FP) 
Sensitivity (Sn) = TP / (TP + FN) 
where TP is the number of true positive predictions (phosphorylation predictions that 
were also present in the positive data set), TN is the number of true negative predictions 
(non-phosphorylated predictions that were also present in the negative data set), FN is the 
number of false negative (non-phosphorylated predictions that were also in the positive 
data set), and FP is the number of false positives (phosphorylation predictions that were 
also in the negative data set). Areas under ROC curves (AROC) were also calculated 
based on the integration and used as the Mann-Whitney U statistic.  
Additional characterization was performed by the following: 
Accuracy (Ac) = (TP + TN) / (TP + FN + TN + FP) 
Precision (Pr) = TP / (TP + FP) 






Equal Error Rate (EER) = (1 – Sn) * (TP + FN) + ((1 – Sp) * (1 – (TP + FN))) * 0.01 
! 
MCC =
(TP "TN) # (FP " FN)
(TP + FP)(TP + FN)(TN + FP)(TN + FN)
 
Generation of Kinase Focused Peptide Libraries. Kinase focused peptide libraries 
were generated based on the values of the PSM. All si,j > 0.9 were chosen as potential 
residues at each position.  Combinatorial peptide sequences were generated from these 
residues and scored against each kinase. Those peptides that scored positive for the 
kinase (or kinase family) of interest and negative for all other kinases (or kinase families) 
were then selected and added to virtual “focused libraries” for further screening. 
Terbium Binding in silico Screening. Following the generation of focused putative 
kinase substrate libraries, sequences were screened for the potential to bind terbium in a 
phosphorylation-dependent manner. A BLOSUM 62 matrix was used to generate a 
sequence similarity score between the focused library of potential kinase substrates and 
the known terbium sensitizing sequence !-syn Y125 (DPDNEAYEMPSEEG). (31, 32) 
In vitro kinase assays. Recombinant kinases were incubated with the kinase reaction 
buffer (15 nM kinase, 100 µM ATP, 10mM MgCl2, 125 ng/!L BSA and 25 mM HEPES 
pH 7.5, total volume 180 !L) containing 12.5 µM biosensor at 30°C. Aliquots (20 !L) 
were taken at designated time points (0.5, 5, 10, 15, 30, 45 and 60 min) and quenched in 
6 M urea (20 !L). The quenched samples were then treated with the luminescence buffer 
(500 !M Tb
3+
 and 500 mM NaCl, 10 !L) for a total volume of 50 !L (final 
concentrations of sample components: 2.4 M urea, 40 µM ATP, 4 mM MgCl2, 50 ng/!L 
BSA and 10 mM HEPES pH 7.5). Luminescence emission spectra were collected as 
described above and the area under each spectrum was integrated using GraphPad Prism. 






An additional aliquot (2 !L) of the kinase reaction mixture was taken at each time point 
for validation of phosphorylation using an ELISA-based chemifluorescent assay as 
previously described. (33) Briefly, each aliquot was quenched with 0.5 M EDTA and 
incubated in a 96-well Neutravidin coated plate (15 pmol biotin binding capacity per 
well, Thermo Scientific) in Tris-buffered saline (TBS) containing 0.1% BSA and 0.05% 
Tween 20 for 1h. Following incubation, each well was washed with the TBS buffer and 
then incubated with mouse anti-phosphotyrosine monoclonal antibody 4G10 (Millipore, 
1:10,000 dilution in TBS buffer) for 1h. Following incubation, each well was washed 
with TBS buffer and incubated with horseradish peroxidase-conjugated goat anti-mouse 
immunoglobulin G (IgG) secondary antibody (Abcam) (1:1000 dilution) for 1h. Wells 
were then washed and treated with Amplex Red reaction buffer (Amplex Red reagent, 
Invitrogen, 20 mM H2O2 and sodium phosphate buffer) for 30 min. Fluorescence was 
measured using a Synergy4 multiwell plate reader (Biotek) with an excitation wavelength 
of 532 nm and emission wavelength of 590 nm. 
Dose-response Inhibition Assay. Kinase (15 nM) was incubated with the kinase reaction 
buffer described above in the presence of DMSO (vehicle) or varying concentrations of 
kinase inhibitors (nilotinib, bosutinib, ruxolitinib) at 30°C for 10 min prior to the start of 
the reaction by adding the peptide substrate. The reaction was started with the addition of 
biosensor (12.5 !M, total reaction volume 20 !L). Each reaction was quenched after 30 
min in 6 M urea (20 !L). The samples were then treated with the luminescence buffer 
(500 !M Tb
3+
 and 500 mM NaCl, 10 !L) for a total volume of 50 !L. 
Growth inhibition curves. K562 cells were seeded into 96-well plates at 10,000 cells 
per well in Iscove’s Modified Dulbecco’s Medium supplemented with 10% fetal bovine 






serum and pen/strep. The cells were dosed with the indicated inhibitor at the indicated 
concentrations (n = 4), and allowed to incubate for 3 days at 37° C. Following incubation, 
XTT reagent (ATCC) was added according to manufacturers protocol, and allowed to 
incubate at 37° C for 3 hours. Absorbance at 475 nm was measured on a Biotek Synergy4 
plate reader. Values were calculated as percent of vehicle (0.1% DMSO), plotted in 
Graphpad Prism 6, and IC50 values generated by fitting a variable slope (four parameter) 
curve. 
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where n is the number of replicates, !pos and !neg are the average luminescence of the 
positive (phosphorylated peptide or uninhibited) and negative (unphosphorylated peptide 
or control inhibitor-treated) controls respectively; !pos and !neg are the standard deviation 
of the positive and negative controls. 







4.4.1 Design and Development of Kinase Specific Substrates For Terbium-Based 
Detection of Phosphorylation 
Identifying optimal peptide substrate sequences for a kinase out of the enormous 
sequence space of a completely random sequence library (e.g. 25 billion possible 
combinations for a 9 amino acid peptide with a fixed phosphorylation site residue) has 
traditionally been a major technical challenge, and has created a bottleneck in the 
development of new specific substrates. The use of degenerative peptide and one-bead-
one-peptide libraries has been successfully applied for the identification of catalytically 
favorable sequences for individual kinases; however, most of these sequences, even when 
phosphorylated, are insufficient to sensitize Tb3+ luminescence. The birth of global 
proteomics and advances in proteomic technologies including protein arrays and 
positional scanning peptide libraries has resulted in an explosion of kinase substrate data 
over the past two decades, and catalyzed the identification of novel phosphorylation sites 
and linear motifs for individual kinases. We aimed at taking advantages of these 
technologies and data to develop a pipeline to identify peptide substrates that would be 
not only efficiently phosphorylated by a given kinase, but also selective to that 
kinase/kinase family as well as able to enhance Tb3+ luminescence in a phosphorylation-
dependent manner. 
Inspired by the general design rules of previous CHEF-based sensors for detection 
of kinase activity (i.e. Sox-Mg2+ and EF-hand-Tb3+ sensors), we aimed at developing a 
general approach to design biosensors for tyrosine kinase activity analysis using 
phosphorylation-dependent enhanced Tb3+ luminescence. Sensors were designed to 






combine nonreceptor tyrosine kinase substrate specificity with the excitation and 
chelation elements governing Tb3+ luminescence. To achieve this, each kinase biosensor 
was developed to contain an optimized substrate sequence with an embedded Tb3+ 
coordination motif, similar to that previously identified from the 14-residue fragment of 
!-synuclein surrounding Y125. (Figure 4-1A) Based on our previous work, we reasoned 
that this design strategy was plausible due to Tb3+ being a hard acid, which gives it 
preferred coordination with hard bases such as the carboxylic acids in the side chains of 
glutamic and aspartic acid. (20) These amino acids are also generally preferred amino 
acids in tyrosine kinase substrate motifs. (34) To further utilize the hard acid character of 
Tb3+ for detection of kinase activity, the incorporation of phosphate into the sequence at 
tyrosine, catalyzed by the kinase, provides an additional bidentate hard base moiety. The 
expectation of phosphate addition by the kinase allows for designed control of the 
number of coordinating water molecules to Tb3+, otherwise known as the hydration 
number. The luminescence of Tb3+ is susceptible to quenching through nonradiative 
energy transfer to O-H oscillators; therefore, water molecules coordinated to Tb3+ can 
quench luminescence emission. The biosensors were designed to use phosphorylation of 
the peptide to decrease the hydration number of Tb3+. This led to an increase in the 
luminescence lifetime as well as increased the binding affinity of the peptide for Tb3+, 
ultimately resulting in enhanced Tb3+ luminescence compared to the unphosphorylated 
form. The final design consideration was excitation of Tb3+, which is Laporte forbidden, 
which results in Tb3+ having an extremely low molar extinction coefficient. This requires 
in a chromophore to absorb the UV-visible radiation and transfer it to Tb3+ to facilitate 
excitation. Sequences containing tyrosine not only provide an appropriate chromophore 






for sensitization of Tb3+, but also maintain the appropriate distance between the 
chromophore and the chelated Tb3+ ion for Förster resonance energy transfer. An 
additional advantage of tyrosine for Tb3+ excitation and detection of kinase activity is the 
resulting shift in the excitation wavelength upon phosphorylation from 275 nm to 266 
nm. This allows for the selective excitation of the phosphorylated biosensor through the 
use of a monochromator. Together these phosphorylation-dependent physical changes in 
the biosensor enable enhanced Tb3+ luminescence of the phosphorylated biosensor 
compared to the unphosphorylated form. (Figure 4-1B) 
For each kinase, a focused virtual library of peptide biosensors was designed, 
optimized and selected in silico through our bioinformatic pipeline, KINATEST-ID 
(Kinase Terbium Emission Sensor Identification) (Fig 4-1C). This method starts with the 
generation of a positional scoring matrix (PSM) (as described below) for a given kinase, 
which uses biologically validated phosphorylation sites for individual kinases as well as 
empirically observed effects of amino acids from positional scanning peptide library data 
(Figure 4-1C Step 1). This matrix represents the relative preference the kinase has for 
each amino acid at each position within the sequence. Additionally, a positional 
selectivity matrix was also generated using these data. These matrices were used to guide 
the generation of a focused library of possible kinase specific peptide substrates, where 
motif-based substitutions were assessed based on site selectivity. In other words, 
particular sites that lack selectivity (thus having more flexibility for a given amino acid at 
that position) but are required for Tb3+ binding could be substituted with the appropriate 
Tb3+ binding residue as opposed to a residue suggested by the catalytic preference motif 
(Figure 4-1C Step 2). Each sequence in the focused library was given a score based on 






the PSM for the given kinase, as well as a score for all other kinases included in the 
analysis using their respective PSMs. (Figure 4-1C Step 2) The focused library was then 
filtered based on classifying the sequences as predicted “substrates” or “nonsubstrates” 
for each kinase as well as “specific” or “nonspecific” for the given kinase. All 
nonsubstrate and nonspecific sequences were then filtered from the library. (Figure 4-1C 
Step 3) Cutoff scores for classifying the sequences as substrates or nonsubstrates for each 
kinase were selected based on the algorithm training parameters to give the lowest false 
discovery rate for the kinase of interest and the highest sensitivity for all off target 
kinases. This ensured that all remaining sequences in the library would have a maximal 
likelihood to be substrates for the desired kinase and not for the other kinases. The 
remaining sequences were compared to the atypical Tb3+ sensitizing peptide derived from 
the !-synuclein Y125 center peptide using BLOSUM sequence alignment scoring. 
(Figure 4-1C Step 4) Sequences with a BLOSUM score below the threshold of 25% 
similarity were removed from the library. This ultimately yielded a compressed library of 
potential kinase-specific peptide substrate sequences that were also likely to sensitize 
Tb3+ luminescence, which were then used in further studies examining kinase specificity 
and Tb3+ sensitization. (Figure 4-1C Step 5).  
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Figure 4-1 Design and development of phosphorylation-dependent enhanced Tb
3+
 
luminescence tyrosine kinase peptide biosensors. A) General biosensor design strategy 
for kinase biosensors capable of phosphorylation induced enhanced Tb
3+
 luminescence. 
B) The detection strategy using the phosphorylation-dependent physical changes in the 
biosensors that result in enhanced Tb
3+
 luminescence. C) To develop a kinase specific 
peptide based biosensor, we first obtain all known phosphorylated substrates for a given 
kinase as the foreground as well as all unphosphorylated tyrosine centered sequences that 
interact with the kinase as the background. In addition position scanning peptide libraries 
screens were perform to provide empirical values for each amino acid. (1) A library of 
sequences were generated in silico based on substrate preferences at each positions along 
with the Tb
3+
 binding motif using the positional selectivity score. The library is scored 
against the kinase of interest as well as all other tyrosine kinases. (2) The library is 
filtered to remove any nonspecific or nonsubstrate sequences for the kinases based on the 
PSM scores. (3) The remaining sequences are scored using BLOSUM matrix to access 
the similarity to the phosphorylation-dependent Tb
3+
 sequence !-syn Y125. (4) The 
remaining sequence are validated for kinase specificity and photophysical properties 
associated with Tb
3+
 luminescence. (5) 






4.4.2 Identification and validation of kinase specific residues 
Endogenous substrate analysis. For the endogenous substrate information, an individual 
prediction model was trained from our collection of non-redundant phosphorylated 
sequences. “Positive” substrates for each kinase were gathered from phosphorylation site 
repositories including Phosphosite Plus, Phospho.ELM and the Human Protein Reference 
Database or the literature. “Negative” sequences were derived from the proteins 
containing substrate sequences and any validated interacting proteins identified from 
HPRD, BioGRID 3.2, String 9.0 and the literature that contained no currently known 
substrate sequences for the kinase of interest—in other words, proteins that are known to 
exist in the proximity of the kinase but which it has not been observed to phosphorylate. 
We reasoned that this would best represent the tyrosine-containing sequences that had the 
highest chance of being phosphorylated by the kinase due to the potential for high local 
concentration, therefore if they are not reported to be phosphorylated, they are more 
likely to represent true negatives. To characterize a sequence of nine amino acids, four 
residues on either side of the phosphorylation site were considered. This range of 
positions was chosen based on the previously characterized disorder in positions beyond -
4 and +4 in substrates. (35) Both the identity and the physiochemical properties of the 
residues at each position were taken into account. Substrate sequences were aligned 
based on the tyrosine phosphorylation site, and the frequency of each amino acid at a 
given position was calculated and compared to the frequency of that amino acids at the 
equivalent position in the entire dataset (negative and positive). To identify property-
based features in a substrate motif, the sequence alignment was analyzed to identify 
redundant properties of the various amino acid side chains (i.e. acidic or basic residues, 






hydrophobic or hydrophilic residues, etc.). We computed a biological probability matrix, 
BPM, based on the frequency of each amino acid in the substrate sequences compared to 
a background corrected frequency. These BPMs were used to generate a score for a given 
kinase and a given substrate. The higher the score, the more closely the sequence 
matched the pattern represented in the substrate preference motif. 
Combined model. One limitation of using biological data to derive a prediction matrix is 
that the biological sequence space does not cover all possible sequence combinations, as 
sequences have evolved to perform multiple functions in a signaling cascade. To enhance 
the model, score outputs from positional scanning peptide libraries (PSPLs) and the 
biological probability matrices (BPMs) were multiplied together and taken as features to 
generate a positional scoring matrix (PSM) for each kinase, using the product of the 
scores as the classifier for each sequence. Combining the positional scanning peptide 
library analysis with these endogenous matrices compensated for the information missing 
from the endogenous substrate dataset. The prediction model was then trained using the 
collection of endogenous positive “substrate” and negative “non-substrate” sequences 
through 4-fold cross validation. Comparing to literature motifs as well as several machine 
learning quality control parameters confirmed the relative quality of the model. An 
additional feature determined for each kinase was the selectivity of each position (defined 
as positional selectivity) within the substrate sequence. The positional selectivity was 
used to describe and determine which positions within the substrate sequence for a given 
kinase were the most influential in determining kinase substrate selectivity and 
specificity.  






Using the values obtained from the PSM and considering the position selectivity 
values, the potential effect of each amino acid at each position in the substrate could be 
predicted. Positional selectivity scores demonstrated that all kinases analyzed displayed 
strongest substrate selectivity based on the residues present at the -1, +1 and +3 positions 
relative to the phosphorylation site. Analysis of amino acid variation at these positions 
revealed that the +3 position displayed the highest selectivity scores, and there was 
limited variation in the preferred residues at this position as all kinases preferred large 
hydrophobic residues (I/L/M/F/V) and/or proline. This lack of variation of residues 
would not allow for manipulation of kinase substrate specificity through amino acid 
selection at the +3 position. However, analysis of the favorable residues at the -1 and +1 
positions demonstrated more diverse preferences at both positions across the kinases 
studied, providing a promising avenue for selectivity tuning.  
Amino acid preference at the -1 position classified nonreceptor tyrosine kinase 
specificity into two main clusters based on preference for acidic residues (D/E), which 
was observed as strong for Jak2 and Syk, or large hydrophobic residues (I/L/V), preferred 
by all other kinases analyzed including Src-family kinases (SFK), Abl, Fer family kinases 
(FFK), Pyk2, Csk and Btk. The “large hydrophobic” cluster could be further partitioned 
based on additional weaker preferences. SFK, Abl and FFK demonstrated weak 
preference for acidic residues, Csk displayed strong preference for glutamine while Pyk2 
and Btk exclusively hydrophobic. (Figure 4.2A) 
The +1 position demonstrated increased variation in amino acid preference 
compared to the -1 position, enabling kinases to be classified into four groups. Src-
family, Abl-family and Fes-family kinases displayed strong preference for acidic residues 






as well as moderate preference for small aliphatic and hydroxyl residues (A/G/S/T). Syk, 
Btk and Pyk2 displayed strong preference for acidic residues with weaker favorability for 
large hydrophobic residues (I/L/V). Jak2 exclusively preferred large hydrophobic 
residues and Csk displayed strong preference for glutamine and weaker preference for 
large hydrophobic residues. (Figure 4.2B) 
Experimental evaluation of the model using mutations of known substrates. These 
differences in amino acid preference at the -1 and +1 positions offer an opportunity to 
control amino acid substrate specificity through selection of the appropriate residues for 
that are favorable for one kinase and unfavorable for the others. To examine the ability 
for our approach to control kinase substrate specificity using these preference definitions, 
a focused library of peptides based on the canonical endogenous substrates often used to 
monitor the cellular activity of Abl, Csk, Jak2 and Syk, with single substitutions at the -1 
or +1 position, were synthesized using split and pool peptide synthesis. (36-39) The 
library was then used in an in vitro kinase assay with the kinase of interest and analyzed 
using liquid chromatography-mass spectrometry (LC-MS). 
 Large hydrophobic residues (I/L/V) were anticipated to be strongly favored at the 
-1 position for Abl. A pool of peptides based on the CrkL Y207 centered sequence, with 
substitutions of the alanine at -1 to arginine and glutamic acid, was analyzed to examine 
the effect of changing the charge of the position. Bioinformatic analysis predicted that the 
substitutions to either residue would decrease substrate phosphorylation. Both 
substitutions resulted in a significant decrease in phosphorylation compared to the wild-
type substrate. Glutamic acid allowed for lower levels of phosphorylation compared to 
the wild-type substrate, while substitution with arginine resulted in complete abrogation 






of phosphorylation. This suggested that arginine may be a non-permissive residue in that 
position. To further examine this, the optimal Abl specific substrate Abltide 
(EAIYAAPF), which is robustly and rapidly phosphorylated under normal conditions, 
was synthesized with arginine substituted at the -1 position. Substitution with arginine at 
-1 was able to completely abrogate phosphorylation of Abltide compared to the wild-type 
substrate, providing strong evidence for non-permissivity of this substitution. 
 At the +1 position, acidic (D/E) and small hydrophobic residues (A/G) were 
predicted to be strongly preferred by Abl. For the peptide pool, substitutions at the +1 
position examined the effect of changing the size as well as the charge of the side chain 
through substitutions of alanine to Glu, Leu, Phe, Val and Gly. It was predicted that 
alanine would be the most preferred followed by glutamic acid and glycine, while 
leucine, phenylalanine and valine would be unfavorable and potentially nonpremissive. In 
kinase assays on the pool, alanine and glycine substitutions resulted in similar levels of 
phosphorylation; however, glutamic acid drastically reduced the level of phosphorylation. 
In agreement with the prediction, Leu, Phe and Val all significantly reduced 
phosphorylation of the peptide. (Figure 4.2C) 
 Bioinformatic analysis of Csk displayed strong preference for large hydrophobic 
residues and glutamine both the -1 and +1 positions. The substition of the -1 position to 
isoleucine did not result in the expected increase in the level of phosphorylation, while 
arginine completely abolished phosphorylation, which was expected. At the +1 position 
the substitutions of methionine and alanine resulted in a significant improvement in 
phosphorylation of Src Y530 sequence, which was not expected. Another unexpected 
result was the low level of phosphorylation associated with the substitution to 






phenylalanine, which was expected to be favorable and was previously shown to be the 
most abundant residue at that position in oriented peptide library screening. (Figure 4-
2D) The lack of accuracy in the prediction of Csk substrate determinant is most likely 
attributed to the bias of substrates generated in the literature, which is fairly sparse for 
Csk compared to several of the other kinases analyzed in the pipeline. It should also be 
noted that synergy between positions was observed, as the dual substitution of isoluecine 
and phenylalanine at the -1 and +1. This result suggest that a relationship exist between 
the two positions, which is lost in the PSM scoring method. 
 Previous studies as well as our bioinformatic analysis of Syk substrate specificity 
demonstrated a strong preference for acidic residues at both the -1 and +1 positions, 
which was unique amongst all kinases. Substitutions of the BLNK Y178 center sequence 
examined the effects of charge and hydrophobicity at both positions. It was predicted that 
substitutions of acidic residues to large hydrophobic amino acids would result in a 
significant decrease in substrate phosphorylation; this prediction was borne out in the 
experimental results. The smaller decrease associated with the substitution to 
phenylalanine (as opposed to leucine or isoleucine) can most likely be attributed to its 
similarity to tyrosine, which is a favorable residue in those positions.  (Figure 4-2E) 
 Jak2 substrate preference also showed a strong preference for acidic residues at 
the -1 position, and large hydrophobic residues at the +1 position. The substrate peptide 
used was derived from the sequence surrounding STAT5 Y694. Substitution from glycine 
at the -1 position to an acidic aspartic acid residue significantly improved 
phosphorylation of the substrate (as predicted), while arginine performed comparably to 
glycine, and glutamine and isoleucine substitutions significantly reduced 






phosphorylation. Substitution from valine at the +1 position to phenyalanine resulted in 
comparable levels of phosphorylation, which was also as expected. Glycine, with its less 
bulky side chain, resulted in a significant decrease in phosphorylation. Glutamic acid at 
the +1 position was also tolerated, which was not predicted. (Figure 4.2F) 
 While the majority of the predictions for individual effects of the substitutions 
were correct, approximately 25% were incorrect. These results suggest two possibilities: 
1) the data obtained and used are insufficient to identify the appropriate value for every 
amino acid at each position in the substrate for each kinase—the limitations of the data 
can arise due to limited data set sizes, bias in the data due to the context and focus of 
studies for the kinase and its substrates, or other mechanisms that regulate specificity 
aside from substrate sequence recognition; or 2) The other possible explanation is the 
computational and prediction approach is incorrect, resulting in the wrong interpretation 
of the data and the incorrect calculation of the PSMs. However, based on the correct 
prediction of the majority of the substitutions, it is reasonable to believe that the incorrect 
predictions are a result of the former rather than the latter. 

































































































































































































































































































































Figure 4-2 Analysis of amino acid preference and substitution effects on substrate specificity. Analysis of amino acid selectivity at the 
-1 (A) and +1 (B) positions relative to the phosphorylation site. The heat map were generated from the positional scoring matrices 
(PSMs) using bidirectional heiracrchial clustering. Relative quantification of split pool peptide libraries using a singly-substituted 
canonical endogenous substrate for each kinase. Abl (C), Csk (D), Syk (E), and Jak2 (F) pools were synthesized using split-pool 
peptide synthesis and assayed by in vitro kinase assays with recombinant active kinase (3 nM for Abl, Syk and Jak2 and 250 nM for 







4.4.3 Identification and Characterization of Abl, Jak2 and Src-family kinase biosensors 
To demonstrate the application of KINATEST-ID for the identification of kinase-
specific peptide biosensors, the algorithm was applied to generate Tb3+-sensitizing 
biosensors predicted to be specific for Abl, Jak2, and Src-family kinases. Initial potential 
substrate sequence libraries were generated by listing all possible permutations of each 
kinase’s preference motif (as determined by the PSM). These virtual libraries started with 
~43,000, 92,000 and 5,500 sequences for Abl, Jak2 and Src-family kinases, respectively. 
These libraries were then filtered by PSM scores for each kinase in the analysis to 
remove predicted nonspecific and nonsubstrate sequences, which drastically reduced the 
library size by ~99% for each kinase. The Tb3+ binding alignment score filter was then 
applied, which reduced the size of the libraries by a further ~50%, leaving libraries 
ranging in size from 11-250 sequences. The remaining sequences for each of the kinases 
contained the identified kinase substrate motifs as well as the ! -syn Y125 Tb3+ binding 
motif or slight shifts in that motif.  
From these libraries, several sequences were selected to evaluate empirically for 
each kinase as kinase artificial substrate peptides (KAStides) for Abl (AbAStide), Jak2 
(JAStide), and Src-family (SFAStide) kinases. The specificity of these sensors was 
assessed by screening the peptides against a panel of kinases representing at least one 
member of each family of nonreceptor tyrosine kinases. The ability of the kinases to 
phosphorylate a given peptide was determined using an endpoint in vitro kinase assay. 
Phosphorylation of each peptide was determined quantitatively using a chemifluorescent 
ELISA-based assay previously developed in our lab. Relative fluorescence units, which 







percent phosphorylation was interpolated from a calibration curve. (Figure 4-3B) As 
predicted by KINATEST-ID all sequences were specific substrates of the intended 
kinases. AbAStide did display some nonspecific phosphorylation by Csk; however this 
was only observed at a concentration of Csk 83-fold greater (250 nM) than the 
concentration of Abl. This result suggested that, while not explicitly measured, the kcat 
and catalytic efficiency of AbAStide for Csk is significantly lower than those for Abl. 
Analysis of Jak2 preference amongst the pool of substrates demonstrated that JAStide-E 
was the most preferred substrate displaying significantly more phosphorylation compared 
to the other substrates (P<0.0001 for JAStide-A and D and P<0.001 for JAStide-B and 
C). This result is consistent with the substrate substitution analysis preference in Jak2 
substrates, for which the -1 position demonstrated the greatest preference for acidic 
residues (JAStide-E) and reduced favorability for arginine (JAStide-A, B, C) and 
phenylalanine (JAStide-D). The Src family substrates displayed comparable levels of 
phosphorylation across all Src family kinases, while maintaining selectivity against all 
other families. The variation in residue properties between the sequences at the -3 and +2 
positions demonstrated that SFKs tolerate substitutions at these positions with little effect 
on phosphorylation (which is in accordance with the positional selectivity matrix results). 
These sequences are the first demonstrated to our knowledge of Jak2 specific substrates 
(JAStide-A-E), and specific substrates for all Src-family kinases (SFAStide A and B). 
The sequence we term SFAStide-A has been previously identified as an optimal Lyn 








AbAStide, JAStide-E and SFAStide-A were selected for further characterization 
based on their specificities in the non-receptor tyrosine kinase screening panel as well as 
their robust phosphorylation by their designated kinases. These biosensors were 
characterized using steady-state kinetics to model the kinase-substrate interaction and 
subsequent phosphorylation of the substrates. In vitro kinase reactions were carried out at 
various concentrations of the substrates. The initial reaction velocities for each kinase-
substrate pair were determined and fitted to the Michaelis-Menten equation. The kinetic 
parameters for each substrate were determined based on the fit, including Km, Vmax, 
turnover number (kcat) and catalytic efficiency (kcat/Km). (Figure 4-3C-E, Table 2) The Km 
values for all the peptides were within ~50-200 µM, which is lower than the range 
typically observed for kinase-substrate pairs for endogenous substrates. (40) Compared to 
the previously published optimal peptide substrates for these kinases, the Km values 
measured for the selected KAStides are ~2-5-fold greater than those reported in the 
literature.  Relatedly, the catalytic efficiencies demonstrated that the AbAStide, JAStide-
E, and SFAStide-A sequences are effective substrates for their respective kinases, and 
these efficiencies are comparable to those reported for the “optimal” kinase substrates. 
These results demonstrate that KINATEST-ID is capable of identifying sequences with a 
high likelihood of being selective substrates that have comparable kinetic parameters to 





























































Kinase Substrate Sequence Abl Btk Csk Fes Jak2 Pyk2 Src Syk Tb3+
Abl AbAStide GGDEDEVAYQPFEDGGK(biotin)GG 92.9 0 9.49 5.59 0 5.53 27.5 19.4 25
Jak2
JAStide-A GGDNDPDRYIRTEDEGGK(biotin)GG 18.7 0 0 5.26 90.6 0 0.41 2.03 25
JAStide-B GGEDEGDRYLKLEEDGGK(biotin)GG 0.88 1.34 0 3.59 99 0.01 2.35 10.5 13
JAStide-C GGEDEGDRYVQLDEGGK(biotin)GG 2.97 0.12 0.07 0.54 99.5 5.04 7.99 0.33 12
JAStide-D GGEDPKFYVQLDEGGK(biotin)GG 26.1 0.04 0.12 1.73 98.8 0 12.2 0.28 12
JAStide-E GGDNDPDEYITLDEDGGK(biotin)GG 34.4 1.14 0.03 0.77 99.7 0.01 79 79.7 25
SFK
SFAStide-A GGEEDEDIYEELDEPGGK(biotin)GG 34.7 19.7 65.1 51.8 0 87 99.6 98.8 26
SFAStide-B GGDNEGDVYDFVEDEGGK(biotin)GG 37 26.3 1.47 66.9 0.35 99.3 91.1 1.45 27






















































































Figure 4-3 Identification, validation, and characterization of kinase specific biosensors 
using KINATEST-ID. A) The kinase substrate sequences selected for further evaluation 
and their prediction scores for the panel of kinases used in the assay B) Screening of 
kinase substrate against a panel of purified recombinant kinases. Color-coded values 
represent the mean of experiments performed in triplicate. C-E) Recombinant, active 
Abl, Jak2 and Lyn (3 nM) were used to carry out the kinase reactions with 100 !M ATP 
and increasing concentrations of AbAStide, JAStide-E and SFAStide-A. Initial rates of 
phosphorylation of the kinase specific biosensors (picomoles of phosphorylated product 
per minute) for AbAStide (C) JAStide-E (D) and SFAStide-A using Lyn (E) were 
calculated and fitted to the Michaelis-Menten equation. Values represent the mean ± 












Table 4-1 Kinetic constants for kinase specific peptide biosensors 






AbAStide 99.2 ± 22.0 107.3 ± 7.2 1430 ± 95.5 14.4 0.92 
JAStide-E 
 186.4 ± 
26.9 
 672.2 ± 37.1 2689 ± 148.4 14.4 0.96 




 luminescence characterization of KINATEST-ID identified biosensors 
 The biosensors that displayed appropriate specificity in the screening panel were 
further evaluated for phosphorylation-dependent enhanced Tb3+ luminescence. The ability 
of the biosensors to have not only appropriate kinase specificity but also to enable large 
increases in Tb3+ luminescence upon phosphorylation is important for robust detection of 
kinase activity. Phosphorylated and unphosphorylated forms of the peptides were 
synthesized and Tb3+ luminescence emission spectra were collected. Steady-state 
measurements of the biosensors revealed a modest range of enhancement (~1-2 fold) in 
Tb3+ luminescence upon phosphorylation. (Table 3.2) However, as we have previously 
observed for a Syk-specific peptide substrate, time-resolved measurements significantly 
improved the enhancement of Tb3+ luminescence to the range of ~5-11 fold 
(approximately 3-5 fold improvement compared to steady-state measurements). The 
observed enhancement of Tb3+ luminescence could be attributed to the differences in 
properties of the sensors including binding affinity, hydration number, luminescence 
lifetime, and excitation wavelength (characterized as described in Table 4.2), which 
validated the phosphorylation-dependent design of the sensors. 
Biosensors were designed such that the incorporation of phosphate into the peptide 







luminescence. Starting with the excitation wavelength, phosphorylation shifted the 
excitation wavelength of tyrosine from 275 nm to 266 nm. Relative to excitation at 275 
nm, selective excitation of the phosphorylated biosensor at 266 nm through the use of a 
monochromator significantly improved detection of the phosphorylated biosensors while 
having little effect on the signal from unphosphorylated forms. The addition of the 
phosphate group to the biosensors also significantly altered the Tb3+ binding affinities for 
the peptides. The unphosphorylated sequences exhibited binding constants (Kd) in the 
range of 9-80 µM, which were significantly weaker than the range of 1-12 µM observed 
for the phosphorylated biosensors (Table 4.2). The differences in binding affinities 
between the two forms of each biosensor resulted in the Tb3+ binding equilibrium 
favoring the phosphorylated peptides over the unphosphorylated peptides. Finally, time-
resolved measurements significantly improved the signal to noise for all the 
phosphorylated biosensors by leveraging the change in luminescence lifetime between 
the two forms of each peptide for favorable detection of the phosphorylated form. The 
luminescence lifetimes of the all the biosensors were increased by an amount in the range 
of 100-200 µsec upon phosphorylation. The time-resolved measurements allowed the 
shorter-lived signal of the unphosphorylated peptide to decay prior to collection. As we 
previously described, these changes in lifetime can be attributed to the change in 
hydration number of the biosensor-Tb3+ complexes upon phosphorylation. As 
incorporated into the design strategy, the phosphorylated tyrosine group most likely 
provides an additional bidentate chelating moiety, which in turn displaces two water 
molecules from the coordination sphere of Tb3+. As in our previous work, this 







vs. deuterium hydroxide (which does not quench the Tb3+ luminescence). Together these 
results demonstrate that this general design strategy can be applied to diverse tyrosine 
kinase substrates, and that these predicted substrates exhibit robust Tb3+ luminescence 
sensitization with photophysical properties consistent with the anticipated detection 
mechanism.  














1.35 ± 0.17 1.35 0.51 4 
SFAStide-A 2.1:1 10.6:1 
9.76 ± 0.54 1.83 0.53 6 
2 
8.16 ± 1.01 1.73 0.71 5 
SFAStide-B 2.1:1 6.2:1 
54.12 ± 10.31 2.13 0.67 7 
2 
1.59 ± 0.21 1.26 0.81 2 
JAStide-B 1.1:1 4.6:1 
15.31 ± 0.46 1.63 0.71 4 
2 
7.89 ± 6.21 1.61 0.62 4 
JAStide-E 1.9:1 6.8:1 
67.6  ± 8.73 2.10 0.72 6 
2 
12.24 ± 2.56 1.65 0.61 4 
AbAStide-A 1.3:1 7.3:1 
25.55 ± 3.72 2.21 0.74 6 
2 
 
4.4.5 In vitro detection of nonreceptor tyrosine kinase activity 
AbAStide, JAStide-E, and SFAStide-A all demonstrated excellent photophysical 
properties and were further characterize for their performance for in vitro detection of 
kinase activity. Conditions for optimal detection of the biosensors were established in the 
kinase reaction conditions as well as calibration curves for each biosensor using various 
ratios of phosphorylated and unphosphorylated forms of the sensors. All sensors 
displayed linear increases in Tb3+ luminescence with increasing percent phosphorylation 
allowing for quantitative determination of phosphorylation. High-throughput screening 







signal widow (SW), which reflect the robustness of detection. All sensors displayed 
appropriate HTS parameters (Z-factor < 0.5 and SW < 2) that support their potential 
application in HTS screening assays (Table 4.3) 











SFAStide-A 7.9 21.8 0.79 13.7 9.1:1 0.95 
JAStide-E 3.1 9.6 0.90 30.8 6.0:1 0.98 
AbAStide-A 4.8 12.1 0.65 5.86 4.2:1 0.95 
 
The sensors were applied for quantitative detection of kinase activity in vitro 
using recombinant active kinases over a 60-minute time course. To obtain kinase activity 
measurements aliquots of the reaction were quenched and Tb3+ time-resolved 
luminescence emission spectra were obtained and percent phosphorylation was 
extrapolated from calibration curves. These data show that enzymatic phosphorylation of 
the biosensors by the kinases results in increasing Tb3+ luminescence over the time 
course. The percent phosphorylation determined by the Tb3+ based read out were in 
agreement with those obtain using the quantitative ELISA-based read out. (Figure 4.4 A-
C) 
 Next, the biosensors were applied to monitor dose-response inhibition of Abl, 
Jak2, and Hck kinase activity by their respective inhibitors imatinib, ruxolitinib, and 
dasatinib. The effects of these inhibitors were assayed in a dilution series from 10 pM to 
500 µM. Luminescence emission spectra were collected and normalized to the vehicle 
(DMSO) control and reported as percent control. The observed IC50 values were 3.88 ± 







respectively. These values are in agreement with those reported in the literature for each 
kinase. (41-43) The Z-factor and SW for these assays were assessed to determine if HTS 
parameters were maintained under the assay conditions. The Z-factors were found to be 
greater than 0.5 and the SW maintained values greater than 2 for all the sensors in the 
assays. These results demonstrate that these sensors can be applied for both the detection 
of kinase activity and inhibition while maintaining robust detection parameters. 


































































































































































Figure 4-4 Quantitative time-resolved phosphorylation-enhanced Tb
3+
 luminescence 
detection of nonreceptor tyrosine kinase activity and inhibition.  Kinase reaction progress 
curves for Abl (A) Hck (B) and Jak2 (C). Dose-response inhibition of Abl with imatinib, 








4.4.6 Application of AbAStide for High Throughput Screening of Small Molecule 
Inhibitions for Chronic Myeloid Leukemia (CML) 
 Chronic myeloid leukemia (CML) is caused by the reciprocal translocation of 
chromosomes 9 and 22, which results in the formation of the Philadelphia chromosome 
or the BCR-ABL fusion gene. This gene product results in the Bcr-Abl fusion protein, 
which results in constitutive Abl kinase activity and drives uncontrolled myeloid 
proliferation. Treatment of CML has achieved great success in the clinic by inhibition of 
Bcr-Abl tyrosine kinase activity using the Abl specific inhibitor imatinib. However, 
resistance to imatinib often arises through the development of a broad range of point 
mutations within the kinase domain, which impairs inhibitor binding, as well as other off-
target mechanisms. The development of the second-generation Abl and dual Abl–Src 
family kinase inhibitors nilotinib, ponatinib, dasatinib, and bosutinib have allowed many 
clinically important mutations to be matched to an appropriate and effective inhibitor. 
However, several mutations still remain insensitive to the currently available inhibitors, 
including the E255V mutation, and others are continually emerging, indicating that 
further development of Abl inhibitors that can address the rapidly evolving clinical 
situation is still warranted. Here we demonstrate the application of AbAStide for the 
identification of novel Abl inhibitors in a high-throughput screening format. 
To scale the assay to a 384-well plate format for reproducible detection of Abl 
tyrosine kinase activity and inhibition using AbAStide, replicate in vitro kinase assays 
were performed in the presence (N=96) or absence (N=96) of imatinib. The peptide 
substrate was incubated with Abl kinase in kinase reaction buffer containing ATP and 
MgCl2 for 60 min. Reactions were quenched in Tb







and Tb3+) and time-resolved luminescence measurements were taken on a Synergy4 plate 
reader (Biotek). To evaluate assay quality, luminescence of positive and negative control 
wells (containing the phosphorylated form and unphosphorylated form of the biosensor, 
respectively, N=96 for each) was also measured. The in vitro kinase assay replicates gave 
highly reproducible detection of AbAStide phosphorylation and Abl inhibition by 
imatinib. (Fig. 4.5A) The Z-factor and SW for the kinase reaction replicates were 0.56 
and 84 respectively, comparable to those for control well readings. These results 
demonstrate that in vitro detection of Abl kinase activity and inhibition using AbAStide-
enhanced Tb3+ luminescence as a read-out is scalable and robust. 
 The robustness of AbAStide for detecting Abl kinase activity was leveraged in a 
high-throughput screen using the GSK PKIS library to identify compounds that inhibit 
Abl kinase activity. Imatinib was used as the positive control and DMSO (vehicle) alone 
was used as the negative control for in these assays. In addition to these experimental 
controls, the phosphorylated and unphosphorylated biosensors in the absence of Abl were 
also used as quality controls. The GSK PKIS library screened consisted of 364 
compounds arrayed in 96-well plates as single compounds at 10 mM in DMSO. The 
library was screened at a constant 1:1000 dilution, with 10 µM final concentration of 
compound in each well (1% DMSO). Compounds were incubated with the kinase for 30 
minutes prior to start of the kinase reaction, which was initiated by the introduction of the 
biosensor substrate. The kinase reaction was allowed to proceed for one hour before 
being quenched with the Tb3+ luminescence buffer (containing urea and Tb3+). The time-
resolved Tb3+ emission intensity was measured and the “percent inhibition” was 







imatinib and no inhibitor, respectively) (Fig. 4.5B). Primary hits were identified as 
compounds reducing Tb3+ luminescence by greater than 3-fold (the top 5% most potent 
inhibitors, which were the top 18 compounds). The primary hits were tested in a 
secondary screen using the same kinase reaction conditions, but employing a 
chemifluorescent ELISA-based detection instead of Tb3+-based detection. The secondary 
screen confirmed that all of the hits inhibited Abl kinase activity by at least 50% 
compared to vehicle.   
 The three most potent inhibitors from the HTS and validation screens were 
GW693917A, GW711782X and GW513184X, developed to target TIE2/VEGFR2, 
ALK5 and GSK3! respectively. These were selected for further evaluation of their 
potency in vitro. In addition to the validated hits, two negative compounds (SB-358518 
and GW607049C) were selected as controls for the assay. Potency (IC50) of the 
compounds was assessed in a dose-response kinase assay with AbAStide. All three hits 
potently inhibited Abl kinase activity, with IC50 values of 0.52 nM, 1.91 nM, and 0.35 nM 
for GW693917A, GW711782X and GW513184X respectively. The selected negative 
compounds did not display inhibition of Abl. (Fig. 4.5C) To determine whether the 
results of the in vitro inhibition studies translate to a CML model, the compounds were 
tested in cellular viability assays against the human CML cell line K562. Cellular IC50 for 
GW693917A was comparable to imatinib, at 81 nM compared to 147 nM. GW711782X 
and GW513184X were less potent in the cell viability assay, at 20 µM and 3.24 µM 
respectively. (Fig. 4.5D) Together these results indicate that AbAStide is a biosensor that 
provides a robust method for the detection of Abl kinase activity, enabling the high-






























































































































Figure 4-5 A high-throughput chemical screen using AbAStide biosensor identifies new 
inhibitors of Abl tyrosine kinase. A) The AbAStide in vitro kinase assay shows highly 
reproducible signal upon imatinib treatment. Green: synthetically phosphorylated peptide 
(positive control); Black: kinase reaction; Red: kinase reaction + imatinib; Blue: 
unphosphorylated peptide (negative control). B) Distribution of compound activities 
identified in a high-throughput screen performed with the GSK PKIS library using 
AbAStide-sensitized Tb luminescence. C) Dose-response inhibition of Abl kinase 
activity by selected compounds from the GSK PKIS. The extent of biosensor 
phosphorylation was interpolated from an externally generated calibration curve (not 
shown) and normalized to vehicle (DMSO) control. D) XTT cytotoxicity assay for 
selected compounds (as in 5C), showing potencies in K562 cells. 
 
4.5 Discussion 
Although other methods using synthetic peptide libraries such as oriented peptide 
libraries and encoded peptide libraries including phage and mRNA displays have been 







costly, laborious and time consuming experimentation, processing and analysis resulting 
in a bottleneck in the development of novel kinase specific peptide substrates. 
Computational approaches offer an alternative to circumvent an empirical bottleneck in 
the generation and evaluation of kinase specific peptide substrates. They are currently 
used to facilitate the discovery of novel phosphorylation sites and to identify the kinases 
responsible for catalyzing the phosphorylation and have yet to be explored for the 
development of artificial kinase specific sequences. Furthermore, these techniques fail to 
simultaneously identify sequences that are not only compatible with the various peptide-
based detection methods, but will also facilitate robust, rapid, sensitive, specific detection 
of kinase activity as is seen with phosphorylation-dependent enhanced Tb3+ 
luminescence. To address these challenges we developed an effective strategy, termed 
KINATEST-ID, which combines the identification of kinase specificity determinants 
with the prediction of kinase-substrate phosphorylation and peptide:Tb3+ complex 
formation to generate kinase specific biosensors for phosphorylation-dependent enhanced 
Tb3+ luminescence detection. A synergy of approaches are used in the development of the 
algorithm, which combines positional scanning peptide library data with validated 
biological phosphorylation sites to predict the individual effects of each amino acid on 
kinase specificity and BLOSUM substitution matrix sequence alignment to evaluate 
phosphorylation dependent Tb3+ luminescence. Together these approaches identify novel 
peptide sequences that are kinase specific and produce robust phosphorylation-dependent 
enhanced Tb3+ luminescence for detection of kinase activity. 
Several lines of evidence suggest that KINATEST-ID is an appropriate and 







of the prediction is demonstrated when compared with other existing phosphorylation 
prediction methods. Comparing the favorable substrate features extracted from the data 
using KINATEST-ID to the recently developed M3 (Motif discovery based on Microarry 
and MS/MS) and NetPhorest there is significant overlap in the identified kinase substrate 
motifs. This overlap in motifs is an encouraging result to confirm the reliability of the 
algorithm, since all three methods use different computational approaches and data sets to 
arrive at similar results. The quality of these features is further demonstrated by the 
empirical validation using substrate substitution analysis of canonical endogenous kinase 
substrates. Among the 35 substitutions across the four kinase-substrate pairs examined, 
the effect of 71.4% (25/35) are correctly predicted based on the PSM values. The weakest 
prediction is for Csk substrates (35.6%, 3/8), which is attributed to the skewed biological 
substrate set due to the context of Csk function and the limited study of its kinase 
activity. This result highlights the importance of obtaining a comprehensive and well 
curated dataset for the development of these prediction algorithms as the model is only as 
good as the data. The ability to correctly determine the individual effect of each amino 
acid on substrate specificity offers the opportunity to generate artificial sequences de 
novo to sever as kinase specific substrates by selecting appropriate residues for individual 
kinases. In the past the exhaustive sequence space covering 2.5 billion sequences was 
screened to identify the most abundant amino acids are each position to give an “optimal” 
substrate. Using the same initial sequence space and KINATEST-ID for prediction of 
specificity the number of sequences to be assayed was significantly reduced by seven 







sequence space can be reduced to a size that is feasible to screen and monitor each 
sequence individual rather than identifying the effect as a population. 
The sequences presented here are predicted to be specific for individual kinases 
and displayed specificity in agreement with this prediction. The characterization of these 
substrates demonstrated that they are all effective reporters of kinase activity. Comparing 
the performance of the substrates to those reported in the literature reveal that the kinetic 
parameters were between those found in optimal substrate and those for endogenous 
substrates. Several Src specific peptide substrates have been developed using one-bead-
one-peptide and oriented peptide libraries with Km values between 20-55 µM, similar to 
SFAStide (Km = 62 µM). AbAStide however displayed a significant increase in Km 
compared to it’s the optimal substrate (Km = 4 µM) and comparable to the endogenous 
substrate CrkL Y207 (Km = 134 µM). However, AbAStide was shown to be a better 
substrate compared to CrkL Y207 due to a higher Vmax and catalytic efficiency. As for 
JAStide (Km = 186 µM) this is the first report of a specific substrate compared to the 
commonly used endogenous phosphorylation site STAT5 Y694 (Km = 306 µM) the Km 
was 2-fold lower. This drop in kinetic parameters is to be expected as catalytic 
parameters are sacrificed to accommodate Tb3+ luminescence detection of 
phosphorylation. Although the sequences presented here did not perform as well 
kinetically as previously identified “optimal” kinase specific substrates the design of the 
sensors can be modified to improvement of kinetic constants. The incorporating of 
ligands targeting protein-protein interaction domains that helps govern kinase substrate 







phosphorylation. This has previously been done using the D-domain of Erk as well as the 
SH2 and SH3 domains of Abl and Hck.  
Aside from the development of the specific peptide substrate another challenge in 
the development of peptide biosensors using sulfonamide-oxine (Sox) fluorophores, 
environmentally sensitive fluorophores and genetically encoded FRET pairs is the time 
required to optimize the phosphorylation responsive signal based on the placement of the 
fluorophore or the molecular switch. The ability to predict the response of the sensor and 
the detection parameters would increase the throughput of development are alleviate the 
optimization time. The design rules applied here for phosphorylation responsive detection 
attempt to facilitate predictable response of the biosensors, but do not provide a metric to 
measure the potential response. The use of BLOSUM substitution matrix sequence 
alignment to identify the similarities between previously identified peptides capable of 
phosphorylation-dependent Tb3+ sensitization and the sequences generated using 
positional scoring matrix. As predicted by the BLOSUM scores and the design rules the 
sequences presented here produced robust Tb luminescence and high throughput 
screening parameters demonstrating the compatibility of the sensors with HTS screening 
assays. Lanthanide-based detection has several desirable properties for high throughput 
screening assays including affordability, non-radioactive, provides label-free and 
antibody-free detection, it is generic, and it is compatible with time-resolved 
measurements. The application the sensors here for HTS presented here offers high 
sensitivity and reproducibility as well as quantitative monitoring of nonreceptor tyrosine 







detection parameters is another advantage of applying computational methods for the 
development of biosensors.   
The rapid development of new kinase specific probes presented here will help 
alleviate the bottleneck in biosensors and facilitate new substrate sequences for novel 
kinases. Aside from generating kinase specific phosphorylation-dependent Tb3+ 
luminescence peptide biosensors the application of the algorithm can be a resource for 
the research community for the development of new artificial peptide substrates for not 
only tyrosine kinases, but also serine/theronine kinases. These sequences can be applied 
for detection of kinase activity using previously developed methods including Sox-based 
CHEF, mass spectrometry, genetically encode FRET-based biosensors and 
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CHAPTER 5. SIMULTANEOUS MUTIPLEXED DETECTION OF LYN AND SYK 
TYROSINE KINASE ACTIVITIES USING TIME-RESOLVED LANTHANIDE-
BASED RESONANCE ENERGY TRANSFER (TR-LRET) 
5.1 Abstract 
SAStide, a Syk specific peptide biosensor, and SFAStide, a Src-family kinase 
specific peptide biosensor, combine the biochemical principles of kinase specificity and 
inorganic properties of terbium coordination for simultaneous rapid, sensitive and 
quantitative detection of Syk and Lyn activity through phosphorylation dependent 
terbium sensitization and time-resolved lanthanide-based resonance energy transfer (TR-
LRET). 
5.2 Introduction 
Numerous leukemias and lymphomas have been characterized by the clonal 
expansion of B-lymphocytes due to the deregulation of the B-cell receptor signaling 
pathway. (1, 2) Tyrosine kinases Lyn, Syk and Btk are the main signal transducers in this 
pathway making them ideal therapeutic targets for small molecule inhibitors. (3) Despite 
the identification of this pathway as the cause of disease there are few therapeutic options 
targeting the B-cell receptor pathway or these kinases. Currently there is a need for the 
development of detection platforms that offer sensitive and specific detection of kinase 
activity that can enhance the depth of information obtained in a single assay. Often, 







targeting common pathways. In order to improve upon existing techniques for 
discovering and evaluating new inhibitors, multiple events need to be monitored 
simultaneously.  
Förster resonance energy transfer (FRET) based assays have been developed to 
monitor multiple dynamic cellular processes simultaneously in a single assay. (4-8) 
However, while useful in some applications, FRET based methods using organic 
fluorophores and fluorescent proteins suffer from a number of disadvantages including 
small dynamic ranges, the requirement for genetic expression, small Stokes shifts, and 
wide emission peaks resulting in spectral bleed through. This ultimately places a limit on 
the number of events that can be detected in a single assay. Lanthanides (Ln
3+
) have been 
explored as probes in biological assays for the detection of ligand binding, enzyme 
activity, and protein-protein interactions due to their unique optical properties. (9-16) 
Compared to organic fluorophores and fluorescent proteins, Ln
3+
 have narrow emission 
bands, large Stokes shifts and long photoluminescence lifetimes, which offer high 
sensitivity and specificity of detection due to the reduced background interference. These 
can also allow for multiplexed detection due to the multiple distinct emission bands 
associated with each Ln
3+
. (17-19) 
Previously, we have demonstrated the development of kinase specific peptide 
biosensors capable of detecting kinase activity through phosphorylation-enhanced 
terbium (Tb
3+
) luminescence. Here we present the development of a multiplexed 
detection platform for the simultaneous monitoring of Lyn and Syk kinase activities 
through intramolecular energy transfer from the luminescence donor phosphopeptide-
Tb
3+








Peptide synthesis, fluorophore conjugation and purification. Peptides were 
synthesized at 50 µmol scale using a Prelude Parallel peptide synthesizer (Protein 
Technologies, Inc.) on MBHA-amide resin (Peptides International). Coupling of standard 
Fmoc (9-fluorenylmethoxy-carbonyl)-protected amino acids (4 equiv) (Peptides 
International) were achieved with HCTU (3.8 equiv) in the presence of NMM (8 equiv) 
in dimethylformamide (DMF) for two 10 min couplings. Fmoc deprotection was 
achieved in 20% piperidine in DMF for two 2.5 min cycles. Side-chain deprotection and 
peptide cleavage from the resin was performed in 5 ml of a cocktail of trifluoroacetic acid 
(TFA)/water/ethanedithiol(EDT)/triisopropylsilane (TIS) (94:2.5:2.5:1). Peptides were 
precipitated and washed three times with cold diethyl ether. The peptides were dissolved 
in acetonitrile/water/TFA (50:50:0.1), flash frozen in liquid nitrogen, and lyophilized. 
The peptides were purified by preparative reverse-phase HPLC (Agilent Technologies 
1200 Series) a using C18 reverse-phase column. Peptides were characterized by LC-MS 
and MALDI-TOF analysis. 
SAStide was labeled with AlexaFluor-488-maleimide (Invitrogen) and Cy5-
maleimide (Lumiprobe) in TCEP (10 mM) and phosphate buffer (100 mM) at pH 6.5. 
Reaction progress was monitored by MALDI-TOF MS and was found to be complete 
after 2 h. The labeled peptide was purified using a C18 cartridge (50 mg, Waters) and 
lyophilized. The labeled peptides were then characterized by LC/MS analysis (see 
supporting information for characterization data). Peptides were dissolved in distilled 
water and diluted using Tris buffer (20 mM), pH 9.0. UV-Vis spectroscopy of 5-FAM, 







was calculated according to Beer’s Law using the respective fluorophore’s !max extinction 
coefficients. 
Luminescence Emission measurements. Emission spectra were collected on a Biotek 
Synergy4 plate reader in black 384-well plates (Greiner Fluotrac 200). Spectra were 
collected from 450-800 nm after excitation at 266 nm (using a monochromator) with a 
delay time of 50 !sec and collection time of 1 msec. Sensitivity was adjusted to 180. 
Luminescence lifetime measurements. Luminescence emission intensities were 
collected on a Biotek Synergy4 plate reader at 23°C in black 384-well plates (Greiner 
Fluortrac 200). Spectra were collected from for the donor peaks (495 nm for AF488 and 
5-FAM and 670 nm for Cy5) after excitation at 266 nm with a delay time starting at 100 
µsec, increasing in steps of 100 µsec to 5000 µsec, and a collection time of 1 ms. 
Samples were prepared with 1 µM pSAStide or SAStide with 10 µM Tb3+ in 100 mM 
NaCl, 10 mM HEPES pH 7.5 in 100 !L total volume. Emission intensities were 
normalized to the intensity obtained at 100 !sec delay and fitted to a single exponential 
decay curve using GraphPad Prism and lifetimes 
Determination of LRET parameters. LRET follows the same principles as FRET and 
can have the same theory applied to calculate the distance between the fluorophore 
acceptor and the terbium-peptide complex donor pair. The fundamental concept of 
Förster theory is that resonance energy transfer is proportional to 
!  
R = R0[(1/E)  1]
1/ 6     (1) 
 
Where E is the energy transferred, R0, is the Förster distance, and R is the distance 







from the lifetime measurements of the donor in the absence of the acceptor, !D, (peptide-
terbium complex (donor) without the conjugated fluorophore (acceptor)) and the donor in 
the presence of the acceptor, !DA. 







      (2) 
 
R0, the Förster distance is determined for each acceptor/donor pair as the distance 
between the acceptor and donor that results in 50% energy transfer by the following 










 is the orientation factor, QD is the quantum yield of the donor (which was 
determined in our previous studies for both peptide-Tb
3+
 complexes), # is the the 
refractive index, which is 1.4 for biological samples in water, and J represents the 
spectral overlap of the emission spectrum of the donor and the excitation spectrum of the 









   (4) 
where FD($) is the corrected fluorescence intensity of the donor, % is the extinction 
coefficient of the acceptor 
In vitro kinase assay. Purified Lyn was obtained from a commercial source (Millipore). 
His-tagged Syk was stably transfected into and purified from HEK293 cells. Cells were 
lysed and Syk was purified using Ni
2+
 magnetic beads (Promega). Syk protein 







enzyme (15 nM) or a combination of both was pre-incubated with the kinase reaction 
buffer (100 !M ATP, 10 mM MgCl2, leupeptide, aprotinin, and HEPES pH 7.5) for 10 
time, followed by initiating the kinase reaction by adding either SAStide-Cy5 (12.5 !M ), 
SFAStide-5-FAM (2.5 !M ) or both at 37 
o
C. Aliquots were removed at designated time 
points and quenched in 6 M Urea pH 7.5. The quenched samples were then treated with 
10 !M Tb
3+
 bring the sample to a volume of 100 !L. 
 
5.4 Results 
Time-resolved lanthanide-based energy transfer (TR-LRET) detection of Lyn and 
Syk kinase activities was achieved by employing the phosphopeptide-Tb
3+
 complexes as 
the energy donors and 5-carboxyfluorescein (5-FAM) and cyanine 5 (Cy5), respectively, 
as the energy acceptors (Figure 5.1A.) Phosphorylation of the peptide substrates results in 
several physical changes in the peptide that ultimately lead to detection of kinase activity, 
including enhancing the Tb
3+
 binding affinity, reducing the Tb
3+
 chelate hydration 
number, increasing the Tb
3+
 luminescence lifetime, and shifting the excitation 
wavelength of tyrosine. (20) Sensitization through tyrosine results in excitation of the 
pSFAStide-Tb
3+
 complex and triggers energy transfer to 5-FAM and results in emission 
from 5-FAM at its characteristic wavelength (~520nm) (Figure 5.1B). 5-FAM was 
selected as the energy acceptor to couple with the pSFAStide-Tb
3+
 complex because its 




F6 emission band of Tb
3+
 
centered at 495 nm. Similarly, detection of Syk kinase activity was achieved with 








F3 emission bands of Tb
3+ 








Figure 5-1 Multiplexed detection using time-resolved lanthanide-based resonance energy 
transfer (TR-LRET) and fluorophore conjugated peptide biosensors. (A) Emission 
spectrum of phosphopeptide-Tb
3+
 complex (black), excitation (dashed lines) and 
emission (solid lines) spectra of the two acceptor fluorophores 5-FAM (green) and Cy5 
(red). Schematic illustrating TR-LRET detection of Lyn (B) and Syk (C) tyrosine kinase 
activities. 
 
Phosphorylated and unphosphorylated forms of SAStide-Cy5 and SFAStide-5-
FAM were synthesized as controls. Excitation of each peptide biosensor in the presence 
of Tb
3+
 resulted in the four characteristic luminescent emission peaks from Tb
3+
 as well 
as the fluorescence emission peak from the conjugated fluorophore label (5-FAM at 520 
nm and Cy5 at 670 nm). (Figure 5.2A,B) Both sensors displayed increased Tb
3+
 
luminescence and fluorescence of their respective organic dyes for the phosphorylated 
peptides relative to the unphosphorylated peptides. Control experiments in the presence 
and absence of Tb
3+









- and LRET-dependent rather than arising from direct excitation of the fluorophores 
for both biosensors. Comparing the differences in Cy5 signals between the 
phosphorylated and unphosphorylated SAStide displayed a 25-fold increase in Cy5 signal 
for the phosphorylated peptide. (Figure 5.2A) Comparing luminescence emission spectra 
of SFAStide-5-FAM to pSFAStide-5-FAM, a 3.9-fold increase in the 5-FAM emission 
intensity was observed. (Figure 5.2B) These changes in the intensity of the fluorophores 
upon phosphorylation of their respective peptides provide sensor-specific spectral 
features that can be monitored to determine phosphorylation of the sensors and 
consequently kinase activity.  
In order to achieve multiplex detection in the same sample, the reaction and 
detection conditions must be optimized to have limited cross-interference between 
sensors. The cross-interference could be evaluated by detecting the presence of the 
fluorophore signal from an unphosphorylated sensor in the presence of the other 
phosphorylated biosensor. To accomplish this, the concentrations of the biosensors and 
Tb
3+
, as well as the delay time, were varied and and TR-LRET spectra collected. 
Quantification of fluorescence signal was accomplished by Gaussian fitting of the 
fluorophore emission peaks and integrating the resulting curves for each peak. The 
conditions were initially optimized using the phosphorylated SAStide sensor (pSAStide-
Cy5) with the unphosphorylated SFAStide-5-FAM peptide. Reducing the concentration 
of SFAStide, increasing the delay time, and varying the concentration of the Tb
3+ 
successfully mitigated any interference from the 5-FAM signal caused by intermolecular 
LRET. (Figure 5.2C) Using the same conditions, the cross-interference from SAStide-







displayed minimal signal from Cy5, while displaying significantly stronger 5-FAM 
signal. (Figure 5.2D) 
 
Figure 5-2 Time-Resolved Lanthanide-based Resonance Energy Transfer (TR-LRET) 
detection of phosphorylation-dependent signals and cross-interference. (A) Time-
resolved luminescence emission spectra for SAStide-Cy5 and pSAStide-Cy5 and (B) 
SFAStide-5-FAM and pSFAStide-5-FAM. Spectra were collected from 15 !M peptide in 
the presence of 100 !M Tb
3+
 in 10 mM HEPES, 100 mM NaCl, pH 7.5,  !ex = 266 nm, in 
50 !L total volume 1 ms collection time, 50 !s delay time, and sensitivity 180. Data 
represent the average of experiments performed in triplicate. (C) pSAStide cross-
interference with SFAStide signal and (D) pSFAStide cross-interference with SAStide 
signal. Spectra were colleted from 0.5 !M SFAStide-5-FAM and 2.5 !M SAStide-Cy5 in 
the presence of 10 !M Tb
3+
 in 10 mM HEPES, 100 mM NaCl, pH 7.5, Urea, ATP, BSA, 
MgCl2, !ex = 266 nm, in 100 !L total volume 1 ms collection time, 50 !s delay time, and 





The distance between the Tb3+ ion and the fluorophore is a critical parameter for 
energy transfer, and is directly proportional to the fluorescence signal displayed in the 
emission spectra. By obtaining the luminescence lifetimes of the biosensors in their 
fluorophore conjugated and unconjugated forms, the energy transfer and LRET 
parameters for each sensor were characterized. SAStide was also conjugated with 
AlexaFluor 488 (AF488) as a control for the measurements to demonstrate the agreement 
in LRET parameters between using different fluorophores. TR-LRET measurements 
demonstrated efficient energy transfer (in the range of 89-93%) from Tb3+ to the various 
fluorophores. The radius representing the distance between Tb3+ and the fluorophores, R, 
and the Förster radius, R0, were determined from these measurements as well. The R and 
R0 values ranged from 50-55 Å and 35-40 Å respectively. As indicated by the efficient 
energy transfer, these parameters are within the optimal range for TR-LRET 
measurements. (21) 
 
Figure 5-3 Luminescence lifetime measurement of phosphopeptide-Tb3+ complexes in 
the conjugate and unconjugated forms for (A) SAStide-Alexafluor488 (B) SAStide-Cy5 
(C) SFAStide-5-FAM.  
 
To demonstrate the utility of these biosensors for quantitative detection of Lyn 







the presence of the unphosphorylated form of the other biosensor and the kinase reaction 
buffer (to best mimic the conditions of a multiplexed kinase reaction). Quantification of 
phosphorylation was calibrated by integrating the signal centered at 520 nm for 5-FAM 
and 670 nm for Cy5. The high signal to noise ratio observed in the initial control 
experiments was maintained in the presence of the reaction buffer with 7.6:1 for Cy5 and 
5.8:1 for 5-FAM. Z’-factor and signal window (SW) values were shown to be appropriate 
for HTS, with Z-factor values of 0.72 and 0.78, and SW of 13.27 and 12.65, for SAStide-
Cy5 and SFAStide-5-FAM, respectively.  
 
Figure 5-4 TR-LRET quantitative calibration of biosensor phosphorylation. (A) 
pSAStide-Tb
3+
 emission spectra with increasing proportions of phosphorylated biosensor 
compared to unphosphorylated. (B) Cy5 emission spectral area calibration curve based on 
spectra from (A). (C) pSFAStide-Tb
3+
 emission spectra at increasing proportions of 
phosphorylated biosensor compared to unphosphorylated. (D) 5-FAM emission spectral 







Detection of Syk and Lyn activities in vitro was accomplished and quantified 
using the purified kinases with kinase reaction buffer and detection conditions described 
above. After pre-incubation of the kinases with the reaction buffer (for 10 min) the kinase 
reaction was initiated by the addition of the biosensor(s). Aliquots were removed from 
the reaction and quenched with urea, treated with Tb
3+
 and brought to a volume of 100 
!L. TR-LRET emission spectra for each respective biosensor displayed an increase in the 
conjugated dye’s fluorescence signal (with minimal bleed through or background 
interference from the other fluorophore) over the time course of the reaction in the 
presence of only one of the kinases (Figure 5.5 A,B,C,D). These results confirmed the 
specificity of each biosensor for its individual kinase. To demonstrate multiplex 
detection, both biosensors were applied with both kinases in a single reaction. A 
simultaneous increase in fluorescence of both fluorophores was seen over the time 
course, indicating an increase in phosphorylation of both peptides. The negative levels of 
phosphorylation observed from the nonsubstrate biosensor indicate that the cross 
interference signal was reduced compared to the calibration curve. This reduction in 
signal could be the result of photobleaching of the fluorophores over the time course of 








Figure 5-5 Simultaneous multiplexed in vitro detection of Syk and Lyn kinase activities. 
(A) In vitro Lyn assay luminescence emission spectra in the presence of both SFAStide-
5-FAM and SAStide-Cy5. (C) In vitro Syk assay luminescence emission spectra in the 
presence of both SFAStide-5-FAM and SAStide-Cy5. (E) In vitro Lyn and Syk assay 
luminescence emission spectra the presence of both SFAStide-5-FAM and SAStide-Cy5. 
(B, D, F) Quantification of SFAStide-5-FAM phosphorylation and SAStide-Cy5 









In summary, we have presented the development of a multiplexed platform for 
detection of kinase activity that leverages the overlap of the multiple distinct emission 
bands of Tb
3+
 with orthogonal fluorescently labeled peptide substrates that are capable of 
phosphorylation-enhanced Tb
3+
 luminescence. Previously, multiplexed kinase activity 
detection has been accomplished using the environmentally sensitive fluorophores 
oxazine and cascade yellow conjugated to Lyn and Abl specific substrates, where 
phosphorylation of the substrates results in enhanced fluorescence. LRET-based 
phosphospecific antibodies conjugated with lanthanide chelates (LanthaScreen) and 
fluorescently labeled peptide substrates have also been applied to simultaneously monitor 
two kinases in a single sample. However, in the case of environmentally sensitive 
fluorophores, they suffer from the disadvantages of the having a small dynamic range and 
background fluorescence, while LanthaScreen is limited by the requirement of 
phosphospecific antibodies to facilitate detection of phosphorylation. The approach 
presented here allows for direct measurements of kinase activity through the 
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